Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023351	s-dpteroe	— (—)	4429	4610	100.00%	Distribution not available
3023351	s-dpteroe	u/ml (u/ml)	4064	4395	2.23%
3023351	d.pteronys	— (—)	578	607	100.00%	Distribution not available
3023351	s-pölyryh	u/ml (—)	221	224	100.00%	Distribution not available
3023351	s-p�lyry	u/ml (—)	216	220	100.00%	Distribution not available
3023351	s-pölyt	u/ml (—)	175	175	100.00%	Distribution not available
3023351	s-pöly-s	u/ml (—)	142	163	100.00%	Distribution not available
3023351	s-pölyerittely	u/ml (—)	110	111	100.00%	Distribution not available
3023351	d.pteronys	u/ml (u/ml)	108	111	0.00%
3023351	s-pölyerittely,igevasta-aineet	u/ml (—)	89	90	100.00%	Distribution not available
3023351	pölyerittely,ige:vat(s-)	u/ml (—)	79	83	100.00%	Distribution not available
3023351	s-pölyryhmä	u/ml (—)	72	72	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Obesity related asthma

876

2133

4.27

323.31

1.2

1.1

1.38

1.76

u/ml

0.67

505

934

Dermatitis and eczema

2522

6677

2.39

312.20

1.1

2.46

1.97

u/ml

1.31

1457

3198

Asthma and allergy, excluding more controls

1067

1124

10.82

307.65

1.2

1.1

2.97

2.84

u/ml

0.09

746

489

1563

3795

4.29

307.65

1.2

1.1

1.98

2.23

u/ml

0.42

982

1834

Allergic asthma (mode), excluding more controls

1449

1791

8.72

307.65

1.2

1.1

2.59

2.62

u/ml

0.03

993

786

Asthma-related infections

1800

4518

4.06

307.65

1.2

1.1

2.28

2.19

u/ml

0.11

1136

2142

Asthma (only as main-diagnosis)

2725

2827

5.86

307.65

1.2

1.1

2.14

2.37

u/ml

0.34

1642

1192

Allergic rhinitis

2182

3366

7.23

307.65

1.2

1.1

2.58

2.20

u/ml

0.67

1381

1614

Chronic sinusitis

1064

2847

3.86

307.65

1.2

1.1

0.93

2.14

u/ml

5.51

586

1269

Asthma

2805

2827

5.44

307.65

1.2

1.1

2.24

2.37

u/ml

0.16

1669

1192

Conjunctivitis

2133

6827

2.69

307.65

1.1

2.39

2.25

u/ml

0.18

1216

3419

Chronic lower respiratory diseases

3734

5633

3.65

307.65

1.2

1.1

2.35

2.15

u/ml

0.39

2158

2620

Allergic conjunctivitis

1820

6044

3.05

307.65

1.1

2.37

2.26

u/ml

0.13

1042

2955

Atopic dermatitis

1967

5668

2.95

307.65

1.2

1.1

3.23

2.13

u/ml

3.09

1183

2734

Atopic dermatitis, strict definition with reimbursement

1258

3742

3.43

307.65

1.2

1.1

3.56

2.34

u/ml

2.43

853

1843

Asthma and allergy

1065

1106

10.97

307.65

1.2

1.1

2.98

2.79

u/ml

0.12

744

478

Asthma (diagnoses ohter than nonallergic)

3025

6277

4.18

307.65

1.2

1.1

2.25

u/ml

0.01

1873

2930

Asthma, hospital admissions , main diagnosis only

2917

6429

4.19

307.65

1.2

1.1

2.13

2.29

u/ml

0.28

1800

3016

Disorders of conjunctiva

2181

7016

2.56

307.65

1.1

2.37

2.24

u/ml

0.18

1243

3503

Allergic asthma (mode)

1449

1792

8.72

307.65

1.2

1.1

2.59

2.62

u/ml

0.03

993

788

Asthma (mode)

2815

2834

5.57

307.65

1.2

1.1

2.31

2.36

u/ml

0.06

1675

1195

Asthma, unspecified (mode), excluding more controls

1314

2457

4.13

307.65

1.2

1.1

1.93

2.42

u/ml

0.74

716

1031

Asthma, unspecified (mode)

1319

2483

4.12

307.65

1.2

1.1

1.92

2.39

u/ml

0.70

719

1047

Desensitization to allergens

519

752

8.53

307.65

1.2

1.1

2.81

3.00

u/ml

0.09

344

396

Asthma, hospital admission 2, infections

1800

4518

4.06

307.65

1.2

1.1

2.28

2.19

u/ml

0.11

1136

2142

Asthma (only as main-diagnosis), excluding more controls

2709

2791

5.84

307.65

1.2

1.1

2.14

2.40

u/ml

0.38

1634

1173

Pollen allergy

1716

2386

8.44

307.65

1.2

1.1

2.47

2.57

u/ml

0.10

1111

1171

Chronic rhinitis, nasopharyngitis and pharyngitis

937

2174

4.51

307.65

1.2

1.1

1.23

2.07

u/ml

2.30

533

994

Asthma/COPD (KELA code 203)

2987

5603

3.79

307.65

1.2

1.1

2.33

2.15

u/ml

0.30

1729

2605

Asthma, excluding more controls

2771

2791

5.42

307.65

1.2

1.1

2.25

2.40

u/ml

0.20

1650

1173

Asthma, including avohilmo

4045

5280

4.48

307.65

1.2

1.1

2.29

2.17

u/ml

0.21

2283

2479

Vasomotor and allergic rhinitis

2279

3330

7.40

307.65

1.2

1.1

2.53

2.39

u/ml

0.19

1419

1567

Other diseases of upper respiratory tract

2423

4482

2.88

307.65

1.2

1.1

2.12

2.32

u/ml

0.34

1382

2072

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1760

5697

3.12

307.65

1.1

2.29

2.23

u/ml

0.06

1003

2768

Suggestive for eosinophilic asthma

354

370

10.43

307.22

1.3

1.1

0.80

2.06

u/ml

1.81

248

166

Nasal polyp

518

838

6.50

306.97

1.2

1.1

1.06

2.39

u/ml

1.97

327

373

Other pulmonary diagnosis

1622

2871

2.89

271.28

1.1

2.12

2.36

u/ml

0.33

893

1215

ILD differential diagnosis

1596

2834

2.88

265.42

1.1

2.07

2.36

u/ml

0.42

881

1195

COPD differential diagnosis

1596

2835

2.87

265.28

1.1

2.10

2.36

u/ml

0.36

882

1195

Excluding asthma or asthma-COPD overlap

1597

2871

2.84

259.98

1.1

2.07

2.36

u/ml

0.41

880

1215

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1059

3310

3.19

253.80

1.1

1.70

2.08

u/ml

0.59

543

1466

Atopic dermatitis, strict definition

1197

4145

2.98

247.29

1.2

1.1

3.62

2.28

u/ml

2.77

825

2105

Cough

990

3031

3.18

234.14

1.2

1.1

1.42

2.61

u/ml

3.58

553

1509

Childhood asthma (age<16)

633

1198

4.43

222.96

1.2

1.1

3.64

3.34

u/ml

0.16

418

553

Childhood asthma (age<16), excluding more controls

633

1200

4.42

222.33

1.2

1.1

3.64

3.33

u/ml

0.16

418

554

Oral corticosteroids

2173

6130

2.14

206.34

1.2

1.1

1.87

2.12

u/ml

0.51

1213

2961

Diseases of the respiratory system

1195

2122

2.87

198.89

1.1

2.13

2.35

u/ml

0.25

643

899

Biological medicines for asthma

180

136

17.21

198.29

1.3

1.1

3.16

2.78

u/ml

0.09

126

Asthma, hospital admissions 3, pneumonia

693

2004

3.54

198.29

1.2

1.1

2.96

1.78

u/ml

1.33

444

928

Asthma-related pneumonia or sepsis

693

2004

3.54

198.29

1.2

1.1

2.96

1.78

u/ml

1.33

444

928

Asthma-related pneumonia

691

1996

3.55

198.07

1.2

1.1

2.97

1.74

u/ml

1.40

443

923

ILD medications: prednisolone, methylprednisolone, prednisone

2271

6265

2.06

193.15

1.2

1.1

1.83

2.15

u/ml

0.72

1249

3086

Undetermined asthma

348

608

5.99

190.60

1.2

1.0

1.03

2.31

u/ml

1.77

191

241

Undetermined asthma, excluding more controls

348

610

5.97

189.94

1.2

1.1

1.03

2.31

u/ml

1.78

191

240

Abnormalities of breathing

1958

5569

2.08

171.74

1.2

1.1

1.87

2.62

u/ml

1.88

1053

2739

Childhood allergy (age < 16)

796

2311

3.04

160.94

1.2

1.1

3.45

2.95

u/ml

0.42

561

1219

ILD medications

2302

6598

1.92

159.84

1.2

1.1

1.96

2.27

u/ml

0.66

1259

3296

Inflammatory bowel disease treatment related agents

2275

6805

1.90

153.82

1.2

1.1

1.85

2.23

u/ml

0.90

1245

3377

Deviated nasal septum

549

1661

3.38

146.59

1.1

1.70

2.05

u/ml

0.37

278

716

Symptoms and signs involving the circulatory and respiratory systems

2123

5603

1.93

146.04

1.1

1.79

2.61

u/ml

3.01

1151

2755

First line medication for Crohn's disease

2193

6523

1.84

134.55

1.2

1.1

1.77

2.32

u/ml

1.58

1195

3259

Chronic diseases of tonsils and adenoids

1429

4346

2.11

133.93

1.1

2.29

2.37

u/ml

0.08

758

2008

FESS (DNB20)

373

941

4.18

132.38

1.2

1.1

0.64

2.41

u/ml

5.15

223

454

Ethmoidectomy

376

971

4.08

129.13

1.2

1.1

0.64

2.41

u/ml

5.29

225

465

Adverse effects, not elsewhere classified

597

2139

2.91

120.75

1.2

1.1

2.87

2.13

u/ml

0.87

412

1094

Dermatitis due to ingested food

281

633

4.95

112.15

1.3

1.1

3.56

3.74

u/ml

0.06

226

365

Non-allergic asthma (mode)

346

940

3.74

107.62

1.1

1.32

2.59

u/ml

1.53

184

395

Non-allergic asthma (mode), excluding more controls

346

953

3.69

105.47

1.1

1.32

2.56

u/ml

1.48

184

400

Urticaria

765

3379

2.33

99.15

1.2

1.1

2.07

2.45

u/ml

0.51

482

1724

Personal history of allergy to analgesic agent

25.20

97.28

1.5

1.2

0.45

3.26

u/ml

1.31

Urticaria and erythema

843

3947

2.19

94.39

1.2

1.1

2.02

2.28

u/ml

0.35

529

2009

Acute upper respiratory infections

1791

6418

1.74

94.19

1.2

1.1

2.15

2.31

u/ml

0.23

946

3207

Dyspnoea

1479

6085

1.82

93.82

1.2

1.1

1.81

2.09

u/ml

0.40

801

3020

Other and unspecified effects of external causes

712

3215

2.28

87.67

1.2

1.1

2.61

2.28

u/ml

0.35

476

1649

Diseases of the skin and subcutaneous tissue

1758

5155

1.73

86.63

1.1

2.47

1.95

u/ml

1.04

1010

2398

Polypectomy (DHB20)

169

331

5.38

82.31

1.3

1.1

0.75

2.67

u/ml

2.14

117

162

Personal history of allergy to drugs, medicaments and biological substances

12.39

82.13

1.4

1.1

0.45

4.33

u/ml

2.03

Acute upper respiratory infections of multiple and unspecified sites

1415

6060

1.75

79.43

1.2

1.1

2.44

2.38

u/ml

0.07

763

3031

Any reimbursement code in KELA

1425

4076

1.78

76.87

1.1

2.55

2.08

u/ml

0.73

776

1987

Insomnia

1607

7075

1.67

76.30

1.1

1.76

2.24

u/ml

1.40

771

3543

Acute sinusitis

1030

5212

1.86

72.80

1.2

1.1

1.28

2.25

u/ml

3.30

522

2589

Sleep disorders

1602

7106

1.65

71.44

1.1

1.85

2.26

u/ml

1.01

778

3578

Diseases of the eye and adnexa

1695

5186

1.66

71.36

1.1

2.15

2.33

u/ml

0.26

947

2576

Bronchitis

1820

7219

1.60

71.05

1.2

1.1

2.21

2.23

u/ml

0.03

981

3580

1830

5924

1.61

69.86

1.2

1.1

1.97

2.23

u/ml

0.46

956

2895

Dermatitis

909

4849

1.89

69.19

1.1

2.61

1.79

u/ml

0.86

518

2280

Sleep apnoea, including avohilmo

1499

5621

1.67

68.28

1.1

1.11

2.01

u/ml

5.23

742

2752

Other medical care

633

2698

2.14

66.97

1.2

1.1

3.12

2.00

u/ml

1.07

395

1334

Allergic contact dermatitis

321

1145

2.90

65.51

1.1

2.27

1.75

u/ml

0.28

176

529

D07AA Corticosteroids, weak (group I)

458

1968

2.41

63.73

1.2

1.1

3.43

2.76

u/ml

0.56

322

1060

Sleep disorders (combined)

1864

6340

1.56

61.99

1.1

1.62

2.47

u/ml

3.83

946

3226

Behavioural syndromes associated with physiological disturbances and physical factors

1616

7358

1.57

59.64

1.1

1.89

2.29

u/ml

1.01

811

3765

Other and unspecified dermatitis

758

4021

1.91

59.57

1.1

2.73

1.84

u/ml

0.79

433

1915

Asthma mixed form (mode), excluding more controls

114

219

5.41

56.61

1.2

1.1

2.51

2.95

u/ml

0.14

Asthma mixed form (mode)

114

220

5.38

56.33

1.2

1.1

2.51

2.91

u/ml

0.13

Pain in joint

1042

3857

1.74

56.08

1.1

1.79

2.33

u/ml

0.96

550

1978

Dentofacial anomalies [including malocclusion]

1335

6899

1.57

50.16

1.2

1.1

2.39

2.22

u/ml

0.22

719

3460

Other and unspecified urticaria

445

2090

2.19

49.95

1.2

1.1

1.91

2.45

u/ml

0.60

271

1058

Other acute lower respiratory infections

872

4849

1.73

49.64

1.2

1.1

2.32

2.30

u/ml

0.01

521

2536

Sleep apnoea

1291

5308

1.59

49.11

1.1

1.06

2.03

u/ml

5.79

654

2562

Medical observation and evaluation for suspected diseases and conditions

1114

3451

1.67

48.81

1.1

1.51

2.38

u/ml

2.53

652

1618

Early onset COPD, excluding more controls

198

636

3.15

48.20

1.1

1.71

1.73

u/ml

0.01

115

247

Migraine

1061

5303

1.64

48.02

1.1

2.16

2.68

u/ml

0.81

558

2676

Headache

1220

6204

1.59

47.91

1.2

1.1

1.98

2.33

u/ml

0.58

624

3118

Diarrhoea and gastroenteritis of presumed infectious origin

1651

7357

1.49

47.39

1.2

1.1

1.69

2.34

u/ml

2.21

849

3773

Voice disturbances

408

1893

2.19

46.94

1.2

1.1

0.92

2.22

u/ml

3.55

214

897

Chronic laryngitis and laryngotracheitis

188

599

3.20

46.66

1.1

1.09

2.37

u/ml

1.48

262

Gastro-oesophageal reflux disease

961

5031

1.66

46.43

1.1

1.63

1.96

u/ml

0.48

476

2499

Recurrent or chronic depression

743

2987

1.77

43.29

1.1

2.04

2.50

u/ml

0.51

379

1495

Examination and observation for other reasons

971

3435

1.65

42.35

1.1

1.81

2.39

u/ml

1.03

541

1610

Asthma and opportunity respiratory infection

113

6.41

41.75

1.1

0.65

1.02

u/ml

0.35

Idiopathic urticaria

183

5.32

41.71

1.2

2.57

4.56

u/ml

0.64

Other special examinations and investigations of persons without complaint or reported diagnosis

1087

3451

1.61

41.56

1.1

2.15

2.38

u/ml

0.27

587

1618

Dermatographic urticaria

183

623

3.07

41.16

1.2

1.1

1.98

2.83

u/ml

0.51

119

314

Bronchiectasis

167

5.20

41.07

1.1

0.59

0.92

u/ml

0.40

Migraine, single triptan purchase ok & required. ICD-code if available is included

1415

6484

1.49

40.93

1.1

2.32

2.29

u/ml

0.02

674

3318

Triptan medication for migraine, single purchase ok

1415

6484

1.49

40.93

1.1

2.32

2.29

u/ml

0.02

674

3318

Depression or dysthymia

1009

3462

1.62

40.75

1.1

1.99

2.41

u/ml

0.56

514

1765

COPD/asthma related infections

1634

5633

1.46

40.56

1.1

2.01

2.23

u/ml

0.37

843

2757

COPD/asthma/ILD related infections

1634

5633

1.46

40.56

1.1

2.01

2.23

u/ml

0.37

843

2757

Symptoms and signs involving speech and voice

449

2290

1.99

40.00

1.2

1.1

0.99

2.06

u/ml

2.96

234

1112

Neurotic, stress-related and somatoform disorders

1508

7376

1.44

36.97

1.1

2.10

2.25

u/ml

0.22

835

3650

COPD

291

1040

2.30

36.95

1.1

1.76

1.44

u/ml

0.22

162

453

Episodal and paroxysmal disorders

1821

6635

1.41

36.69

1.1

1.65

2.57

u/ml

3.69

959

3412

Any death

110

2538

0.31

36.52

1.1

0.67

1.50

u/ml

2.73

1282

Anxiety disorders

1511

7381

1.44

36.48

1.1

2.10

2.25

u/ml

0.20

837

3651

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

724

2127

1.73

36.00

1.1

2.09

2.89

u/ml

1.21

376

1072

Pain (limb, back, neck, head abdominally)

1207

4017

1.52

35.84

1.1

2.23

2.40

u/ml

0.20

645

2102

Pain in throat and chest

1258

5127

1.48

34.98

1.1

1.48

2.52

u/ml

4.26

672

2480

Other chronic obstructive pulmonary disease

271

980

2.29

34.22

1.1

1.72

1.20

u/ml

0.40

155

423

Abnormalities of heart beat

480

2599

1.83

33.40

1.1

1.65

2.28

u/ml

0.89

239

1264

Acute bronchitis

572

3268

1.73

33.09

1.2

1.1

2.30

2.09

u/ml

0.17

314

1682

Intestinal infectious diseases

1742

7231

1.38

32.95

1.1

1.62

2.36

u/ml

2.73

890

3699

Irritable bowel syndrome

470

2603

1.83

32.70

1.1

1.03

2.05

u/ml

3.62

234

1293

Dorsalgia

1591

6167

1.39

30.57

1.1

2.18

2.19

u/ml

0.01

826

3092

Special screening examination for infectious and parasitic diseases

570

2474

1.72

30.47

1.1

1.53

2.52

u/ml

1.66

303

1112

All anxiety disorders

1178

6543

1.44

28.88

1.1

2.21

2.42

u/ml

0.26

656

3267

Low back pain

1156

5794

1.44

28.83

1.1

2.55

2.14

u/ml

0.47

580

2874

Anxiety disorders, excluding more controls

1337

6217

1.41

28.76

1.1

2.08

2.26

u/ml

0.23

743

3056

Malignant neoplasm

570

5482

0.61

28.56

1.1

1.92

1.96

u/ml

0.03

275

2704

Temporomandibular joint disorders, including avohilmo

853

5607

1.52

28.48

1.2

1.1

2.53

2.23

u/ml

0.33

473

2770

Other dorsopathies, not elsewhere classified

1621

6235

1.37

28.23

1.1

2.12

2.27

u/ml

0.21

844

3143

Eosinophilic disease (BM)

8.85

28.15

1.4

1.0

0.74

3.08

u/ml

0.91

Tonsillectomy and adenotomy

1250

6195

1.42

28.06

1.1

2.56

2.38

u/ml

0.21

665

3233

Any event in cancer register

712

6431

0.65

27.44

1.1

2.08

1.98

u/ml

0.09

352

3184

Other headache syndromes

647

4103

1.59

26.99

1.1

1.51

2.40

u/ml

1.94

340

1986

Solid cancers, helper endpoint

552

5266

0.61

26.97

1.1

1.99

1.86

u/ml

0.10

261

2582

Anxiety (asthma-related co-morbidities)

1142

6253

1.43

26.88

1.1

2.26

2.47

u/ml

0.25

639

3102

Caries of enamel

1422

7519

1.37

26.79

1.1

2.31

2.13

u/ml

0.23

778

3768

Atopic conjunctivitis

120

414

3.03

26.56

1.2

1.1

4.20

3.13

u/ml

0.28

229

Persons encountering health services for examination and investigation

1009

3451

1.48

26.55

1.1

2.29

2.38

u/ml

0.09

538

1618

Soft tissue disorders

1704

6559

1.35

26.54

1.1

1.88

2.44

u/ml

1.31

890

3411

Malignant neoplasm, wide definition for exclusion

637

5815

0.64

26.35

1.1

1.88

1.97

u/ml

0.09

307

2878

Exposure to unspecified factor

1518

8124

1.35

25.99

1.1

1.94

2.28

u/ml

0.56

854

4107

Provisional assignment of new diseases of uncertain etiology

789

5277

1.51

25.71

1.1

1.81

2.08

u/ml

0.35

395

2726

Codes for special purposes

789

5287

1.50

25.48

1.1

1.81

2.11

u/ml

0.39

395

2729

Other soft tissue disorders, not elsewhere classified

1473

6390

1.36

25.18

1.1

1.80

2.45

u/ml

1.58

787

3306

Neurological diseases

1525

5682

1.36

25.01

1.1

2.00

2.65

u/ml

1.56

822

2929

Triptan medication for migraine, min. 3 purchases

1093

5937

1.42

24.99

1.1

1.95

2.32

u/ml

0.58

523

2956

Other specific joint derangements/joint disorders

1297

6111

1.38

24.89

1.1

1.69

2.48

u/ml

2.41

666

3141

Conjunctivitis (acute, non atopic)

460

2752

1.69

24.20

1.1

2.13

2.38

u/ml

0.25

265

1432

Parasetamol

1323

4888

1.38

24.19

1.1

2.29

2.54

u/ml

0.32

688

2488

Mycoses

1254

8007

1.37

24.06

1.1

1.79

2.24

u/ml

1.03

644

4042

Acetic acid derivatives and related substances

383

1095

1.83

23.82

1.1

2.53

2.86

u/ml

0.19

188

611

Myalgia

380

2176

1.77

23.80

1.1

1.31

2.20

u/ml

1.46

214

1072

Depression

1468

7455

1.34

23.73

1.1

1.94

2.29

u/ml

0.59

794

3697

Other disorders of lacrimal gland

435

2619

1.68

22.62

1.2

1.1

1.93

1.94

u/ml

0.01

235

1240

Functional dyspepsia

354

2022

1.77

22.35

1.1

1.32

2.05

u/ml

1.27

172

977

Dorsopathies

1650

6409

1.32

22.12

1.1

2.27

2.32

u/ml

0.06

853

3273

Other antidepressants

1452

5583

1.34

22.09

1.1

1.82

2.28

u/ml

0.90

751

2789

Covid-19 suspected case

435

2642

1.67

22.08

1.1

1.85

2.29

u/ml

0.42

203

1331

Abnormal findings on diagnostic imaging of lung

385

2164

1.72

21.84

1.1

1.70

1.58

u/ml

0.10

196

1048

Diseases of the musculoskeletal system and connective tissue

1101

3977

1.40

21.77

1.1

2.04

2.63

u/ml

1.05

584

2104

Diseases of oesophagus, stomach and duodenum

1482

6725

1.32

21.55

1.1

1.72

2.07

u/ml

0.65

768

3369

Lower back pain or/and sciatica

1482

7367

1.32

21.40

1.1

2.28

2.04

u/ml

0.31

752

3655

Mood [affective] disorders

1513

7500

1.31

21.10

1.1

1.88

2.27

u/ml

0.74

812

3729

Other anxiety disorders

894

5524

1.42

20.75

1.1

2.41

2.51

u/ml

0.09

509

2758

Soft tissue disorders related to use, overuse and pressure

307

1721

1.80

20.67

1.1

1.54

2.04

u/ml

0.43

151

810

Mood disorders

1511

7502

1.31

20.59

1.1

1.88

2.27

u/ml

0.73

811

3730

Neurological diseases, wide definition

712

2406

1.50

20.36

1.1

2.34

2.88

u/ml

0.59

394

1322

Coxibs

379

1152

1.75

20.35

1.1

2.04

3.08

u/ml

1.26

190

650

Disorders of lacrimal system

511

3276

1.57

20.32

1.2

1.1

1.88

2.19

u/ml

0.32

267

1573

Selective serotonin reuptake inhibitors

1440

5718

1.32

20.12

1.1

2.05

2.33

u/ml

0.42

730

2886

Abdominal and pelvic pain

1499

5757

1.31

20.04

1.1

2.30

2.37

u/ml

0.08

764

3008

Gastrointestinal diseases

1166

4315

1.36

19.81

1.1

2.45

2.43

u/ml

0.02

621

2270

Bronchitis, not specified as acute or chronic

103

382

2.74

19.76

1.2

1.1

1.72

2.29

u/ml

0.28

164

Certain infectious and parasitic diseases

1145

4224

1.37

19.73

1.1

1.99

2.44

u/ml

0.73

588

2129

Other joint disorders

1542

6284

1.30

19.33

1.1

1.88

2.50

u/ml

1.53

799

3246

Opioids

1526

6115

1.30

19.26

1.1

1.67

2.20

u/ml

1.51

791

3015

COPD (mode)

169

610

2.19

19.21

1.1

2.26

1.23

u/ml

0.55

253

Diseases of middle ear and mastoid

1025

6185

1.37

19.18

1.2

1.1

2.26

2.40

u/ml

0.15

558

3215

Speech therapy

292

1663

1.77

18.71

1.2

1.1

1.19

2.10

u/ml

0.98

126

830

Codeine

1411

5888

1.31

18.60

1.1

1.67

2.09

u/ml

0.92

720

2890

Codeine or tramadol medication

1579

6749

1.29

18.28

1.1

1.61

2.07

u/ml

1.16

804

3303

Migraine with aura

476

3096

1.56

18.18

1.1

1.74

2.42

u/ml

1.09

254

1556

Pain and other conditions associated with female genital organs and menstrual cycle

423

2464

1.60

17.95

1.1

2.63

u/ml

0.00

204

1239

Symptoms and signs involving the digestive system and abdomen

1482

5757

1.30

17.93

1.1

2.26

2.37

u/ml

0.13

764

3008

Allergic contact dermatitis due to drugs in contact with skin

120

4.18

17.59

1.1

1.73

2.76

u/ml

0.35

Simple and mucopurulent chronic bronchitis

115

4.17

17.55

1.1

0.94

0.86

u/ml

0.05

Cystitis

1199

5418

1.32

17.39

1.1

2.27

2.13

u/ml

0.16

605

2732

Candidiasis

419

2683

1.58

17.14

1.1

1.57

2.22

u/ml

1.07

204

1352

Viral infections characterized by skin and mucous membrane lesions

1237

8182

1.30

16.65

1.1

1.96

2.26

u/ml

0.49

647

4189

Eosinophilia

5.04

16.58

1.4

1.1

0.74

2.61

u/ml

1.30

Lichen simplex chronicus and prurigo

314

2.77

16.57

1.1

3.57

1.83

u/ml

0.39

160

Propionic acid derivatives

447

1429

1.59

16.56

1.1

3.04

3.32

u/ml

0.17

241

854

Exposure to other specified factors

1128

7932

1.31

16.56

1.1

2.14

2.24

u/ml

0.13

640

4022

Oxicams

241

746

1.85

16.04

1.1

0.96

2.45

u/ml

2.22

100

404

Exfoliative dermatitis

7.23

15.87

1.1

9.19

1.87

u/ml

0.98

Dysphagia

237

1336

1.79

15.79

1.1

1.24

1.73

u/ml

0.64

130

661

Renal tubulo-interstitial diseases

650

6754

0.71

15.66

1.1

1.91

2.16

u/ml

0.23

346

3407

Depression medications

727

2609

1.41

15.47

1.1

2.91

2.77

u/ml

0.10

375

1354

Haemorrhage from respiratory passages

285

1531

1.69

15.31

1.2

1.1

2.22

2.47

u/ml

0.12

159

741

Mood disorders, excluding more controls

1326

6212

1.28

15.18

1.1

1.89

2.26

u/ml

0.61

708

3035

Pain in thoracic spine

219

1224

1.81

15.14

1.2

1.1

1.71

2.17

u/ml

0.40

116

578

Non-allergic asthma

107

461

2.36

15.10

1.1

1.32

1.57

u/ml

0.11

226

General symptoms and signs

1633

6566

1.25

14.99

1.1

1.89

2.34

u/ml

1.00

864

3319

Early onset COPD

198

1076

1.86

14.93

1.1

1.71

1.67

u/ml

0.02

115

533

Later onset COPD, excluding more controls

188

2.93

14.81

1.1

1.78

0.55

u/ml

0.60

Migraine with aura and triptan purchases

328

2063

1.62

14.72

1.1

1.90

2.09

u/ml

0.17

174

1069

Diabetes, insulin treatment (Kela reimbursement)

783

6370

0.74

14.72

1.1

1.48

1.96

u/ml

0.97

383

3207

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

614

3902

1.41

14.69

1.1

1.60

1.87

u/ml

0.31

316

1922

Migraine without aura

425

2842

1.52

14.45

1.1

2.21

2.55

u/ml

0.27

226

1448

Acute bronchiolitis

216

1106

1.82

14.31

1.3

1.2

2.80

3.37

u/ml

0.32

162

693

Persons encountering health services for specific procedures and health care

1587

7685

1.24

14.24

1.2

1.1

1.99

2.24

u/ml

0.36

907

3865

Anti-inflammatory and antirheumatic products, non-steroids

435

1433

1.54

14.23

1.1

3.21

3.31

u/ml

0.05

234

857

Acute pharyngitis

318

1988

1.61

14.12

1.2

1.1

1.93

3.07

u/ml

1.23

177

1084

Allergic urticaria

162

846

1.96

14.05

1.2

1.1

2.29

2.74

u/ml

0.25

102

463

Symptoms and signs involving the skin and subcutaneous tissue

897

6684

1.32

13.96

1.1

1.73

2.04

u/ml

0.58

479

3329

Emphysema

112

3.79

13.95

1.2

1.1

4.17

1.55

u/ml

0.52

Other diseases of hard tissues of teeth

695

2598

1.39

13.76

1.1

2.17

2.05

u/ml

0.11

363

1223

Vocal cord dysfunction

216

1107

1.77

13.68

1.2

1.1

1.57

2.09

u/ml

0.29

121

536

Pruritus

146

741

2.00

13.66

1.2

1.1

0.97

2.09

u/ml

1.59

349

Other enthesopathies

355

2311

1.55

13.58

1.2

1.1

1.75

1.98

u/ml

0.16

171

1085

Injuries to the wrist and hand

1437

8018

1.25

13.57

1.1

1.64

2.31

u/ml

2.43

752

4088

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

765

6146

0.75

13.48

1.1

1.50

1.99

u/ml

0.96

376

3109

Allergic colitis

108

501

2.30

13.39

1.3

1.2

5.41

3.47

u/ml

0.56

331

Other chronic obstructive pulmonary disease, including avohilmo

369

1994

1.54

13.35

1.1

2.14

1.48

u/ml

0.53

214

981

All kidney diseases

892

7928

0.77

13.28

1.1

1.70

2.15

u/ml

0.71

474

4016

Paracetamol or NSAID medication

317

991

1.63

13.15

1.1

3.43

3.71

u/ml

0.12

173

614

Arthropathies

1549

6365

1.24

13.07

1.1

2.04

2.48

u/ml

0.83

804

3311

Pain in limb

1147

6046

1.27

13.06

1.1

1.89

2.38

u/ml

0.80

597

3107

Diseases of the ear and mastoid process

1728

7117

1.22

13.00

1.1

2.13

2.22

u/ml

0.13

909

3590

Suppurative and unspecified otitis media

725

4797

1.35

12.97

1.2

1.1

2.50

2.43

u/ml

0.06

394

2576

Schizophrenia or delusion

195

3335

0.58

12.91

1.1

1.58

2.07

u/ml

0.27

111

1683

Schizophrenia, schizotypal and delusional disorders

196

3343

0.58

12.85

1.1

1.58

2.07

u/ml

0.27

111

1686

Other nutritional deficiencies

948

6930

1.30

12.78

1.1

1.52

2.16

u/ml

1.93

527

3423

Chronic conjunctivitis

214

2.90

12.69

1.2

1.1

2.55

3.44

u/ml

0.15

121

Schizophrenia

1591

0.40

12.68

1.1

3.40

2.04

u/ml

0.23

815

Fenamates

180

665

1.85

12.67

1.1

1.68

2.74

u/ml

0.79

355

ILD, hospital admissions 1, main diag only

439

2.25

12.67

1.1

1.40

2.20

u/ml

0.44

231

Other and unspecified vaccines and biological substances

5.20

12.46

1.2

1.05

1.52

u/ml

0.21

Mouth breathing

489

3450

1.43

12.43

1.1

1.34

2.26

u/ml

2.18

254

1820

Somatoform disorder

242

1474

1.66

12.39

1.2

1.1

1.00

2.00

u/ml

1.86

123

701

Accidents

1242

4953

1.26

12.36

1.1

1.98

2.31

u/ml

0.52

665

2414

Heartburn

149

793

1.91

12.17

1.1

1.51

1.85

u/ml

0.20

405

Diaphragmatic hernia

293

1873

1.57

12.17

1.1

1.11

1.59

u/ml

0.91

167

884

Other bacterial diseases

728

6461

0.75

12.16

1.1

2.69

1.92

u/ml

0.96

422

3262

Trochanteric bursitis

146

772

1.91

12.12

1.1

0.98

2.15

u/ml

1.40

370

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1560

6946

1.23

12.11

1.1

1.64

2.32

u/ml

2.27

865

3486

Migraine without aura and triptan purchases

335

2217

1.53

12.09

1.1

2.33

2.25

u/ml

0.04

170

1159

Malignant neoplasm of breast, HER2-negative

223

2384

0.61

11.95

1.1

1.66

1.69

u/ml

0.01

102

1089

Follow-up examination after treatment for conditions other than malignant neoplasms

587

2822

1.38

11.92

1.1

1.26

2.32

u/ml

2.02

293

1304

Malignant neoplasm of breast, including Hilmo

243

2518

0.62

11.90

1.1

1.58

1.68

u/ml

0.07

109

1150

Malignant neoplasm of breast, HER2-negative, including Hilmo

243

2518

0.62

11.90

1.1

1.58

1.68

u/ml

0.07

109

1150

Diabetes medication

958

7232

0.78

11.89

1.1

1.48

2.09

u/ml

1.74

484

3639

Other general symptoms and signs

125

629

2.02

11.87

1.2

0.96

3.08

u/ml

2.81

371

Disorders of skin appendages

723

5478

1.33

11.77

1.1

2.29

2.32

u/ml

0.03

391

2793

Other menopausal disorders

323

1176

1.56

11.67

1.1

0.91

1.83

u/ml

1.86

149

538

Other external causes of accidental injury

1234

4953

1.25

11.65

1.1

1.99

2.31

u/ml

0.49

667

2414

Other diseases of urinary system

1347

6139

1.24

11.64

1.1

2.04

2.21

u/ml

0.25

677

3110

Malignant neoplasm of breast

232

2430

0.62

11.55

1.1

1.63

1.69

u/ml

0.03

104

1108

COPD, hospital admissions

270

1443

1.59

11.47

1.1

1.72

1.43

u/ml

0.20

155

712

Diabetes mellitus

976

7212

0.79

11.42

1.1

1.70

2.11

u/ml

0.81

488

3641

Diabetes, varying definitions

967

7173

0.79

11.40

1.1

1.70

2.11

u/ml

0.80

484

3624

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

109

367

2.12

11.40

1.1

1.31

2.19

u/ml

0.46

179

Herpesviral [herpes simplex] infections

387

2669

1.46

11.34

1.1

2.66

2.07

u/ml

0.43

217

1316

Persons encountering health services in other circumstances, wide

1630

6948

1.21

11.31

1.1

1.98

2.32

u/ml

0.68

889

3487

Chronic gastritis

189

1103

1.72

11.30

1.1

0.47

1.78

u/ml

4.73

110

528

Other and unspecified tonsillitis

647

4079

1.34

11.23

1.1

1.95

2.68

u/ml

1.15

337

2131

Intestinal infectious diseases

1315

8144

1.23

11.22

1.2

1.1

1.97

2.27

u/ml

0.54

707

4157

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

131

689

1.93

11.17

1.2

1.1

2.20

2.26

u/ml

0.03

348

COPD, early/later onset

271

1456

1.57

11.12

1.1

1.72

1.44

u/ml

0.19

155

719

Other respiratory diseases principally affecting the interstitium

121

623

1.96

10.89

1.2

1.1

1.25

2.03

u/ml

0.55

336

Inflammatory diseases of female pelvic organs

913

5283

1.28

10.80

1.2

1.1

1.94

2.14

u/ml

0.23

468

2553

ILD, hospital admissions

104

509

2.06

10.80

1.1

1.35

2.05

u/ml

0.40

268

Other interstitial pulmonary diseases

104

509

2.06

10.80

1.1

1.35

2.05

u/ml

0.40

268

Interstitial lung disease endpoints

104

511

2.05

10.69

1.1

1.35

2.04

u/ml

0.40

269

Interstitial lung disease

104

511

2.05

10.69

1.1

1.35

2.04

u/ml

0.40

269

Nummular dermatitis

375

2.24

10.63

1.1

1.17

2.23

u/ml

0.89

183

Benign neoplasm: Colon

372

2456

1.45

10.57

1.1

1.86

1.44

u/ml

0.27

183

1182

Enthesopathies of lower limb, excluding foot

273

1779

1.55

10.55

1.1

1.37

2.11

u/ml

1.13

136

829

Other bacterial diseases

914

7307

0.79

10.55

1.1

2.78

1.95

u/ml

1.18

516

3691

Dermatophytosis

753

5825

1.30

10.55

1.1

1.85

2.02

u/ml

0.19

390

2921

Other and unspecified nonorganic psychotic disorders

136

2412

0.56

10.49

1.1

1.76

2.19

u/ml

0.16

1246

Acute suppurative otitis media

580

4049

1.35

10.48

1.2

1.1

2.48

2.58

u/ml

0.07

321

2182

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

299

1995

1.52

10.45

1.2

1.1

1.38

2.37

u/ml

1.66

160

969

Other viral diseases

679

5160

1.32

10.43

1.2

1.1

1.47

2.60

u/ml

2.91

366

2748

Prurigo nodularis

3.83

10.38

1.0

1.1

1.40

1.51

u/ml

0.04

Disturbances of skin sensation

398

2810

1.43

10.30

1.2

1.1

1.35

2.02

u/ml

1.35

219

1373

Injuries to the ankle and foot

1105

7971

1.24

10.27

1.2

1.1

2.17

2.30

u/ml

0.15

632

4056

Benign neoplasm: Colon, unspecified

164

947

1.74

10.25

1.2

1.1

2.36

1.54

u/ml

0.27

474

External causes of morbidity and mortality

1045

4183

1.26

10.22

1.1

2.11

2.38

u/ml

0.33

554

2041

Disorders of eyelid, lacrimal system and orbit

992

6044

1.25

9.99

1.1

2.04

2.12

u/ml

0.08

528

3002

Other noninfective gastroenteritis and colitis

335

2304

1.47

9.96

1.2

1.1

3.07

2.43

u/ml

0.38

197

1246

Kela-code for severe mental illness

246

3742

0.65

9.96

1.1

1.98

1.95

u/ml

0.01

139

1874

Rotator cuff syndrome

576

3090

1.34

9.91

1.1

1.16

1.79

u/ml

1.48

286

1436

Cervicobrachial syndrome

261

1709

1.54

9.90

1.2

1.1

1.13

2.07

u/ml

1.49

132

786

Schizophrenia or delusion, excluding more controls

195

3075

0.62

9.78

1.1

1.58

2.03

u/ml

0.25

111

1524

Disorders of synovium and tendon

665

4477

1.31

9.74

1.1

1.67

2.01

u/ml

0.51

304

2203

Any gastric operation

1384

5752

1.21

9.61

1.1

2.42

2.41

u/ml

0.02

724

3000

GASTRO-related operations

1384

5752

1.21

9.61

1.1

2.42

2.41

u/ml

0.02

724

3000

Oedema, not elsewhere classified

312

2103

1.47

9.58

1.1

1.52

2.00

u/ml

0.53

160

1024

Injury, poisoning and certain other consequences of external causes

872

3447

1.27

9.57

1.1

2.26

2.35

u/ml

0.08

455

1697

Other/unspecified dorsalgia

437

3147

1.38

9.55

1.1

1.99

2.04

u/ml

0.04

258

1549

Obesity

872

6719

1.26

9.52

1.1

1.35

2.19

u/ml

3.27

482

3307

Shoulder lesions

814

3873

1.28

9.52

1.1

1.46

1.90

u/ml

0.60

401

1844

Obesity and other hyperalimentation

873

6731

1.26

9.37

1.1

1.35

2.18

u/ml

3.26

483

3317

Unspecified threat to breathing

3.62

9.26

1.3

1.2

0.31

3.08

u/ml

1.50

ILD, hospital admission 2, with pulmonary infections

281

2.33

9.25

1.1

1.66

2.23

u/ml

0.19

133

Vasomotor rhinitis (mode)

438

2.06

9.25

1.1

0.38

2.48

u/ml

4.24

226

Other diseases of lip and oral mucosa

455

3353

1.37

9.14

1.2

1.1

1.99

2.03

u/ml

0.03

240

1661

Other inflammation of eyelid

162

966

1.70

9.14

1.1

2.74

2.27

u/ml

0.17

492

Cervicalgia

220

1417

1.56

9.03

1.2

1.1

1.58

2.03

u/ml

0.30

110

671

Psychiatric diseases

1341

5589

1.21

8.91

1.1

2.14

2.30

u/ml

0.20

695

2833

Transport accidents

671

4500

1.29

8.87

1.1

2.20

2.35

u/ml

0.14

361

2190

Other and unspecified rosacea

112

609

1.87

8.73

1.2

1.1

1.54

2.50

u/ml

0.66

294

Sciatica+with lumbago

583

4121

1.31

8.68

1.1

2.14

1.85

u/ml

0.25

304

1973

Mental and behavioural disorders due to alcohol, excluding acute intoxication

251

3678

0.68

8.67

1.2

1.1

2.89

1.88

u/ml

0.54

147

1825

Other diseases of oesophagus

401

2.07

8.65

1.2

1.1

5.04

2.66

u/ml

0.51

209

Dental pulpitis, including avohilmo

1370

7471

1.19

8.62

1.1

1.97

2.20

u/ml

0.40

722

3706

Acute laryngitis and tracheitis

263

1754

1.50

8.61

1.2

1.1

3.29

2.96

u/ml

0.18

151

966

Other intervertebral disc disorders

982

4804

1.23

8.59

1.1

1.36

1.90

u/ml

1.31

503

2313

Inflammatory diseases of prostate (prostatitis)

103

547

1.90

8.58

1.1

1.61

1.76

u/ml

0.08

279

Alcohol use disorder, Swedish definition

342

4352

0.72

8.41

1.1

2.66

1.84

u/ml

0.55

187

2150

Restless leg syndrome

148

882

1.70

8.40

1.2

1.1

2.07

2.22

u/ml

0.06

438

Lichen simplex chronicus

161

2.73

8.37

1.1

4.86

2.09

u/ml

0.30

Noninflammatory disorders of female genital tract

709

2788

1.28

8.33

1.1

2.65

2.80

u/ml

0.12

365

1438

Cerebrovascular diseases

332

3261

0.71

8.32

1.1

1.53

1.77

u/ml

0.19

154

1600

Subjective visual disturbances

294

2047

1.45

8.31

1.1

1.36

2.15

u/ml

1.39

167

1015

Alcohol use disorder, ICD-based

231

3420

0.67

8.24

1.2

1.1

2.70

1.86

u/ml

0.42

134

1697

Peritonsillar abscess

246

1658

1.49

8.23

1.1

1.68

2.38

u/ml

0.67

121

771

429

5049

0.74

8.22

1.1

2.82

1.90

u/ml

0.77

235

2524

Cervicocranial syndrome

125

716

1.77

8.20

1.2

1.1

2.26

u/ml

0.00

343

Disease of hard tissues of teeth, NOS

621

2510

1.30

8.15

1.1

1.73

2.14

u/ml

0.50

304

1157

Excessive attrition of teeth

795

6416

1.25

8.06

1.1

1.91

2.24

u/ml

0.55

417

3214

Disorders of the thyroid gland

1208

6588

1.20

7.91

1.1

1.80

2.11

u/ml

0.65

572

3337

Rosacea

146

883

1.67

7.89

1.2

1.1

1.95

2.24

u/ml

0.17

414

Other (not insulin) diabetes medications

786

5778

0.80

7.88

1.1

1.20

1.87

u/ml

2.58

392

2805

Organic, including symptomatic, mental disorders

112

1384

0.57

7.85

1.1

0.65

1.51

u/ml

1.77

692

Alcohol dependence

108

1873

0.57

7.75

1.2

1.1

3.97

2.03

u/ml

0.51

948

Dermatitis due to substances taken internally

379

2.04

7.71

1.1

1.81

2.28

u/ml

0.20

187

Type 2 diabetes

862

6163

0.81

7.67

1.1

1.39

1.91

u/ml

1.59

420

3012

Factors influencing health status and contact with health services

391

1428

1.38

7.66

1.1

2.55

2.78

u/ml

0.15

213

629

Other viral diseases, not elsewhere classified

463

3506

1.32

7.60

1.2

1.1

1.24

2.51

u/ml

4.13

242

1891

400

4814

0.75

7.55

1.1

2.92

1.90

u/ml

0.83

222

2419

Hypertrophy of breast in women and men

263

1830

1.45

7.54

1.1

1.82

2.02

u/ml

0.12

117

867

Mental and behavioural disorders due to psychoactive substance use

452

5481

0.76

7.53

1.1

2.57

1.96

u/ml

0.49

250

2732

All chronic kidney diseases

307

3482

0.72

7.51

1.1

1.90

2.22

u/ml

0.18

156

1812

General examination and investigation of persons without complaint and reported diagnosis

819

3451

1.24

7.50

1.1

2.39

2.38

u/ml

0.01

418

1618

Other gastritis (incl. Duodenitis)

177

1135

1.57

7.49

1.3

1.1

1.26

1.86

u/ml

0.81

101

547

Occupational exposure to risk-factors

171

2.57

7.48

1.1

1.51

1.73

u/ml

0.10

Biguanides

744

5612

0.81

7.44

1.1

1.16

1.84

u/ml

2.57

371

2716

Unspecified chronic bronchitis

3.46

7.40

1.2

1.1

4.19

1.52

u/ml

0.34

Continuous positive airway pressure

216

1216

1.51

7.39

1.2

1.1

2.09

1.85

u/ml

0.11

110

665

Substance abuse

431

5317

0.76

7.37

1.1

2.52

1.94

u/ml

0.45

241

2664

Infective dermatitis

113

650

1.76

7.35

1.1

2.67

1.79

u/ml

0.35

300

Malignant neoplasm of digestive organs

1361

0.57

7.32

1.1

2.62

1.45

u/ml

0.33

693

COPD, hospital admissions 1, only main diagnosis

182

1006

1.55

7.28

1.1

1.68

1.55

u/ml

0.07

106

512

Genitourinary diseases

923

3797

1.22

7.25

1.2

1.1

2.44

2.51

u/ml

0.06

512

2057

COPD related to multimorbidity

197

1095

1.52

7.21

1.1

1.57

1.50

u/ml

0.04

111

538

Stroke, including SAH

234

2452

0.69

7.19

1.1

1.24

1.64

u/ml

0.31

103

1226

Irregular menses

789

5078

1.23

7.17

1.1

2.19

2.12

u/ml

0.06

410

2455

Unspecified acute lower respiratory infection

185

1214

1.54

7.13

1.2

1.1

1.62

2.45

u/ml

0.78

114

606

Other and unspecified drugs and medicaments

105

598

1.78

7.11

1.2

1.1

2.45

2.41

u/ml

0.01

304

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

425

3229

1.33

7.11

1.2

1.1

2.40

2.47

u/ml

0.04

239

1660

Lumbar disc prolapse

716

4428

1.24

7.10

1.1

1.56

1.82

u/ml

0.35

374

2135

Fibromyalgia

132

802

1.67

7.07

1.2

1.1

0.82

2.82

u/ml

2.91

371

Oesophagitis

244

2.24

7.07

1.1

1.07

1.86

u/ml

0.68

132

Other extrapyramidal and movement disorders in other diseases

213

1441

1.49

7.06

1.2

1.1

1.90

2.02

u/ml

0.06

109

711

Internal derangement of knee

436

3310

1.32

7.04

1.1

2.64

2.02

u/ml

0.50

209

1598

Hyperkinetic disorders, excluding more controls

309

2151

1.39

6.98

1.2

1.1

2.67

2.99

u/ml

0.19

188

1180

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1107

5632

1.19

6.97

1.1

2.88

2.23

u/ml

0.80

623

2756

1107

5632

1.19

6.97

1.1

2.88

2.23

u/ml

0.80

623

2756

Excessive, frequent and irregular menstruation

617

2673

1.27

6.95

1.1

2.22

2.55

u/ml

0.33

313

1360

Oter anti-inflammatory and antirheumatic agents, non-steroids

151

511

1.64

6.93

1.2

1.1

1.81

2.79

u/ml

0.42

255

Female infertility

485

2268

1.31

6.85

1.1

1.84

2.33

u/ml

0.48

231

1121

Visual disturbances

544

4288

1.27

6.84

1.1

1.12

2.19

u/ml

4.52

305

2197

4.15

6.84

1.1

0.30

0.82

u/ml

—

Diseases of oral cavity, salivary glands and jaws

637

2600

1.26

6.82

1.1

2.36

2.05

u/ml

0.33

344

1225

Type 2 diabetes, definitions combined, including avohilmo

804

5696

0.82

6.81

1.1

1.41

1.83

u/ml

1.05

399

2769

Otalgia

126

768

1.67

6.72

1.3

1.2

3.41

2.88

u/ml

0.15

438

Diarrhoea and gastroenteritis of presumed infectious origin

970

7326

1.20

6.66

1.2

1.1

1.92

2.28

u/ml

0.56

540

3763

Selective deficiency of immunoglobulin G [IgG] subclasses

4.37

6.66

1.2

0.93

3.41

u/ml

—

Hypothyroidism, other/unspecified

1126

6267

1.19

6.66

1.1

2.12

2.07

u/ml

0.06

531

3171

Dislocation, sprain and strain of joints and ligaments of knee

849

6484

1.21

6.65

1.1

1.61

2.13

u/ml

1.15

427

3217

Other reaction to severe stress, and adjustment disorders

583

4654

1.26

6.64

1.2

1.1

2.33

2.20

u/ml

0.11

340

2273

Other disorders of white blood cells

304

2.07

6.64

1.3

1.1

0.55

3.38

u/ml

3.70

173

Disorders of muscles

121

732

1.67

6.60

1.1

1.89

2.52

u/ml

0.29

357

Hypothyreosis and Thyroxine purchase for inclusion criteria

1161

6473

1.18

6.53

1.1

2.10

2.03

u/ml

0.08

546

3270

Chondrocostal junction syndrome [Tietze]

234

2.22

6.50

1.1

2.52

3.11

u/ml

0.15

127

Acute and transient psychotic disorders

1099

0.50

6.49

1.1

1.38

2.20

u/ml

0.62

551

Disorders of breast

628

4595

1.25

6.47

1.1

1.95

1.89

u/ml

0.05

302

2202

Unspecified privation

129

798

1.63

6.47

1.2

1.1

1.12

2.35

u/ml

2.23

397

Unspecified mental disorder

326

4357

0.74

6.47

1.2

1.1

1.61

1.95

u/ml

0.21

184

2186

Other disorders of patella

236

1660

1.43

6.46

1.1

1.49

2.03

u/ml

0.65

111

779

Insulin medication

414

4514

0.77

6.45

1.1

1.68

2.04

u/ml

0.36

210

2343

Adenomyosis (Endometriosis of uterus)

142

900

1.59

6.42

1.2

1.1

1.28

1.74

u/ml

0.27

418

Other and unspecified polyneuropathies, also in other diseases

127

783

1.63

6.41

1.2

1.1

2.32

2.06

u/ml

0.08

394

Sequelae of other external causes

357

1.96

6.38

1.1

2.91

2.71

u/ml

0.05

190

Olecranon bursitis

255

2.14

6.37

1.1

3.90

2.32

u/ml

0.31

126

Dislocation, sprain and strain of joints and ligaments at neck level

249

1775

1.42

6.36

1.2

1.1

1.89

2.45

u/ml

0.53

138

884

Malignant neoplasm of breast, ER-positive, including Hilmo

165

1909

0.66

6.33

1.1

1.93

1.40

u/ml

0.35

864

Disorders of thyroid, IBD co-morbidities

264

1324

1.41

6.32

1.1

2.40

2.43

u/ml

0.01

128

672

Malignant neoplasm of breast, HER-positive

159

1869

0.66

6.27

1.1

1.98

1.42

u/ml

0.36

846

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1022

0.49

6.26

1.1

0.88

1.23

u/ml

0.29

503

Mental and behavioural disorders due to alcohol

354

4477

0.76

6.25

1.1

2.96

1.93

u/ml

0.74

201

2242

Hypothyroidism, strict autoimmune

966

5339

1.19

6.24

1.1

2.08

2.02

u/ml

0.07

446

2688

Drug-induced adrenocortical insufficiency

121

2.73

6.24

1.3

1.1

0.37

2.44

u/ml

1.64

Hypertrophy of breast

237

1681

1.42

6.22

1.1

1.77

2.01

u/ml

0.14

101

789

Dementia, including avohilmo

871

0.54

6.22

1.2

1.1

0.75

1.45

u/ml

0.67

442

Hypothyroidism, levothyroxine purchases

536

2393

1.27

6.21

1.1

2.16

2.70

u/ml

0.58

260

1246

Hypothyroidism and >3 levothyroxin purchases

536

2393

1.27

6.21

1.1

2.16

2.70

u/ml

0.58

260

1246

Diseases of external ear

375

2857

1.32

6.20

1.2

1.1

3.30

2.19

u/ml

0.87

210

1477

Other disorders of eyelid

288

2004

1.37

6.20

1.1

1.16

1.77

u/ml

1.19

141

949

Stroke, excluding SAH

208

2175

0.70

6.18

1.1

1.24

1.55

u/ml

0.20

1078

Any operation in hilmo

229

1.90

6.18

1.2

1.1

2.73

2.10

u/ml

0.19

106

Generalized anxiety disorder

302

2235

1.36

6.16

1.2

1.1

1.94

2.49

u/ml

0.37

170

1110

Other diseases of intestines

1537

7616

1.15

6.14

1.1

1.88

2.31

u/ml

0.81

760

3965

STROKE

342

3077

0.75

6.12

1.1

1.17

1.82

u/ml

0.96

165

1482

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

779

5106

1.21

6.10

1.1

2.43

1.93

u/ml

0.63

347

2468

Hypothyroidism (congenital or acquired)

541

2422

1.27

6.09

1.1

2.23

2.72

u/ml

0.50

264

1264

Anomalies of dental arch relationship, including avohilmo

375

2585

1.32

6.04

1.2

1.1

2.59

2.85

u/ml

0.20

213

1420

Female infertility, cervical, vaginal, other or unspecified origin

434

2185

1.30

6.04

1.1

1.85

2.29

u/ml

0.37

201

1072

Type 2 diabetes, strict (exclude DM1)

797

5619

0.83

5.95

1.1

1.34

1.81

u/ml

1.26

396

2724

Cervical disc disorders

310

2312

1.35

5.94

1.1

1.22

1.95

u/ml

0.87

161

1046

Type 2 diabetes, definitions combined

796

5610

0.83

5.93

1.1

1.34

1.84

u/ml

1.37

395

2723

Other degenerative diseases of the nervous system

1158

0.59

5.92

1.2

1.1

0.95

1.78

u/ml

0.81

532

Renal failure

149

1984

0.66

5.90

1.2

1.1

2.18

1.88

u/ml

0.08

1032

Substance abuse, excluding more controls

431

4681

0.78

5.90

1.1

2.52

2.12

u/ml

0.28

241

2289

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

511

3634

1.26

5.83

1.1

2.66

2.91

u/ml

0.20

293

2027

Other enthesopathy of foot (+metatarsalgia)

119

742

1.62

5.82

1.1

1.37

2.50

u/ml

0.95

358

Disturbance of activity and attention

311

2290

1.35

5.82

1.2

1.1

2.59

2.86

u/ml

0.16

191

1320

Striking against or struck by other objects

482

3826

1.27

5.79

1.1

3.30

2.34

u/ml

0.76

264

2070

Other disorders of urethra and urinary system

816

4917

1.20

5.79

1.1

2.38

2.08

u/ml

0.29

382

2422

Erysipelas

469

4505

0.79

5.72

1.1

2.48

1.72

u/ml

0.87

259

2169

Dental operations

634

2641

1.24

5.69

1.1

1.90

1.87

u/ml

0.03

332

1282

Benign neoplasm: Liver/bile ducts

176

2.33

5.69

1.1

1.95

2.95

u/ml

0.42

Pulmonary eosinophilia, not elsewhere classified

4.87

5.67

1.2

1.1

0.16

1.72

u/ml

—

Certain infectious and parasitic diseases

1430

6239

1.15

5.65

1.1

1.92

2.32

u/ml

0.80

766

3139

Visual disturbances and blindness

563

4561

1.24

5.64

1.1

1.12

2.15

u/ml

4.44

317

2341

Liquid cancers, helper endpoint

157

2020

0.68

5.62

1.2

1.1

1.47

1.82

u/ml

0.17

1048

Disorders of sclera, cornea, iris and ciliary body

625

5124

1.22

5.62

1.1

2.44

1.93

u/ml

0.54

335

2570

Obesity, other/unspecified

460

3649

1.27

5.61

1.1

1.24

2.00

u/ml

1.60

256

1782

Ganglion

264

1942

1.37

5.60

1.1

2.22

2.11

u/ml

0.07

124

920

Rheumatism, unspecified

126

804

1.58

5.59

1.2

1.1

1.22

1.97

u/ml

0.71

383

Spondylolisthesis/Spondylolysis

166

1125

1.48

5.57

1.1

1.45

2.02

u/ml

0.52

520

Benign neoplasm of other and ill-defined parts of digestive system

138

900

1.54

5.55

1.2

1.1

2.32

2.15

u/ml

0.07

439

Endometriosis of pelvic peritoneum

235

1619

1.39

5.54

1.1

1.34

2.18

u/ml

0.73

785

Injuries to the knee and lower leg

1597

7803

1.14

5.50

1.1

1.83

2.30

u/ml

1.14

824

3976

Benign neoplasm: Liver

160

2.37

5.49

1.1

2.04

3.21

u/ml

0.46

Mycoses

278

2070

1.35

5.45

1.1

2.22

2.15

u/ml

0.04

144

1042

Hyperkinetic disorders

325

2433

1.32

5.41

1.2

1.1

2.55

2.90

u/ml

0.23

202

1393

Nontoxic goitre/thyroid nodule

235

1706

1.38

5.40

1.1

1.04

1.64

u/ml

0.88

119

808

Ovarian cyst

514

2374

1.26

5.37

1.2

1.1

1.20

2.41

u/ml

3.71

256

1181

Metatarsalgia

109

680

1.62

5.36

1.1

1.37

2.46

u/ml

0.82

338

Disorders of tooth development and eruption

260

1551

1.37

5.34

1.2

1.1

2.22

2.21

u/ml

0.01

137

779

COPD, hospital admission 2, with asthma infections

162

940

1.48

5.34

1.1

0.69

1.66

u/ml

2.22

472

Candidiasis

158

1074

1.48

5.27

1.1

1.65

2.29

u/ml

0.49

540

Radiculopathy

124

800

1.56

5.26

1.2

1.1

1.19

2.10

u/ml

0.90

365

Panic disorder

267

1991

1.35

5.26

1.1

2.40

2.28

u/ml

0.05

154

971

Congenital malformations, deformations and chromosomal abnormalities

973

7688

1.17

5.26

1.1

1.76

2.42

u/ml

1.20

521

3953

Postmenopausal atrophic vaginitis

208

807

1.43

5.24

1.1

0.76

1.86

u/ml

2.03

379

Tramadol

909

4742

1.18

5.23

1.2

1.1

1.76

1.85

u/ml

0.10

485

2292

Noninfective enteritis and colitis

583

4785

1.22

5.16

1.2

1.1

2.58

2.17

u/ml

0.33

299

2514

Seborrhoeic dermatitis

534

1.68

5.11

1.1

3.82

1.98

u/ml

0.47

264

Septicaemia

201

2604

0.72

5.10

1.1

3.89

1.94

u/ml

0.97

116

1365

Otitis externa

276

2077

1.34

5.09

1.2

1.1

3.82

2.31

u/ml

1.00

154

1079

Mental retardation, wide definition

653

0.43

5.06

1.3

1.2

0.61

3.18

u/ml

4.50

437

Other disorders of adrenal gland

395

1.80

5.05

1.2

1.1

1.79

3.51

u/ml

0.99

218

Other disorders of breast

159

1094

1.47

5.02

1.2

1.1

2.29

2.18

u/ml

0.04

527

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

247

2.03

5.00

1.2

1.1

2.17

2.90

u/ml

0.27

129

Epiphora

2.78

4.98

1.1

0.74

2.63

u/ml

—

Degenerative diseases of the nervous system

589

0.49

4.97

1.3

1.1

0.26

1.28

u/ml

2.87

296

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

175

1214

1.44

4.95

1.2

2.31

2.94

u/ml

0.38

735

Acute tubulo-interstitial nephritis

474

5043

0.81

4.94

1.1

2.16

2.03

u/ml

0.09

250

2560

Spondylosis

434

2822

1.26

4.94

1.1

1.32

1.89

u/ml

0.81

204

1298

Nonsuppurative otitis media

449

3123

1.25

4.90

1.1

3.03

2.92

u/ml

0.06

272

1722

Viral pneumonia

142

960

1.49

4.90

1.2

1.1

1.71

2.62

u/ml

0.75

508

Pain, not elsewhere classified

338

2629

1.29

4.90

1.2

1.1

1.65

2.16

u/ml

0.58

182

1308

Vulvovaginal ulceration/inflammation in other diseases

110

706

1.58

4.89

1.1

3.33

2.97

u/ml

0.13

337

Chronic periodontitis, including avohilmo

787

6212

0.85

4.88

1.1

1.94

1.78

u/ml

0.18

425

2997

Hypermobility syndrome

103

652

1.61

4.87

1.2

1.1

3.28

3.07

u/ml

0.05

333

Extrapyramidal and movement disorders

280

2125

1.32

4.85

1.1

2.05

1.76

u/ml

0.18

142

1038

Other diseases of the respiratory system

125

824

1.52

4.84

1.1

0.80

2.33

u/ml

2.03

451

Other respiratory disorders and diseases

125

824

1.52

4.84

1.1

0.80

2.33

u/ml

2.03

451

Blepharochalasis

173

1216

1.43

4.84

1.1

1.26

1.53

u/ml

0.26

568

Periodontitis

791

6222

0.85

4.83

1.1

1.93

1.78

u/ml

0.16

428

3003

Other contact dermatitis

566

1.64

4.83

1.2

1.1

2.34

1.80

u/ml

0.19

269

All influenza

283

2154

1.32

4.82

1.2

1.1

2.05

2.24

u/ml

0.11

158

1158

Polyneuropathies and other disorders of the peripheral nervous system

151

1036

1.46

4.82

1.1

2.36

1.98

u/ml

0.14

517

Mental retardation

638

0.44

4.80

1.3

1.2

0.61

3.23

u/ml

4.58

429

ILD, hospital admissions 3, with pneumonia sepsis

243

1.99

4.78

1.1

2.13

1.28

u/ml

0.22

116

Malaise and fatigue

529

3484

1.23

4.78

1.2

1.1

2.77

2.17

u/ml

0.46

287

1779

Persons encountering health services in other circumstances

527

4303

1.22

4.77

1.1

2.11

2.40

u/ml

0.27

258

2218

Recurrent aphthous stomatitis , including avohilmo

177

1255

1.42

4.77

1.1

2.40

2.28

u/ml

0.06

678

Ischaemic Stroke, excluding all haemorrhages

189

1950

0.72

4.76

1.1

1.30

1.64

u/ml

0.21

969

Embedded and impacted teeth

580

3963

1.22

4.76

1.1

2.99

2.66

u/ml

0.21

326

2114

Ocular pain

117

766

1.55

4.75

1.1

0.76

2.67

u/ml

4.61

402

Benign neoplasm of colon, rectum, anus and anal canal

426

2962

1.25

4.74

1.1

1.78

1.57

u/ml

0.14

207

1407

Adrenocortical insufficiency

266

1.95

4.73

1.2

1.1

0.46

3.07

u/ml

3.36

151

Tinnitus

211

1542

1.38

4.73

1.1

1.04

1.87

u/ml

1.50

108

743

Spinal osteochondrosis

3.11

4.73

1.2

1.1

0.28

3.98

u/ml

1.17

Benign neoplasm: Choroid

259

1.95

4.69

1.1

0.17

2.38

u/ml

2.71

131

Atypical facial pain

339

1.82

4.64

1.1

0.58

1.69

u/ml

1.52

177

Infections of the skin and subcutaneous tissue

752

6338

1.18

4.58

1.1

2.78

2.09

u/ml

0.75

418

3289

Any dementia

650

0.54

4.56

1.2

1.1

0.80

1.32

u/ml

0.39

327

Erysipelas

297

3383

0.77

4.55

1.1

2.90

1.69

u/ml

1.13

173

1648

Other shoulder lesions

113

741

1.54

4.55

1.1

0.86

2.40

u/ml

3.02

356

Other disorders of eye and adnexa

185

1334

1.40

4.55

1.1

0.99

2.20

u/ml

3.34

108

684

Keratitis

401

3216

1.25

4.54

1.1

3.05

1.97

u/ml

0.96

221

1595

Contact with other specified venomous animals

3.56

4.54

1.2

1.1

0.89

1.79

u/ml

—

Infections with a predominantly sexual mode of transmission

693

5461

1.19

4.54

1.1

2.02

2.46

u/ml

0.62

340

2778

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

782

0.51

4.52

1.1

0.87

1.41

u/ml

0.64

396

Unspecific neurodegenerative disorder

638

0.55

4.52

1.2

1.1

0.28

1.05

u/ml

2.68

329

Flat foot [pes planus] (acquired)

631

1.58

4.52

1.1

1.60

2.58

u/ml

0.65

311

Disorders of other endocrine glands

547

4459

1.21

4.51

1.2

1.1

1.88

2.30

u/ml

0.44

295

2357

Dementia

781

0.59

4.48

1.2

1.1

0.71

1.19

u/ml

0.43

396

Polyp of the female genital tract

336

1504

1.29

4.47

1.1

1.77

2.07

u/ml

0.19

157

718

Condition for Implicit Sepsis (Organ dysfunction codes)

718

5962

0.85

4.47

1.1

1.75

2.02

u/ml

0.39

386

3015

Lateral epicondylitis

140

963

1.46

4.46

1.2

1.1

0.88

2.34

u/ml

2.33

444

Other maternal disorders predominantly related to pregnancy

847

4556

1.17

4.43

1.1

2.87

2.00

u/ml

1.10

395

2211

ILD-related respiratory insufficiency

2.85

4.40

1.1

1.2

0.93

2.79

u/ml

—

Polyarthropathies

597

4656

0.84

4.39

1.1

0.98

2.23

u/ml

6.05

293

2335

Other systemic involvement of connective tissue

242

1831

1.33

4.35

1.1

2.07

1.93

u/ml

0.08

123

895

Peripheral artery disease

102

1235

0.66

4.33

1.1

0.85

1.48

u/ml

1.26

624

Other septicaemia

172

2277

0.72

4.29

1.1

3.63

1.93

u/ml

0.72

100

1194

Herpesviral [herpes simplex] infections

140

972

1.45

4.28

1.2

1.1

4.18

2.24

u/ml

0.74

488

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

612

5131

1.19

4.28

1.2

1.1

2.16

2.45

u/ml

0.31

357

2654

Benign neoplasm: Duodenum

2.73

4.27

1.3

1.1

2.53

1.47

u/ml

0.28

Urticaria due to cold and heat

2.85

4.27

1.2

1.1

3.44

3.24

u/ml

0.04

Inflammatory disease of uterus

216

1617

1.35

4.24

1.2

1.1

1.83

2.11

u/ml

0.15

110

768

Heart failure, not strict

426

3552

0.81

4.23

1.1

1.93

1.87

u/ml

0.03

208

1774

Other and unspecified nerve root and plexus disorders, also in other diseases

205

1521

1.36

4.23

1.1

1.06

1.92

u/ml

1.04

104

728

Care involving use of rehabilitation procedures

710

5568

1.18

4.21

1.1

1.14

2.11

u/ml

3.51

389

2780

Other/unspecified enthesopathies, not elsewhere classified

455

1.66

4.20

1.3

1.1

2.28

2.72

u/ml

0.14

218

Alzheimer disease, including avohilmo

513

0.51

4.20

1.3

1.1

0.29

0.83

u/ml

3.47

257

Other systemic involvement of connective tissue (FG)

239

1791

1.32

4.20

1.2

1.1

2.12

1.86

u/ml

0.15

120

859

Other bursopathies

106

698

1.53

4.20

1.1

3.09

2.34

u/ml

0.22

330

Endometriosis

462

2210

1.23

4.19

1.1

1.09

2.42

u/ml

3.49

216

1090

COPD-related respiratory insufficiency

291

1.83

4.19

1.2

1.1

2.66

2.23

u/ml

0.09

142

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

874

0.55

4.19

1.2

1.1

4.00

2.30

u/ml

0.22

455

Uterine polyps

580

1.58

4.18

1.1

0.61

1.69

u/ml

2.72

273

Other complications of surgical and medical care, not elsewhere classified

111

740

1.51

4.17

1.2

1.1

1.54

2.44

u/ml

0.71

363

Mental and behavioural disorders due to opioids

442

0.38

4.17

1.0

1.1

0.44

2.55

u/ml

—

228

Deforming dorsopathies

309

2431

1.28

4.17

1.1

2.38

u/ml

0.00

162

1226

Dipeptidyl peptidase 4 (DPP-4) inhibitors

214

2277

0.75

4.16

1.1

1.52

1.70

u/ml

0.11

1099

Any dementia, excluding more controls

617

0.56

4.16

1.2

1.1

0.81

1.47

u/ml

0.47

303

All influenza (not pneumonia)

188

1381

1.37

4.16

1.2

1.1

1.37

2.19

u/ml

1.27

104

744

Diseases of male genital organs

552

2308

1.21

4.15

1.1

2.01

2.26

u/ml

0.23

304

1289

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1017

7552

0.87

4.15

1.2

1.1

1.59

2.26

u/ml

1.45

538

3848

Viral and other specified intestinal infections

506

4055

1.21

4.13

1.2

1.1

1.97

2.78

u/ml

1.24

268

2226

Mental retardation, excluding more controls

588

0.47

4.12

1.3

1.2

0.61

2.80

u/ml

3.42

388

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

682

3680

1.18

4.11

1.1

2.34

2.25

u/ml

0.08

366

1778

Pleural plaque

141

2.21

4.11

1.2

1.1

1.06

1.17

u/ml

0.06

Panniculitis affecting regions of neck and back

216

1.97

4.08

1.2

1.1

8.40

1.90

u/ml

0.66

105

Separation of retinal layers (serosa)

230

1.94

4.08

1.2

1.1

4.50

1.98

u/ml

0.32

121

Other diseases of peritoneum

230

1.94

4.08

1.1

1.29

1.77

u/ml

0.22

117

Cholecystectomy

669

4908

1.18

4.07

1.1

1.28

1.74

u/ml

0.88

323

2339

Other arthrosis

472

2688

1.22

4.06

1.1

0.88

1.90

u/ml

3.10

248

1250

Nonalcoholic fatty liver disease

110

737

1.51

4.06

1.1

1.65

2.09

u/ml

0.34

362

Carpal tunnel syndrome

598

4446

1.19

4.04

1.2

1.1

1.41

1.78

u/ml

0.58

280

2102

Other disorders of bone

248

1908

1.31

4.01

1.2

1.1

2.29

u/ml

0.00

140

958

Deep bite

233

1558

1.33

4.01

1.2

4.07

3.22

u/ml

0.37

142

945

Insulin, combination of fast acting with intermediate-acting or long-acting

414

4616

0.82

4.01

1.1

1.68

2.00

u/ml

0.31

210

2398

Dysplasia of cervi uteri

356

2063

1.26

4.01

1.1

2.80

2.30

u/ml

0.33

173

1003

Abnormal findings in secretions and smears from cervix uteri vagina vulva

725

4695

1.17

4.00

1.1

2.36

1.94

u/ml

0.48

333

2254

Transplanted organ and tissue status

812

0.55

4.00

1.3

1.2

0.38

2.52

u/ml

5.20

453

Disorders of ocular muscles, binocular movement, accommodation and refraction

665

5632

1.17

3.95

1.1

1.46

2.48

u/ml

2.38

355

2962

Schizoaffective disorder

768

0.54

3.93

1.1

3.60

2.22

u/ml

0.17

386

Cerebrovascular diseases (FINNGEN)

224

2075

0.76

3.92

1.1

1.68

1.83

u/ml

0.08

104

996

Explicit Sepsis

251

3014

0.77

3.91

1.1

3.60

2.11

u/ml

0.79

138

1565

Gingivitis and periodontal diseases

1275

5845

1.13

3.90

1.1

2.46

2.04

u/ml

0.61

693

2901

Other diseases of stomach and duodenum

262

1.85

3.90

1.1

2.48

1.62

u/ml

0.19

141

Crossbite

179

1224

1.37

3.87

1.2

3.11

3.54

u/ml

0.21

119

760

Other acute skin changes due to ultraviolet radiation

152

2.13

3.86

1.2

1.1

0.97

2.54

u/ml

0.97

Benign neoplasm: Transverse colon

382

1.69

3.84

1.1

2.56

1.81

u/ml

0.17

191

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

346

1.73

3.83

1.2

1.1

3.19

2.81

u/ml

0.07

188

Injury of muscle and tendon at shoulder and upper arm level

249

1928

1.30

3.83

1.2

1.1

1.90

1.86

u/ml

0.02

129

933

Acute appendicitis, no complications

726

6233

1.16

3.82

1.1

2.19

2.02

u/ml

0.17

342

3081

Hard cardiovascular diseases

643

4493

0.85

3.81

1.1

1.97

1.85

u/ml

0.09

301

2280

Fissure and fistula of anal and rectal regions

240

1852

1.30

3.80

1.1

0.94

2.06

u/ml

2.73

112

928

Autoimmune diseases excluding thyroid diseases

1171

7188

0.89

3.78

1.1

2.10

2.27

u/ml

0.19

606

3743

Obesity due to excess calories

600

5105

1.18

3.78

1.1

1.54

2.15

u/ml

1.28

327

2533

Other/unspecified enthesopathies of lower limb, excluding foot

548

1.57

3.77

1.1

1.36

1.98

u/ml

0.43

253

Other diseases of intestine

643

1.52

3.76

1.1

2.75

1.87

u/ml

0.25

328

Certain disorders involving the immune mechanism

198

1491

1.34

3.76

1.1

1.79

2.25

u/ml

0.25

106

764

Other skin changes

150

1081

1.39

3.76

1.1

3.56

2.23

u/ml

0.63

549

Myotonic disorders

3.10

3.74

1.3

1.1

0.15

2.90

u/ml

—

Other deformities of toe(s)

161

2.07

3.73

1.1

0.60

3.08

u/ml

1.89

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

379

1.68

3.72

1.1

2.15

3.21

u/ml

0.39

188

Dialysis, with operation codes

794

0.56

3.70

1.3

1.1

1.12

2.25

u/ml

0.99

437

Other and unspecified acute skin changes due to ultraviolet radiation

2.82

3.70

1.1

1.88

3.36

u/ml

—

Other sleep disorders

117

810

1.45

3.69

1.2

1.1

1.36

2.45

u/ml

1.18

398

Endocrine, nutritional and metabolic diseases

1329

6018

1.12

3.68

1.1

2.07

2.54

u/ml

0.90

688

3132

Substance use, excluding alcohol

159

2153

0.73

3.68

1.1

1.80

2.03

u/ml

0.09

1094

Other obstetric conditions, not elsewhere classified

685

3742

1.17

3.67

1.1

2.34

2.24

u/ml

0.08

368

1800

Contracture of joint

2.92

3.66

1.1

0.32

4.05

u/ml

—

Obsessive-compulsive disorder

141

1014

1.41

3.66

1.1

2.39

2.81

u/ml

0.25

538

Other and unspecified disorders of vitreous body

265

2054

1.28

3.63

1.1

0.64

1.62

u/ml

3.72

131

958

Autoimmune diseases excluding thyroid diseases, strict definition

1148

7061

0.89

3.63

1.1

2.13

2.28

u/ml

0.17

595

3674

Meniscus derangement

535

3034

1.19

3.62

1.1

1.67

1.83

u/ml

0.17

273

1423

Other and unspecified follicular disorders

292

1.77

3.61

1.1

3.00

3.02

u/ml

0.00

154

Other neurological diseases

441

4161

0.83

3.60

1.1

1.19

1.93

u/ml

1.61

228

2063

Diseases of salivary glands

340

2756

1.24

3.60

1.2

1.1

1.12

2.18

u/ml

3.30

173

1357

Atherosclerosis, excluding cerebral and coronary sclerosis

1018

0.66

3.59

1.1

1.00

1.41

u/ml

0.56

513

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

749

0.56

3.59

1.2

1.1

1.56

2.01

u/ml

0.17

385

Other infestations

2.70

3.59

1.0

1.2

2.47

4.68

u/ml

—

Congenital malformations, deformations and chromosomal abnormalities

885

7405

1.14

3.59

1.1

1.87

2.42

u/ml

0.82

480

3828

Sub-endpoint used in defining T1D endpoints

235

2957

0.78

3.58

1.1

2.57

2.29

u/ml

0.13

121

1581

Implicit viral Sepsis

258

2027

1.28

3.57

1.2

1.1

1.83

1.95

u/ml

0.08

147

1051

Inhalation and ingestion of food causing obstruction of respiratory tract

2.89

3.57

1.5

1.2

5.54

5.24

u/ml

0.03

N06DA Anticholinesterases

530

0.53

3.54

1.3

1.1

0.39

0.82

u/ml

2.16

266

Use of anticholinesterases

530

0.53

3.54

1.3

1.1

0.39

0.82

u/ml

2.16

266

Viral warts

310

2496

1.25

3.53

1.2

1.1

1.53

2.71

u/ml

1.93

142

1325

Other and unspecified mental retardation

358

0.37

3.52

1.1

1.3

0.21

2.94

u/ml

—

272

Appendicitis, broad definition

907

7226

1.14

3.52

1.1

2.03

2.00

u/ml

0.03

431

3584

Impetigo

592

1.53

3.50

1.2

4.03

3.22

u/ml

0.16

351

Sequelae of external causes of morbidity and mortality

216

1664

1.30

3.50

1.1

1.45

2.04

u/ml

0.54

130

836

Polyuria

159

1172

1.36

3.49

1.1

1.51

2.04

u/ml

0.53

581

Type 2 diabetes, wide definition

522

3946

0.84

3.47

1.1

1.19

1.80

u/ml

1.46

256

1882

Benign neoplasm: Small intestine

132

2.14

3.46

1.2

1.1

2.61

1.41

u/ml

0.41

Polyarthrosis

125

822

1.42

3.45

1.1

0.88

1.55

u/ml

0.88

378

Acute renal failure

891

0.60

3.45

1.1

0.42

2.13

u/ml

5.36

455

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

504

4218

1.19

3.42

1.1

1.45

2.39

u/ml

2.71

280

2239

Stomatitis and related lesions

244

1918

1.28

3.41

1.1

1.96

2.13

u/ml

0.13

124

992

Suppurative otitis media, unspecified

246

1.82

3.40

1.0

1.2

3.43

2.91

u/ml

0.11

148

Superficial injury of hip and thigh

124

882

1.41

3.39

1.2

1.1

2.02

2.28

u/ml

0.11

455

Single spontaneous delivery

372

2396

0.82

3.39

1.1

2.86

2.07

u/ml

0.74

199

1241

Postviral fatigue syndrome

102

2.35

3.38

1.3

1.1

0.19

2.97

u/ml

2.68

Alzheimer disease

417

0.51

3.36

1.3

1.1

0.29

0.84

u/ml

2.94

205

Alcohol withdrawal state with delirium

330

0.36

3.36

1.0

1.1

0.42

2.15

u/ml

—

167

Diseases of appendix

909

7242

1.13

3.36

1.1

2.03

2.00

u/ml

0.03

432

3591

Other noninflammatory disorders of vulva and perineum

114

802

1.43

3.35

1.1

1.07

2.36

u/ml

1.46

386

Hypersensitivity pneumonitis due to organic dust

2.76

3.34

1.2

1.1

2.17

0.82

u/ml

—

Malignant neoplasm of respiratory system and intrathoracic organs

537

0.54

3.34

1.1

0.65

1.39

u/ml

1.36

274

Implicit Sepsis

555

4894

0.85

3.34

1.2

1.1

1.53

2.05

u/ml

0.99

304

2478

Abnormal involuntary movements

133

962

1.39

3.32

1.1

1.98

2.17

u/ml

0.12

484

Antihypertensive medication - note that there are other indications

1184

5618

1.12

3.31

1.1

2.10

2.49

u/ml

0.63

601

2982

Disorder of lipoprotein metabolism, unspecified

461

1.57

3.31

1.1

0.60

1.78

u/ml

1.93

246

Mental and behavioural disorders due to use of other stimulants, including caffeine

368

0.40

3.31

1.2

1.1

0.62

2.81

u/ml

—

191

Tracheo-bronchomalasia

3.50

3.30

1.2

1.1

1.04

1.08

u/ml

—

Synovial cyst of popliteal space [Baker]

330

1.68

3.29

1.1

1.30

2.32

u/ml

0.63

166

Immunodeficiency with predominantly antibody defects

227

1.84

3.29

1.1

0.77

3.02

u/ml

2.37

138

Malignant neoplasm of skin

216

1899

0.78

3.28

1.1

1.10

1.36

u/ml

0.25

103

917

Thyroiditis, ILD-related definition

151

1119

1.36

3.27

1.1

2.21

2.60

u/ml

0.20

559

Malignant neoplasm of breast, ER-negative, including Hilmo

1262

0.68

3.27

1.1

0.87

1.41

u/ml

0.70

596

Benign neoplasm of eye and adnexa

535

1.52

3.26

1.1

0.78

2.46

u/ml

2.70

280

Other and unspecified local infections of skin and subcutaneous tissue

104

723

1.45

3.26

1.1

5.35

2.39

u/ml

0.95

372

Gluteal tendinitis

227

1.83

3.26

1.0

1.1

1.05

1.46

u/ml

0.17

116

Peroneal tendinitis

103

2.28

3.26

1.1

1.17

3.21

u/ml

0.84

Nonorganic sleeping disorders, excluding more controls

278

2234

1.25

3.25

1.2

1.1

2.46

2.20

u/ml

0.15

147

1111

Hypothyroidism, strict autoimmune, 3 medication purchases required

1006

6042

1.13

3.25

1.1

1.97

2.04

u/ml

0.08

457

3027

Injuries to the neck

300

2431

1.24

3.25

1.2

1.1

1.76

2.28

u/ml

0.62

165

1230

Diseases of arteries, arterioles and capillaries

310

2814

0.81

3.25

1.1

1.30

1.75

u/ml

0.72

149

1380

Iron deficiency

341

1.68

3.24

1.1

2.16

3.36

u/ml

0.51

181

Covid-19 confirmed case

343

2818

1.22

3.23

1.2

1.1

1.56

2.14

u/ml

0.62

188

1441

Exclusions for E4_PCOS_CONSORTIUM

856

6067

0.88

3.20

1.1

2.41

2.19

u/ml

0.21

410

3084

Benign neoplasm: Ascending colon

505

1.53

3.20

1.1

5.74

1.47

u/ml

0.78

261

Other specified/unspecified soft tissue disorders

221

1.83

3.20

1.1

0.88

2.73

u/ml

1.32

117

Haemorrhoids and perianal venous thrombosis

238

1877

1.27

3.18

1.1

3.08

1.76

u/ml

0.55

112

921

Other/unspecified soft tissue disorders related to use, overuse and pressure

193

1.89

3.18

1.1

0.42

3.66

u/ml

2.53

Impingement syndrome of shoulder

178

1356

1.32

3.17

1.1

0.70

1.71

u/ml

2.63

633

Immunodeficiencies

405

1.60

3.16

1.1

0.91

3.85

u/ml

3.82

228

Other disorders of cornea

580

1.49

3.15

1.1

4.78

1.81

u/ml

0.74

281

Sulfonylureas

802

0.64

3.14

1.1

1.25

1.18

u/ml

0.04

414

Nephropathy related operations

780

0.60

3.13

1.3

1.1

0.56

2.33

u/ml

3.88

428

Other symptoms and signs involving the circulatory and respiratory systems

366

1.62

3.13

1.2

1.1

2.16

3.01

u/ml

0.35

190

Other disorders of penis

103

721

1.44

3.12

1.2

1.06

2.77

u/ml

2.25

428

Budesonide

151

1127

1.35

3.12

1.1

1.50

2.36

u/ml

0.43

534

Other specified disorders of external ear

138

2.05

3.12

1.1

4.69

1.89

u/ml

0.33

Type 1 diabetes, wide definition

209

2655

0.78

3.11

1.1

2.34

u/ml

0.00

107

1420

Acute appendicitis

857

7096

1.13

3.10

1.1

2.01

u/ml

0.00

409

3518

Other diseases of anus and rectum

236

1866

1.27

3.10

1.1

1.27

1.90

u/ml

1.01

118

937

Hyperlipidaemia, other/unspecified

220

1589

1.28

3.10

1.1

0.80

1.45

u/ml

1.15

103

801

Fever of other and unknown origin

646

4999

1.15

3.09

1.1

1.13

2.39

u/ml

5.13

359

2566

L04AD Calcineurin inhibitors

1045

0.66

3.09

1.2

2.42

u/ml

0.00

593

Delirium, not induced by alcohol and other psychoactive substances

345

0.40

3.09

1.1

0.87

1.79

u/ml

—

171

Benign neoplasm: Sigmoid colon

106

747

1.42

3.08

1.1

1.82

1.54

u/ml

0.10

378

Nontoxic multinodular goitre

136

1001

1.36

3.07

1.1

0.90

1.69

u/ml

0.92

471

Melanocytic naevi

344

2845

1.21

3.07

1.1

2.12

2.21

u/ml

0.05

180

1421

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.55

3.07

1.2

1.1

0.64

3.93

u/ml

—

Secondary uncertain malignant neoplasm

560

0.53

3.06

1.2

1.1

2.12

2.14

u/ml

0.00

299

Bacterial Sepsis

219

2367

0.79

3.05

1.1

1.93

2.00

u/ml

0.04

128

1233

Umbilical hernia

250

2000

1.25

3.05

1.1

1.53

2.21

u/ml

0.70

137

994

Metabolic disorders

859

5911

0.88

3.04

1.1

1.20

1.98

u/ml

2.22

430

2970

Ehlers-Danlos syndrome

107

2.22

3.03

1.2

1.1

1.61

2.15

u/ml

0.14

Haemangioma, any site

635

1.46

3.03

1.2

1.1

2.43

2.53

u/ml

0.03

343

Coronary artery bypass grafting

532

0.59

3.01

1.0

1.1

4.69

1.24

u/ml

0.61

275

Superficial injury of lower leg

306

2508

1.23

3.00

1.2

1.1

2.33

2.67

u/ml

0.20

164

1292

Nerve, nerve root and plexus disorders

1188

6560

1.11

3.00

1.1

1.53

1.91

u/ml

0.71

585

3217

Superficial injury of wrist and hand

298

2438

1.23

2.99

1.2

1.1

1.10

2.53

u/ml

3.49

158

1286

Complications predominantly related to the puerperium

373

3120

1.20

2.98

1.1

2.90

1.92

u/ml

0.65

188

1513

Malignant neoplasm of breast, HER-negative

1089

0.67

2.97

1.1

0.94

1.32

u/ml

0.39

524

Complications of medical and surgical care

748

6059

1.14

2.96

1.1

1.59

1.96

u/ml

0.63

410

2938

Rash and other nonspecific skin eruption

101

713

1.43

2.95

1.2

1.1

1.76

2.56

u/ml

0.55

388

Any mental disorder

1408

6407

1.10

2.95

1.1

2.15

2.26

u/ml

0.14

753

3194

Subacute thyroiditis

250

1.74

2.94

1.1

0.28

2.45

u/ml

2.94

125

Other acquired deformities of musculoskeletal system and connective tissue

280

1.70

2.94

1.1

1.98

2.03

u/ml

0.02

147

Menorrhagia

405

1881

1.20

2.94

1.1

1.82

2.18

u/ml

0.35

200

912

Impacted teeth

429

3235

1.19

2.93

1.2

1.1

3.81

2.89

u/ml

0.49

242

1751

Cardiovascular diseases

1216

5906

1.11

2.92

1.1

2.22

2.40

u/ml

0.22

638

3114

Insulin, intermediate and long-acting

362

4199

0.84

2.92

1.1

1.68

2.06

u/ml

0.35

185

2175

Falls/tendency to fall

1553

7104

1.10

2.92

1.1

1.88

2.33

u/ml

1.01

846

3571

malignant neoplasm of male genital organs

730

0.68

2.92

1.0

1.1

0.61

1.37

u/ml

1.67

377

Other local infections of skin and subcutaneous tissue

107

765

1.41

2.92

1.1

5.17

2.38

u/ml

0.91

395

Disturbances of smell and taste

221

1.78

2.91

1.1

0.51

1.94

u/ml

1.59

112

Acne

221

1758

1.27

2.88

1.2

1.1

2.01

2.82

u/ml

0.72

135

954

Unspecified event, undetermined intent

208

1.81

2.86

1.3

1.1

1.72

3.18

u/ml

0.57

109

Post-traumatic stress disorder

162

1242

1.32

2.85

1.2

1.1

2.23

2.70

u/ml

0.28

644

Cholecystitis

601

1.45

2.85

1.2

1.1

0.69

2.37

u/ml

3.01

296

ILD medications: immunosuppressive drugs

689

5627

1.14

2.85

1.1

2.44

2.21

u/ml

0.17

345

2792

Haemangioma and lymphangioma, any site

101

719

1.42

2.84

1.2

1.1

2.27

2.67

u/ml

0.17

388

Superficial injury of thorax

143

1076

1.34

2.84

1.1

2.27

2.28

u/ml

0.01

546

Muscle strain

238

1.75

2.83

1.1

0.95

3.47

u/ml

1.94

122

Condition for Implicit Sepsis (Organ dysfunction codes)

866

6690

0.89

2.82

1.2

1.1

1.93

2.06

u/ml

0.15

458

3410

Other otitis externa (chronic)

481

1.51

2.82

1.1

5.26

2.71

u/ml

0.44

265

Idiopathic pulmonary fibrosis

172

1.87

2.81

1.1

0.58

2.06

u/ml

1.32

Alcoholic liver disease

426

0.49

2.81

1.1

2.83

1.53

u/ml

0.30

218

Type 1 diabetes, wide definition, subgroup 1

204

2563

0.79

2.81

1.1

2.17

2.32

u/ml

0.07

105

1369

Postpartum care and examination

209

1665

0.79

2.80

1.1

2.69

2.20

u/ml

0.22

818

Trigger finger

124

915

1.36

2.80

1.1

0.89

2.28

u/ml

2.40

424

Fracture of femur

919

0.67

2.80

1.1

1.73

2.08

u/ml

0.11

489

Malignant neoplasm of bronchus and lung

431

0.54

2.79

1.1

0.56

1.42

u/ml

1.58

217

Dizziness and giddiness

759

5324

1.13

2.78

1.1

1.42

2.00

u/ml

1.23

402

2615

Fibroblastic disorders

147

1113

1.32

2.78

1.1

0.80

2.14

u/ml

2.34

516

Otitis media, unspecified

229

1692

1.26

2.78

1.3

1.1

2.73

3.35

u/ml

0.29

144

994

Major anomalies of jaw size

240

1.74

2.77

1.2

1.1

2.81

2.59

u/ml

0.05

135

Short Achilles tendon (acquired)

159

1.91

2.77

1.2

1.1

1.58

3.81

u/ml

0.91

Pericarditis

166

1.89

2.77

1.2

1.1

5.45

3.19

u/ml

0.21

Keratoconus

181

1.85

2.76

1.1

10.26

2.10

u/ml

0.94

Toxic effect of contact with venomous animals

340

1.61

2.76

1.1

2.67

3.58

u/ml

0.28

184

Chondropathies

188

1475

1.28

2.76

1.1

2.68

2.21

u/ml

0.26

108

746

Mental and behavioural disorders due to cannabinoids

420

0.49

2.75

1.2

1.1

1.00

2.54

u/ml

1.47

221

Concussion

682

4899

1.14

2.75

1.2

1.1

1.91

2.59

u/ml

1.22

371

2515

Sacrococcygeal disorders, not elsewhere classified

218

1.77

2.75

1.1

0.49

2.13

u/ml

1.69

114

Dyshidrosis [pompholyx]

125

2.04

2.74

1.1

1.74

3.54

u/ml

0.57

Unspecified/other endometriosis

151

1153

1.32

2.74

1.1

1.55

2.02

u/ml

0.27

568

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

278

1.66

2.74

1.0

1.1

5.56

1.44

u/ml

0.80

138

Disorders of parathyroid gland

122

890

1.36

2.73

1.1

1.60

1.47

u/ml

0.04

443

Other and specified injuries of hip and thigh

2.17

2.72

1.1

2.04

3.83

u/ml

0.43

Other erythematous conditions

189

1.82

2.72

1.1

3.47

2.76

u/ml

0.12

Persons encountering health services in circumstances related to reproduction

848

5094

1.12

2.71

1.1

2.63

2.31

u/ml

0.39

464

2679

Oligomenorrhoea

374

1.57

2.70

1.1

2.24

3.00

u/ml

0.26

185

Type 1 diabetes

237

2914

0.81

2.70

1.1

2.55

2.33

u/ml

0.10

122

1573

Supernumerary teeth EXCLUDE clefts and syndromes

2.80

2.69

1.2

1.70

4.00

u/ml

—

Thyroiditis

585

1.45

2.69

1.1

1.87

2.13

u/ml

0.08

306

Other spirochaetal diseases

273

2240

1.22

2.69

1.1

2.06

1.91

u/ml

0.08

134

1101

Diagnoses used for exclusion with ILD

180

1409

1.28

2.68

1.2

1.1

1.64

2.13

u/ml

0.25

700

Other and unspecified visual disturbances

685

1.41

2.68

1.2

1.1

0.75

2.45

u/ml

3.50

347

Benign neoplasm: Other and unspecified parts of mouth

154

1.90

2.67

1.0

1.1

8.50

2.73

u/ml

0.53

Other disorders of veins

358

2997

1.19

2.67

1.1

1.89

1.60

u/ml

0.20

183

1391

Open wound of wrist and hand

544

4628

1.15

2.66

1.1

1.59

2.18

u/ml

1.07

274

2348

Neuralgia and neuritis, unspecified

304

1.63

2.66

1.1

1.65

2.64

u/ml

0.44

152

Persistent mood disorders

205

1634

1.26

2.65

1.2

1.1

1.52

2.14

u/ml

0.42

110

803

Arthropod-borne viral fevers and viral haemorrhagic fevers

183

1439

1.28

2.64

1.1

1.15

2.22

u/ml

2.14

119

765

Other immunodeficiencies

100

2.16

2.63

1.1

1.2

1.26

5.69

u/ml

1.91

Later onset COPD

392

1.49

2.63

1.1

1.73

1.20

u/ml

0.20

196

Other mycoses, not elsewhere classified/unspecified

2.19

2.63

1.2

1.1

1.01

3.94

u/ml

1.28

Disorders of refraction and accommodation

398

3376

1.18

2.63

1.2

1.1

1.48

2.59

u/ml

3.00

208

1829

Tic and related disorders

238

1.74

2.63

1.1

1.2

2.88

3.46

u/ml

0.14

164

Viral haemorrhagic fevers, not elsewhere classified/unspecified

167

1299

1.29

2.62

1.1

1.17

2.26

u/ml

1.95

110

690

Bruxism

170

1.86

2.62

1.1

0.31

3.23

u/ml

2.65

Injury of muscle and tendon at lower leg level

138

1047

1.32

2.62

1.2

1.1

2.06

2.66

u/ml

0.28

541

Tic disorders

231

1.74

2.61

1.1

1.3

2.98

3.00

u/ml

0.00

160

Other factor of the environment

2.35

2.61

1.1

2.70

2.61

u/ml

0.01

Other puerperal infections

150

1155

1.31

2.60

1.1

5.16

2.23

u/ml

1.08

568

Retained placenta and membranes, without haemorrhage

141

1075

1.32

2.60

1.1

2.12

2.00

u/ml

0.05

487

Other bacterial intestinal infections

201

1602

1.26

2.60

1.1

1.82

2.09

u/ml

0.21

110

793

Benign neoplasm of mouth and pharynx

622

1.42

2.59

1.1

3.56

2.20

u/ml

0.33

313

Other viral diseases

457

3930

1.16

2.58

1.2

1.1

1.65

2.52

u/ml

1.26

251

2126

Use of pramipexole

147

1128

1.31

2.57

1.1

0.73

1.97

u/ml

2.56

542

Retinal breaks without detachment

110

809

1.37

2.56

1.1

1.20

1.91

u/ml

0.59

400

Androgenic alopecia

2.57

2.56

1.1

0.56

2.06

u/ml

—

Insulin, fast-acting (human)

115

1536

0.74

2.56

1.1

1.23

2.33

u/ml

1.49

789

Symptoms and signs involving the nervous and musculoskeletal systems

595

5226

1.14

2.55

1.2

1.1

1.77

2.03

u/ml

0.31

350

2659

Other viral hepatitis

663

0.61

2.55

1.2

1.1

1.61

2.67

u/ml

0.62

324

Other spirochaetal diseases

278

2300

1.21

2.54

1.1

2.04

1.93

u/ml

0.06

138

1136

Perforation of tympanic membrane

105

769

1.37

2.53

1.1

1.95

2.73

u/ml

0.41

410

Pleural plaque without asbestos

2.62

2.53

1.2

1.1

1.61

1.53

u/ml

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

301

1.62

2.53

1.1

3.36

2.42

u/ml

0.19

180

Complications associated with artificial fertilization

217

1.74

2.53

1.1

1.82

2.78

u/ml

0.33

107

Lichen ruber planus, wide definition including periferal and oral lichen planus

164

1280

1.29

2.53

1.1

2.01

1.78

u/ml

0.10

609

Familial hypercholesterolemia

517

1.46

2.52

1.1

0.68

2.24

u/ml

2.63

281

Disorders of choroid and retina

521

4248

0.87

2.52

1.1

1.59

1.83

u/ml

0.23

267

2054

Urethritis and urethral syndrome

122

1.99

2.52

1.3

1.1

6.62

2.02

u/ml

0.61

Use of disulfiram, acamprosate or naltrexone

711

0.63

2.52

1.2

1.1

0.81

2.50

u/ml

2.44

354

Adhesive capsulitis of shoulder

118

880

1.35

2.52

1.2

1.1

2.31

1.98

u/ml

0.07

403

Other superficial mycoses

148

1144

1.30

2.49

1.1

1.41

2.37

u/ml

1.00

587

Nausea and vomiting

287

2338

1.21

2.49

1.2

1.1

0.98

2.54

u/ml

3.65

154

1293

Abrasion of teeth

336

2836

1.19

2.48

1.1

1.53

1.93

u/ml

0.49

166

1368

Zoster [herpes zoster]

395

3324

1.17

2.48

1.1

1.89

2.08

u/ml

0.11

210

1621

Contraceptive management

586

3607

1.14

2.48

1.1

1.90

2.09

u/ml

0.20

287

1790

Sicca syndrome [Sjögren]

520

1.45

2.47

1.1

1.33

2.01

u/ml

0.63

254

Drug-induced cataract

130

1.95

2.47

1.4

1.1

3.10

1.82

u/ml

0.18

Implicit Sepsis

688

5657

0.89

2.47

1.1

1.80

2.02

u/ml

0.28

369

2870

Deep bite that required surgery

2.13

2.46

1.1

0.41

3.18

u/ml

—

Pulmonary embolism

178

1408

1.27

2.46

1.1

0.93

1.84

u/ml

1.75

687

Pulmonary heart disease

178

1408

1.27

2.46

1.1

0.93

1.84

u/ml

1.75

688

Sexual dysfunction

2.12

2.45

1.0

1.1

0.22

2.44

u/ml

—

Persistent delusional disorders

469

0.55

2.45

1.2

1.1

0.25

2.18

u/ml

4.35

234

Other and unspecified injuries of ankle and foot

473

1.48

2.45

1.2

1.1

2.62

3.22

u/ml

0.11

253

Appendectomy

816

7006

1.12

2.44

1.1

2.20

2.05

u/ml

0.14

389

3463

Fall on same level involving ice and snow

590

5201

1.14

2.44

1.1

1.60

2.12

u/ml

0.96

312

2595

Suicide or other Intentional self-harm

226

2762

0.81

2.43

1.1

1.21

2.17

u/ml

1.72

118

1389

Type 1 diabetes, strict (exclude DM2)

123

1607

0.76

2.43

1.1

1.2

3.43

2.84

u/ml

0.17

915

Demyelinating diseases of the central nervous system

908

0.68

2.43

1.1

1.41

2.18

u/ml

0.42

454

Excessive earwax

471

3989

1.15

2.43

1.1

2.49

2.00

u/ml

0.38

250

2049

Redundant prepuce, phimosis and paraphimosis

211

1690

1.24

2.42

1.1

1.74

2.29

u/ml

0.32

114

933

Benign neoplasm: Skin of ear and external auricular canal

138

1.90

2.42

1.1

1.99

1.78

u/ml

0.09

Spirochaetal infections, other/unspecified

268

2222

1.21

2.42

1.1

2.05

1.88

u/ml

0.09

135

1087

Haemorrhage in early pregnancy

386

3217

1.17

2.41

1.1

1.52

1.89

u/ml

0.40

178

1548

Other and unspecified trigeminal disorders

2.15

2.41

1.1

1.06

2.22

u/ml

—

Fracture at wrist and hand level

406

3483

1.17

2.41

1.1

1.83

2.39

u/ml

0.54

224

1812

Lichen planus, including avohilmo

137

1052

1.31

2.41

1.1

2.40

1.77

u/ml

0.24

500

Major coronary heart disease event excluding revascularizations

250

2022

0.82

2.40

1.1

2.73

1.43

u/ml

0.64

112

1002

Other functional intestinal disorders

459

3692

1.16

2.40

1.1

2.13

2.36

u/ml

0.19

249

1954

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

296

2480

1.20

2.39

1.2

1.1

2.11

2.00

u/ml

0.06

161

1257

Viral hepatitis

725

0.64

2.39

1.2

1.1

1.51

2.48

u/ml

0.61

358

Lyme disease

265

2198

1.21

2.38

1.1

2.04

1.89

u/ml

0.08

133

1074

Other specified/unspecified bacterial intestinal infections

369

1.53

2.38

1.1

2.43

2.36

u/ml

0.02

194

Colorectal adenocarcinoma

651

0.63

2.37

1.1

0.94

1.41

u/ml

0.52

328

Dementia in Alzheimer disease

213

0.40

2.37

1.5

1.1

0.08

0.84

u/ml

—

102

Sequelae of cerebrovascular disease

104

1204

0.74

2.37

1.1

1.11

1.45

u/ml

0.41

602

Ehlers-Danlos syndrome

140

1.91

2.37

1.2

1.1

1.52

2.79

u/ml

0.39

Hallux rigidus

608

1.40

2.37

1.1

1.46

1.63

u/ml

0.06

293

Other and/or unspecified nontoxic goitre

443

1.48

2.35

1.1

0.77

1.52

u/ml

0.92

215

Chronic periodontitis, complicated

314

3679

0.84

2.35

1.1

1.69

1.81

u/ml

0.08

175

1741

Oxycodone

163

1862

0.79

2.35

1.1

2.64

1.74

u/ml

0.42

886

Hernia of abdominal wall

380

3257

1.17

2.34

1.1

1.87

1.90

u/ml

0.02

196

1599

Primary hyperparathyroidism

477

1.45

2.32

1.1

0.29

1.51

u/ml

2.87

250

Other specified disorders of muscle

162

1.81

2.32

1.1

2.04

1.98

u/ml

0.02

Systemic connective tissue disorders

293

2460

1.19

2.32

1.1

1.93

1.98

u/ml

0.03

155

1191

Dental caries, including avohilmo

818

3753

1.12

2.32

1.1

2.17

1.99

u/ml

0.18

431

1826

Galactorrhea

2.12

2.31

1.1

1.2

0.19

2.69

u/ml

—

Benign paroxysmal vertigo

210

1708

1.23

2.30

1.1

1.31

1.87

u/ml

0.49

106

816

Seborrhoeic keratosis

126

963

1.31

2.30

1.1

1.22

1.50

u/ml

0.18

467

Benign neoplasm of middle ear and respiratory system

372

1.51

2.30

1.1

1.36

2.00

u/ml

0.37

199

Other infective otitis externa

405

1.49

2.30

1.2

1.1

0.73

2.88

u/ml

3.17

215

Contact with machinery

629

1.39

2.30

1.1

1.09

2.41

u/ml

1.74

324

Malignant neoplasm of brain, including Hilmo

315

0.47

2.29

1.3

1.1

7.02

2.09

u/ml

—

178

Benign mammary dysplasia

110

826

1.34

2.29

1.1

1.63

1.89

u/ml

0.10

398

Mild mental retardation

313

0.47

2.28

1.3

1.2

1.04

3.88

u/ml

—

195

Noninfectious colitis NAS

151

1185

1.28

2.28

1.2

1.1

2.71

2.34

u/ml

0.13

625

Other demyelinating diseases of the central nervous system

392

0.53

2.27

1.1

0.15

2.69

u/ml

—

192

Type 1 diabetes, definitions combined

125

1611

0.77

2.26

1.1

1.2

3.43

2.83

u/ml

0.18

917

L04AA Selective immunosuppressants

167

2088

0.80

2.26

1.1

1.83

2.16

u/ml

0.11

1064

Benign neoplasms

1353

6868

1.09

2.26

1.1

2.51

2.21

u/ml

0.39

683

3517

Viral pneumonia (unknown virus, not influenza)

514

1.43

2.26

1.2

1.1

2.52

2.60

u/ml

0.03

267

Colonic or urogenital fistula

244

2022

1.21

2.24

1.1

1.00

2.07

u/ml

2.54

115

991

MS-disease / Multiple Sclerosis

773

0.67

2.24

1.1

1.70

2.28

u/ml

0.24

397

Abnormal findings on diagnostic imaging of breast

2.37

2.23

1.2

1.1

0.35

2.69

u/ml

—

Familial hypercholesterolemia, with ischemic heart disease

209

1.68

2.23

1.1

1.01

1.67

u/ml

0.46

101

Examination and encounter for administrative purposes

202

1.69

2.21

1.2

1.1

2.12

2.79

u/ml

0.17

Mixed conductive and sensorineural hearing loss

541

1.41

2.20

1.1

2.83

2.13

u/ml

0.10

284

Type 1 diabetes, strict definition

111

1446

0.76

2.19

1.1

1.2

2.93

2.72

u/ml

0.06

832

Type 1 diabetes, strict definition, subgroup 1

105

1378

0.75

2.19

1.1

1.2

2.68

2.65

u/ml

0.01

787

Struck by thrown, projected or falling objec

443

1.46

2.18

1.2

1.1

0.68

2.96

u/ml

3.98

237

Other and unspecified erythematous conditions

173

1.75

2.18

1.1

3.85

2.99

u/ml

0.14

Speech and linguistic disorders, excluding more controls

177

1341

1.25

2.18

1.2

3.01

2.83

u/ml

0.06

114

814

Other/unspecified synovitis and tenosynovitis

107

807

1.33

2.18

1.0

1.1

0.66

2.51

u/ml

4.10

390

Enlarged lymph nodes

164

1308

1.26

2.18

1.2

1.1

1.95

2.03

u/ml

0.04

101

670

Viral pneumonia (known virus, not influenza)

151

1.81

2.18

1.2

0.49

3.34

u/ml

2.55

Patellar tendinitis

144

1.84

2.17

1.2

1.1

2.12

2.56

u/ml

0.09

Ptosis of eyelid

451

1.45

2.17

1.2

1.1

0.44

1.84

u/ml

2.80

237

Malignant neoplasm of bronchus and lung, including Hilmo

545

0.64

2.16

1.1

0.47

1.32

u/ml

2.17

278

Female infertility, tubal origin

444

1.45

2.16

1.1

2.86

1.87

u/ml

0.24

205

Other benign neoplasms of uterus

151

1.80

2.16

1.1

9.59

2.03

u/ml

0.91

Primary_lymphoid and hematopoietic malignant neoplasms

1212

0.74

2.16

1.2

1.1

2.35

2.22

u/ml

0.03

647

Other abnormal products of conception

563

3297

1.13

2.16

1.1

1.67

2.18

u/ml

0.68

248

1598

160

1165

1.26

2.16

1.1

1.12

1.34

u/ml

0.16

580

Fasciculation

2.14

2.15

1.0

1.1

0.31

2.82

u/ml

—

Severe mental retardation

0.00

2.15

0.0

1.3

—

3.06

—

Mucosal proctocolitis

1299

0.75

2.13

1.1

0.39

2.25

u/ml

7.82

660

Syncope and collapse

400

2967

1.16

2.13

1.1

2.16

2.17

u/ml

0.01

199

1509

Acute alcohol intoxication

170

2106

0.80

2.13

1.2

1.1

2.45

2.04

u/ml

0.23

1068

Inflammation of lacrimal passages (acute and unspecified)

2.07

2.13

1.3

1.1

0.27

2.14

u/ml

—

Other predominantly sexually transmitted diseases, not elsewhere classified

353

3039

1.17

2.13

1.2

1.1

1.56

2.24

u/ml

0.94

175

1539

Congenital malformations of the respiratory system

221

1.66

2.12

1.2

2.92

2.98

u/ml

0.01

150

Cellulitis

232

1926

1.21

2.12

1.1

2.24

2.23

u/ml

0.00

126

1004

Anogenital herpesviral [herpes simplex] infection

180

1458

1.24

2.12

1.1

2.34

2.48

u/ml

0.08

736

Injuries to the thorax

373

3221

1.16

2.11

1.1

1.92

2.05

u/ml

0.10

193

1601

Artrosis, including avohilmo

915

4547

1.10

2.11

1.1

1.93

1.85

u/ml

0.08

442

2214

Premenstrual syndrome

124

1.90

2.11

1.0

1.1

6.14

3.14

u/ml

—

Tic and related disorders

254

1.62

2.11

1.1

1.2

2.88

2.33

u/ml

0.14

171

Benign neoplasm: Scapula and long bones of upper limb

2.31

2.10

1.1

0.31

2.15

u/ml

—

Kidney transplant status

433

0.57

2.09

1.4

1.2

0.37

2.52

u/ml

3.68

260

Valvular heart disease excluding rheumatic fever

255

2195

0.84

2.09

1.1

3.13

1.74

u/ml

0.76

125

1167

Whooping cough

2.25

2.09

1.2

1.1

2.66

5.30

u/ml

—

Pedal cyclist injured in collision with pedestrian or animal

2.97

2.09

1.2

1.1

9.06

3.00

u/ml

—

Mental and behavioural disorders due to sedatives or hypnotics

642

0.65

2.09

1.1

0.54

2.62

u/ml

4.01

325

Injury of muscle and tendon at hip and thigh level

701

1.35

2.08

1.2

1.1

1.42

2.54

u/ml

0.71

346

Other diseases of liver

165

1325

1.25

2.08

1.1

1.98

1.73

u/ml

0.19

655

Pre-eclampsia or poor fetal growth

353

4069

0.86

2.08

1.1

2.87

2.01

u/ml

0.67

155

1964

Other noninflammatory disorders of vagina

582

1.38

2.07

1.1

1.14

2.39

u/ml

0.88

269

Atrial septal defect, secundum type

453

0.58

2.07

1.1

1.2

7.41

3.33

u/ml

0.37

316

Implicit bacterial Sepsis

173

1892

0.81

2.07

1.1

1.48

1.82

u/ml

0.28

105

956

Nonorganic sleeping disorders

278

2353

1.19

2.07

1.2

1.1

2.46

2.28

u/ml

0.10

147

1181

Chronic mastoiditis

2.04

2.06

1.1

0.21

1.63

u/ml

—

Dislocation, sprain and strain of joints and ligaments of thorax

230

1.63

2.06

1.1

1.43

3.68

u/ml

1.56

119

Secondary polycythaemia

103

1.96

2.06

1.3

1.1

0.26

1.83

u/ml

1.02

Abnormal findings on diagnostic imaging of other body structures

105

797

1.32

2.06

1.2

1.1

1.49

2.48

u/ml

0.57

398

Congenital malformations of trachea and bronchus

2.16

2.06

1.3

1.2

3.96

3.17

u/ml

0.08

Pleural plaque with presence of asbestos

103

1.95

2.05

1.2

1.1

0.50

1.42

u/ml

—

Ischemic heart diseases

618

4153

0.89

2.05

1.1

1.99

1.91

u/ml

0.05

289

2099

Endometriosis of ovary

187

1488

1.23

2.05

1.1

1.37

2.16

u/ml

0.64

714

L02BG Aromatase inhibitors

135

1705

0.79

2.05

1.1

1.58

1.33

u/ml

0.14

803

Atrial septal defect

560

0.63

2.04

1.1

1.2

6.71

3.27

u/ml

0.34

389

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

192

1.68

2.04

1.1

1.54

2.50

u/ml

0.33

107

208

1.66

2.03

1.1

1.34

1.87

u/ml

0.28

111

Type1 diabetes, definitions combined, early onset

1257

0.75

2.03

1.1

1.2

3.19

2.87

u/ml

0.08

741

Pterygium

2.12

2.03

1.1

0.56

1.24

u/ml

—

LeFortI or BSSO operation

434

1.44

2.03

1.1

0.38

2.73

u/ml

4.44

219

Acute otitis externa, noninfective

2.08

2.03

1.2

1.1

3.20

3.17

u/ml

—

Other prurigo

2.54

2.02

1.1

1.2

0.44

2.25

u/ml

—

Alzheimer disease, excluding more controls

252

0.55

2.02

1.3

1.1

0.29

1.24

u/ml

0.95

121

Lichen planus

636

1.36

2.01

1.1

3.36

1.79

u/ml

0.47

324

Right bundle-branch block

111

1.90

2.01

1.1

3.01

2.12

u/ml

—

Hyperparathyroidism

722

1.33

2.01

1.1

0.39

1.34

u/ml

3.29

365

Congenital absence, atresia and stenosis of large intestine

0.00

2.01

0.0

1.3

—

1.96

—

Otitis externa, unspecified

135

1065

1.28

2.00

1.2

1.1

4.49

2.42

u/ml

0.94

563

Respiratory insufficiency

140

1.79

1.99

1.2

1.1

0.54

0.86

u/ml

0.49

L04AC Interleukin inhibitors

561

0.64

1.98

1.1

0.53

2.58

u/ml

4.71

298

Non-selective monoamine reuptake inhibitors

285

2338

1.18

1.97

1.1

0.99

1.90

u/ml

2.11

163

1075

Testicular dysfunction

241

1.59

1.97

1.2

1.1

3.23

1.80

u/ml

0.26

119

Viral infections characterized by skin and mucous membrane lesions

468

4129

1.14

1.97

1.2

1.1

2.39

2.32

u/ml

0.04

267

2174

Pulmonary heart disease, diseases of pulmonary circulation

190

1559

1.22

1.96

1.1

0.88

1.86

u/ml

2.20

775

Focal epilepsy

153

1895

0.80

1.96

1.2

1.1

1.80

2.48

u/ml

0.55

1035

Persons encountering health services for specific procedures, not carried out

744

1.33

1.95

1.2

1.1

1.09

2.63

u/ml

2.42

359

Polyarthritis, unspecified

218

1.62

1.95

1.1

0.82

3.69

u/ml

2.42

115

Benign neoplasm: Other and unspecified parts of small intestine

2.59

1.95

1.0

1.2

1.82

2.29

u/ml

—

Arteriovenous malformation of cerebral vessels

2.49

1.94

1.0

1.1

0.09

3.85

u/ml

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

976

7331

0.92

1.93

1.2

1.1

1.70

2.12

u/ml

0.70

537

3706

Endometriosis ASRM stages 1,2

237

1993

1.19

1.93

1.1

1.33

1.92

u/ml

0.47

100

957

Postdysenteric arthropathy

2.29

1.93

1.2

1.1

0.17

2.86

u/ml

—

Testicular hypofunction

211

1.63

1.93

1.2

1.1

3.36

1.85

u/ml

0.23

101

Other hammer toe(s) (acquired)

638

1.33

1.92

1.1

0.69

1.63

u/ml

1.21

310

Myocardial infarction

184

1576

0.82

1.92

1.2

1.1

3.25

1.35

u/ml

0.76

773

Erosion of teeth , including avohilmo

347

3010

1.16

1.92

1.2

1.1

1.45

2.30

u/ml

1.13

190

1537

Viral infections of central nervous system, not elsewhere classified/unspecified

2.03

1.92

1.1

5.43

1.58

u/ml

—

Chronic viral hepatitis

568

0.65

1.91

1.2

1.1

1.49

2.55

u/ml

0.57

281

Diverticular disease of intestine

531

3011

1.13

1.91

1.1

1.09

1.66

u/ml

1.01

242

1433

Acute alcohol intoxication, ICD10

150

1857

0.80

1.91

1.2

1.1

2.65

2.26

u/ml

0.19

954

Other disorders of conjunctiva

642

1.34

1.91

1.1

1.19

2.00

u/ml

0.77

321

Maternal care for other conditions predominantly related to pregnancy

353

3008

1.16

1.91

1.1

3.07

2.06

u/ml

0.60

174

1466

Impacted maxillary canine

167

1.74

1.90

1.1

1.2

5.00

4.67

u/ml

0.04

109

Bleeding

616

4874

0.90

1.90

1.1

2.04

1.94

u/ml

0.09

333

2439

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

516

4588

1.13

1.90

1.1

1.45

1.82

u/ml

0.56

283

2218

Ulcer of vagina/vulva

220

1.61

1.90

1.2

1.1

4.24

4.11

u/ml

0.01

115

Use of biperiden

306

0.52

1.90

1.1

0.53

2.45

u/ml

—

160

Osteopathies and chondropathies

517

4286

1.13

1.90

1.1

2.28

2.05

u/ml

0.19

288

2135

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

456

1.41

1.90

1.1

1.38

1.77

u/ml

0.24

235

Family history of malignant neoplasm

1104

0.75

1.90

1.1

1.67

2.05

u/ml

0.20

527

Autonomic disorders

136

1.79

1.89

1.1

0.52

2.25

u/ml

1.51

Disorders of vitreous body

314

2612

1.16

1.88

1.1

0.64

1.61

u/ml

4.87

155

1223

Procedures for purposes other than remedying health state

151

1.74

1.88

1.2

1.1

0.25

1.36

u/ml

2.00

Non-Hodgkin lymphoma, all, including Hilmo

543

0.64

1.88

1.0

1.1

5.89

1.93

u/ml

0.46

295

Calculus of kidney and ureter

216

1805

1.20

1.87

1.2

1.1

0.65

2.08

u/ml

5.82

115

906

False labour

553

3078

1.12

1.87

1.1

2.02

2.12

u/ml

0.08

263

1524

Poor fetal growth

156

1915

0.81

1.87

1.1

4.21

2.04

u/ml

1.07

937

Other bursitis of knee

2.06

1.87

1.1

0.29

3.18

u/ml

—

Lesion of ulnar nerve

121

951

1.28

1.87

1.1

0.99

2.23

u/ml

2.00

453

Glaucoma suspect

211

1760

1.20

1.86

1.1

1.90

1.72

u/ml

0.06

865

Postmenopausal bleeding

163

700

1.25

1.86

1.1

0.54

1.63

u/ml

2.86

332

Secondary and unspecified malignant neoplasm of lymph nodes

406

0.59

1.86

1.2

1.1

2.47

2.39

u/ml

0.02

214

Other superficial mycoses

167

1.70

1.86

1.2

1.1

0.55

2.72

u/ml

2.17

Complications of procedures, not elsewhere classified

866

6555

1.09

1.86

1.1

1.37

1.99

u/ml

1.76

450

3194

Delivery

401

2415

0.87

1.85

1.1

3.71

2.13

u/ml

1.31

217

1250

Fitting and adjustment of other devices

194

1448

1.21

1.85

1.2

1.1

0.99

1.84

u/ml

1.59

700

Myocarditis

350

1.47

1.85

1.2

1.1

1.48

1.72

u/ml

0.12

178

Other arrhythmias

697

4759

1.11

1.85

1.1

1.37

1.90

u/ml

1.23

347

2340

Faecal incontinence

383

1.44

1.85

1.1

0.53

1.67

u/ml

1.55

196

Localized swelling, mass and lump of skin and subcutaneous tissue

296

2545

1.17

1.84

1.1

1.19

2.22

u/ml

1.90

153

1285

Bacterial infection, other or unspecified

316

3169

0.86

1.84

1.1

1.90

1.82

u/ml

0.04

174

1622

Bacterial infection, other or unspecified

372

3594

0.87

1.84

1.1

2.22

1.84

u/ml

0.26

206

1829

Pain associated with micturition

108

839

1.29

1.83

1.1

2.68

2.38

u/ml

0.09

438

Injury of muscle and tendon at ankle and foot level

183

1.66

1.83

1.1

1.52

3.42

u/ml

0.61

Other protozoal intestinal diseases

191

1.65

1.83

1.1

0.72

3.83

u/ml

2.34

106

Bilateral sagittal split ramus osteotomy operation

352

1.47

1.83

1.1

0.37

2.99

u/ml

3.94

177

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

328

0.55

1.82

1.0

1.1

1.42

1.36

u/ml

—

160

Thyroiditis, unspecified

101

1.91

1.82

1.2

1.1

0.92

2.87

u/ml

—

Presence of cardiac and vascular implants and grafts

151

1385

0.81

1.82

1.1

1.99

1.57

u/ml

0.16

707

Bicipital tendinitis

230

1.58

1.82

1.2

1.1

0.28

2.44

u/ml

2.50

118

Diseases of tongue

327

1.48

1.81

1.1

0.46

2.26

u/ml

1.75

140

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

167

2030

0.82

1.81

1.1

1.25

2.28

u/ml

1.36

1020

Residual foreign body in soft tissue

402

1.43

1.81

1.1

1.61

3.24

u/ml

0.84

207

Biological medication for rheuma

164

1997

0.82

1.81

1.1

0.41

2.38

u/ml

11.44

1014

Ectropion of eyelid

2.27

1.80

1.1

0.24

1.08

u/ml

—

Dislocation, sprain and strain of joint and ligaments of hip

153

1.71

1.80

1.2

1.1

0.28

2.13

u/ml

1.63

Insulin, fast-acting or short human

285

3305

0.86

1.79

1.1

2.06

2.16

u/ml

0.06

137

1742

Exposure to other and unspecified inanimate mechanical forces

703

1.32

1.79

1.1

1.23

2.80

u/ml

1.93

381

Benign lipomatous neoplasm

225

1898

1.19

1.78

1.1

1.68

1.97

u/ml

0.13

104

919

Focal epilepsy, mode (most common among epilepsy diagnosis)

129

1605

0.80

1.76

1.2

1.1

2.07

2.47

u/ml

0.23

882

Disorders of vitreous body and globe

322

2685

1.15

1.76

1.1

0.64

1.64

u/ml

5.16

158

1260

Coronary atherosclerosis

315

2300

0.87

1.76

1.1

2.67

1.52

u/ml

0.72

156

1116

Certain conditions originating in the perinatal period

220

1648

1.19

1.75

1.2

2.91

3.41

u/ml

0.24

140

1007

Insulin, fast-acting

285

3297

0.86

1.74

1.1

2.06

2.16

u/ml

0.06

137

1740

Non-rheumatic valve diseases

251

2122

0.85

1.74

1.1

3.12

1.79

u/ml

0.70

123

1118

Female genital prolapse

253

1213

1.18

1.74

1.1

1.27

2.01

u/ml

0.93

113

567

Other congenital malformations of skin

423

1.41

1.74

1.1

1.2

1.45

2.97

u/ml

0.83

248

Melanocytic naevi of other and unspecified parts of face

465

1.39

1.73

1.2

1.1

0.88

2.80

u/ml

2.53

236

Dental caries

247

2025

1.18

1.72

1.2

1.1

2.18

2.23

u/ml

0.02

153

982

Additional codes for the location of defect, injury or illness

398

1.42

1.72

1.1

3.01

2.72

u/ml

0.05

221

Medicines for HER+ breast cancer

207

2327

0.84

1.72

1.1

1.85

1.59

u/ml

0.19

109

1058

Scleritis and episcleritis

466

1.38

1.71

1.1

1.90

2.47

u/ml

0.16

232

Biomechanical lesions, not elsewhere classified

250

1.53

1.71

1.3

1.1

0.93

2.74

u/ml

1.23

126

Intracranial injury

645

5534

1.10

1.71

1.2

1.1

1.60

2.19

u/ml

1.17

356

2875

Other follicular disorders

682

1.31

1.71

1.1

1.92

2.31

u/ml

0.20

344

Helminthiases

111

1.83

1.70

1.3

1.2

0.26

3.32

u/ml

—

Atrial fibrillation and flutter

223

1708

0.84

1.70

1.1

2.39

1.68

u/ml

0.29

106

828

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

259

1.52

1.70

1.1

1.69

3.61

u/ml

0.65

135

Other symptoms and signs involving the digestive system and abdomen

149

1215

1.23

1.70

1.2

1.1

1.23

2.02

u/ml

0.89

631

Amblyopia ex anopsia

502

1.37

1.69

1.1

1.2

1.01

3.22

u/ml

2.48

313

Malignant neoplasm of head and neck

281

0.53

1.69

1.1

0.17

1.61

u/ml

—

135

Benign neoplasm: Stomach

399

1.41

1.69

1.1

1.07

1.73

u/ml

0.43

202

Dialysis

280

0.53

1.68

1.7

1.1

0.19

1.98

u/ml

—

176

Spirochaetal infections, other/unspecified

510

1.36

1.68

1.2

1.1

2.90

2.39

u/ml

0.11

274

Acute lymphadenitis

623

1.33

1.68

1.1

1.58

2.80

u/ml

0.68

324

Carcinoma in situ of skin of other and unspecified parts of face

126

1.75

1.67

1.1

0.76

0.87

u/ml

0.08

Benign neoplasm: Vagina

2.13

1.67

1.1

1.54

2.87

u/ml

—

Acute nasopharyngitis (common cold)

124

987

1.25

1.66

1.1

1.99

2.68

u/ml

0.28

530

Open wound of hip and thigh

293

1.48

1.66

1.1

2.17

3.70

u/ml

0.44

158

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

469

1.37

1.65

1.1

2.06

2.55

u/ml

0.16

243

Special screening examination for neoplasms

236

1.53

1.65

1.2

1.1

2.82

2.71

u/ml

0.02

108

All-cause Heart Failure

202

1692

0.84

1.64

1.1

1.58

1.49

u/ml

0.04

863

Alopecia areata

237

1.54

1.64

1.0

1.1

2.48

3.11

u/ml

0.12

129

Exposure to other and unspecified man-made environmental factors

120

1.78

1.64

1.1

4.64

2.64

u/ml

0.23

Other retinal artery occlusion

2.26

1.64

1.0

1.2

0.82

1.27

u/ml

—

Burns and corrosions confined to eye and internal organs

205

1.58

1.64

1.1

2.18

3.09

u/ml

0.29

110

Pilonidal cyst

1043

0.76

1.63

1.1

1.09

2.32

u/ml

1.57

520

Disorders of eyelid in diseases classified elsewhere

205

1.58

1.63

1.2

1.1

2.33

2.84

u/ml

0.16

111

Heart failure, strict

207

1727

0.84

1.63

1.1

1.55

1.49

u/ml

0.03

101

885

Contusion of toe(s) with damage to nail

1.90

1.63

1.2

1.1

6.13

3.03

u/ml

—

Other inflammation of vagina/vulva

404

1.40

1.61

1.1

1.55

2.74

u/ml

0.48

193

Disorders of orbit

295

1.47

1.61

1.0

1.1

0.89

2.15

u/ml

1.05

159

Inflammatory disorders of breast

733

1.29

1.61

1.2

1.1

2.28

2.78

u/ml

0.18

372

Other, unspecified and serous retinal detachments

128

1.73

1.61

1.2

1.1

2.54

2.58

u/ml

—

Heart failure,strict

200

1671

0.84

1.60

1.1

1.63

1.40

u/ml

0.10

853

Malignant neoplasm of prostate

600

0.76

1.60

1.0

1.1

0.38

1.37

u/ml

2.74

310

Major coronary heart disease event

598

3981

0.91

1.60

1.1

2.09

1.85

u/ml

0.18

272

2013

Fall involving playground equipment

177

1.65

1.59

1.4

1.3

3.56

4.62

u/ml

0.12

134

Burn and corrosion confined to eye and adnexa

175

1.62

1.59

1.1

2.52

2.16

u/ml

0.09

Adenocarcinoma and papilloma adenocarcinoma of rectum

313

0.57

1.58

1.0

1.1

1.42

1.35

u/ml

—

150

Supplementary factors related to causes of morbidity and mortality classified elsewhere

345

3039

1.14

1.58

1.2

1.1

2.18

2.35

u/ml

0.12

201

1585

Abnormal findings on diagnostic imaging of central nervous system

363

1.42

1.58

1.1

4.97

2.92

u/ml

0.28

193

Other disorders of the musculoskeletal system and connective tissue

106

840

1.27

1.58

1.2

1.1

1.29

2.02

u/ml

0.72

418

Pedestrian injured in collision with pedal cycle

191

1.58

1.1

0.79

2.43

u/ml

1.54

103

Coeliac disease

140

1146

1.23

1.57

1.1

3.30

2.54

u/ml

0.27

615

Acute generalized exanthematous pustulosis

330

1.44

1.57

1.1

0.61

3.00

u/ml

3.34

180

Care involving dialysis

447

0.65

1.57

1.4

1.2

0.83

2.49

u/ml

1.91

240

Acute gastritis

338

1.43

1.57

1.1

0.63

1.91

u/ml

1.60

176

Gastric ulcer

594

1.32

1.57

1.1

1.10

1.73

u/ml

0.69

306

Malignant neoplasm of rectum

324

0.58

1.56

1.2

1.1

1.29

1.33

u/ml

—

157

Myocardial infarction, strict

171

1457

0.83

1.56

1.2

1.1

2.47

1.36

u/ml

0.50

717

Caries of dentine, including avohilmo

909

4285

1.09

1.56

1.1

2.58

2.08

u/ml

0.55

482

2116

Unspecified kidney failure

311

0.58

1.55

1.2

1.1

0.30

1.91

u/ml

—

162

Puerperal sepsis

119

959

1.25

1.55

1.1

2.81

1.84

u/ml

0.24

462

Anosmia

126

1.71

1.54

1.1

0.63

1.78

u/ml

0.80

Hypertensive diseases

819

5019

0.92

1.54

1.1

2.26

1.89

u/ml

0.38

425

2474

Other congenital malformations of tongue, mouth and pharynx

407

1.40

1.54

1.2

2.09

3.06

u/ml

0.50

285

Poisoning by drugs, medicaments and biological substances

251

2899

0.86

1.54

1.2

1.1

1.44

2.27

u/ml

1.18

145

1480

Other benign neoplasm of uterus: Other parts/unspecified

2.04

1.54

1.2

7.57

1.17

u/ml

—

Benign neoplasm: Tongue

115

1.75

1.53

1.2

1.1

0.32

1.98

u/ml

1.12

DVT of lower extremities and pulmonary embolism

254

2186

1.16

1.53

1.1

1.00

1.74

u/ml

1.80

127

1067

Basal cell carcinoma, including avohilmo

189

1542

0.84

1.53

1.1

0.71

1.18

u/ml

1.33

764

Ulcerative colitis (strict definition, require KELA)

145

1751

0.82

1.52

1.1

1.15

2.24

u/ml

1.39

903

Symptoms and signs concerning food and fluid intake

102

808

1.27

1.52

1.2

1.1

1.65

2.76

u/ml

0.64

460

Other malignant neoplasms of skin (=non-melanoma skin cancer)

187

1519

0.84

1.52

1.1

1.11

1.19

u/ml

0.06

755

Other female pelvic inflammatory diseases

153

1269

1.21

1.51

1.1

2.81

2.08

u/ml

0.23

571

Congenital malformations of the musculoskeletal system, not elsewhere classified

178

1.60

1.51

1.2

1.45

4.19

u/ml

1.06

109

Reimbursement for rheumatic diseases

468

5173

0.90

1.51

1.1

1.28

1.97

u/ml

1.21

227

2594

Ankle and foot

2.11

1.51

1.1

14.48

2.34

u/ml

—

Diseases of pulp and periapical tissues and dental caries

722

3385

1.09

1.51

1.1

2.24

2.06

u/ml

0.18

387

1627

Acute epiglottitis

1.92

1.50

1.3

1.1

0.52

3.49

u/ml

—

Whooping cough

147

1.66

1.50

1.3

1.2

1.84

5.66

u/ml

1.75

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

677

0.72

1.49

1.1

3.83

1.78

u/ml

0.40

351

Retinal detachments and breaks

199

1692

1.18

1.49

1.1

1.16

1.65

u/ml

0.63

103

816

Collagenous colitis

600

1.31

1.49

1.1

0.45

2.23

u/ml

4.75

307

Alzheimer’s disease, strict definition

335

0.64

1.49

1.3

1.1

0.30

0.74

u/ml

2.19

159

Hypertension

819

5008

0.92

1.48

1.1

2.26

1.90

u/ml

0.37

425

2468

Glucosamine medication

209

1421

1.18

1.48

1.1

0.76

1.22

u/ml

1.06

111

689

Other abnormal uterine and vaginal bleeding

204

1242

1.18

1.47

1.2

1.1

1.56

1.96

u/ml

0.32

105

600

Colorectal cancer

840

0.76

1.47

1.1

0.76

1.35

u/ml

1.10

423

Oral leukoplakia, including avohilmo

109

1.76

1.47

1.2

1.1

3.18

2.30

u/ml

—

Achilles tendinitis

636

1.29

1.47

1.1

1.78

1.68

u/ml

0.05

293

Intermittent heterotropia

877

0.76

1.47

1.1

1.2

0.76

3.15

u/ml

3.57

540

COPD, hospital admissions 3, with asthma pneumonia sepsis

662

1.27

1.47

1.1

0.92

1.79

u/ml

0.96

342

Other and unspecified corneal deformities and disorders

203

1.54

1.46

1.0

1.1

0.37

2.05

u/ml

2.36

106

Other abnormal auditory perceptions

1.91

1.46

1.2

2.38

1.96

u/ml

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

143

1195

0.83

1.46

1.1

1.03

1.75

u/ml

0.89

580

Complications following infusion, transfusion and therapeutic injection

1.90

1.46

1.3

1.2

2.57

3.26

u/ml

—

Benign intracranial hypertension

133

1.69

1.46

1.2

1.1

2.99

4.03

u/ml

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

157

1872

0.84

1.45

1.1

1.96

2.20

u/ml

0.09

965

Early lumbar disc prolapse, operated

145

1204

1.21

1.44

1.1

3.02

2.41

u/ml

0.20

571

Astigmatism

753

1.27

1.44

1.1

1.2

2.05

3.39

u/ml

0.95

459

Extracorporeal dialysis

316

0.60

1.44

1.5

1.1

1.16

2.45

u/ml

—

174

Other bursal cyst

2.06

1.44

1.0

1.1

3.48

1.97

u/ml

—

Endometriosis of rectovaginal septum and vagina

542

1.32

1.44

1.2

1.1

1.73

1.85

u/ml

0.03

252

Hydronephrosis

649

0.72

1.44

1.1

6.02

2.37

u/ml

0.41

329

Ulcerative colitis (strict definition, all Crohn cases excluded)

121

1477

0.82

1.44

1.1

1.29

2.29

u/ml

0.93

757

Chronic apical periodontitis

1237

7508

0.94

1.44

1.1

1.82

2.07

u/ml

0.38

661

3713

Other disorders of prostate

1.93

1.44

1.1

0.43

2.83

u/ml

—

Unspecified fall

513

4584

1.10

1.44

1.2

1.1

3.27

2.18

u/ml

1.02

284

2451

Fall on and from stairs and steps

236

2042

1.16

1.43

1.1

2.04

2.13

u/ml

0.05

131

1034

Pure hypercholesterolaemia

471

3407

0.90

1.43

1.1

1.01

1.79

u/ml

1.96

248

1646

Hypertrophic scar

543

1.32

1.43

1.1

2.06

2.84

u/ml

0.36

278

Other orthopaedic follow-up care

328

1.41

1.43

1.1

0.70

2.52

u/ml

1.89

159

Sequelae of injuries, of poisoning and of other consequences of external causes

233

2015

1.16

1.43

1.1

1.64

2.02

u/ml

0.31

131

1013

Monoamine oxidase A inhibitors

692

1.28

1.43

1.1

0.91

2.15

u/ml

1.90

334

Congenital malformations of the respiratory system

205

1.54

1.42

1.2

3.07

2.88

u/ml

0.03

141

Other neurotic disorders

237

1.49

1.42

1.3

1.1

0.37

1.79

u/ml

1.79

117

Tumor necrosis factor alpha inhibitors

153

1823

0.84

1.42

1.1

0.42

2.41

u/ml

10.68

931

Other diseases of pleura

245

1862

1.15

1.42

1.1

1.11

1.84

u/ml

0.91

125

955

Palmar fascial fibromatosis [Dupuytren]

465

1.34

1.41

1.1

0.87

2.00

u/ml

1.00

234

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

142

1703

0.83

1.41

1.1

1.16

2.29

u/ml

1.40

882

Habitual aborter

263

1.46

1.41

1.1

0.65

2.43

u/ml

1.50

119

Open wound of abdomen, lower back and pelvis

271

1.45

1.41

1.2

1.1

2.09

4.27

u/ml

0.59

150

Pregnancy, childbirth and the puerperium

308

1826

0.88

1.40

1.1

3.16

2.66

u/ml

0.32

164

948

Benign neoplasm: Skin of eyelid, including canthus

783

1.26

1.40

1.1

3.89

2.19

u/ml

0.40

384

Sequelae of injuries of upper limb

757

1.26

1.39

1.1

1.72

2.08

u/ml

0.15

387

Cystic kidney disease

237

0.54

1.39

1.1

1.16

3.54

u/ml

—

144

Other disorders starting during childhood or adolecense, excluding more controls

128

1011

1.22

1.39

1.2

2.35

2.84

u/ml

0.23

625

Maternal care for other known or suspected fetal problems

383

2710

0.89

1.39

1.1

3.30

2.21

u/ml

0.94

174

1362

Retention of urine

129

1282

0.82

1.39

1.2

1.1

1.38

1.79

u/ml

0.35

643

Superficial injury of shoulder and upper arm

115

937

1.23

1.39

1.1

3.33

2.40

u/ml

0.30

474

Misadventures to patients during surgical and medical care

116

946

1.23

1.38

1.2

1.1

1.33

2.23

u/ml

0.66

464

Hypertensive Renal Disease

1.95

1.38

1.0

1.1

1.23

2.28

u/ml

—

Inflammatory disease of cervix uteri

356

1.38

1.2

1.1

0.85

1.68

u/ml

0.56

161

Eustachian salpingitis and obstruction

119

975

1.23

1.37

1.1

5.79

2.62

u/ml

0.81

491

Nontoxic single thyroid nodule

468

1.33

1.37

1.1

1.51

2.09

u/ml

0.24

235

Other specified and unspecified disorders of choroid

3.01

1.37

1.2

1.0

0.95

1.82

u/ml

—

Congenital malformations of the urinary system

641

0.73

1.37

1.1

1.2

0.61

3.11

u/ml

5.05

379

Focal epilepsy, strict definition

139

1664

0.83

1.36

1.2

1.1

1.44

2.58

u/ml

1.31

921

Urolithiasis

221

1911

1.16

1.36

1.2

1.1

0.64

2.10

u/ml

6.04

117

956

Ill-defined and unknown causes of mortality

236

0.55

1.36

1.1

1.19

2.34

u/ml

—

120

Benign neoplasm: Parotid gland

374

1.37

1.36

1.2

1.1

0.98

2.41

u/ml

1.38

195

Chondromalacia

183

1.54

1.35

1.3

1.1

0.51

2.10

u/ml

1.63

Non-follicular lymphoma

359

0.64

1.35

1.0

1.1

10.78

2.27

u/ml

—

199

Lesion of radial nerve

183

1.54

1.35

1.1

11.79

2.27

u/ml

0.64

Barrett oesophagus

175

1.55

1.34

1.1

0.30

2.03

u/ml

2.11

Other retinal disorders

362

3152

0.89

1.34

1.1

1.90

1.80

u/ml

0.06

177

1590

Presence of other functional implants

277

2184

0.88

1.34

1.2

1.1

1.45

1.62

u/ml

0.14

121

1079

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

845

5821

0.93

1.33

1.1

1.62

1.83

u/ml

0.26

407

2820

Generalized skin eruption due to drugs and medicaments

291

1.42

1.33

1.1

0.66

2.70

u/ml

2.61

160

Juvenile osteochondrosis

385

1.36

1.33

1.1

1.28

3.60

u/ml

1.49

207

Chronic kidney disease

105

1264

0.81

1.33

1.2

1.1

2.99

1.90

u/ml

0.25

665

Generalized epilepsy, strict definition

275

1.44

1.33

1.2

2.07

3.11

u/ml

0.34

162

Sarcoidosis

107

870

1.23

1.32

1.1

1.61

2.10

u/ml

0.17

413

Intestinal malabsorption

325

1.39

1.32

1.1

3.53

2.43

u/ml

0.15

179

Benign neoplasm of major salivary glands

462

1.33

1.32

1.2

1.1

0.80

2.15

u/ml

1.75

243

Other congenital malformations of circulatory system

160

1.58

1.32

1.1

3.43

3.23

u/ml

0.02

Other disorders of optic disc

1.76

1.32

1.4

1.2

3.40

3.78

u/ml

—

Emotional disorders starting during childhood or adolecense, excluding more controls

119

957

1.22

1.32

1.1

1.2

2.63

3.00

u/ml

0.13

585

Infections with a predominantly sexual mode of transmission

460

4168

1.10

1.32

1.1

1.85

2.06

u/ml

0.21

222

2089

Implicit bacterial Sepsis

209

2086

0.86

1.32

1.1

2.01

1.76

u/ml

0.17

126

1069

Congenital malformations of the urinary system

671

0.74

1.32

1.1

1.2

0.57

3.07

u/ml

5.40

396

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

341

3813

0.89

1.32

1.1

1.54

2.10

u/ml

0.85

173

1921

Sulfasalazine

251

2198

1.14

1.31

1.1

1.23

1.94

u/ml

0.87

113

1021

Stenosis and insufficiency of lacrimal passages

533

1.30

1.31

1.2

1.1

1.69

2.61

u/ml

0.29

281

Autoimmune thyroiditis

169

1.56

1.30

1.1

3.63

3.16

u/ml

0.05

Impacted cerumen

551

1.29

1.30

1.2

2.08

2.56

u/ml

0.12

311

Other/unspecified rheumatoid arthritis

556

0.72

1.30

1.2

1.1

0.89

1.88

u/ml

0.71

281

Hyperhidrosis

276

1.43

1.29

1.2

1.1

3.34

3.04

u/ml

0.06

134

Other bursitis of hip

1.77

1.29

1.1

2.53

3.08

u/ml

—

Varicose veins

363

3056

0.90

1.29

1.1

2.36

1.60

u/ml

0.44

144

1425

Cardiac murmurs and other cardiac sounds

121

989

1.21

1.29

1.2

1.1

3.34

3.27

u/ml

0.02

544

Polycystic ovarian syndrome, consortium definition

962

5323

1.07

1.29

1.1

2.28

2.15

u/ml

0.13

487

2591

Diabetic nephropathy, excluding more controls

580

0.75

1.28

1.0

1.1

0.73

1.33

u/ml

0.69

296

Benign neoplasm: Larynx

114

1.68

1.28

1.1

0.45

2.41

u/ml

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

543

4906

1.09

1.28

1.1

1.40

1.81

u/ml

0.67

297

2371

Scleritis

1.81

1.28

1.1

0.51

2.73

u/ml

—

Congenital malformations of breast

244

1.46

1.28

1.2

1.1

1.86

3.51

u/ml

0.69

128

Other and unspecified injuries of lower leg

731

1.25

1.28

1.1

0.94

2.70

u/ml

2.72

393

Tobacco use

405

1.34

1.27

1.1

6.62

2.87

u/ml

0.43

199

Varicose veins of other sites

405

1.34

1.27

1.1

3.06

1.81

u/ml

0.38

201

Malignant neoplasm of corpus uteri, including Hilmo

365

0.66

1.27

1.3

1.1

0.45

1.26

u/ml

—

192

Myopia

188

1620

1.17

1.26

1.1

1.79

2.32

u/ml

0.50

835

Actinic keratosis

122

935

1.21

1.26

1.1

1.20

1.15

u/ml

0.03

475

Cystic kidney disease

254

0.59

1.26

1.1

1.02

3.39

u/ml

—

151

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

147

1.60

1.26

1.1

1.2

2.41

4.04

u/ml

0.31

Mixed specific developmental disorders

579

0.74

1.25

1.1

1.3

4.81

2.84

u/ml

0.29

409

Hordeolum and other deep inflammation of eyelid

520

1.30

1.25

1.2

1.1

3.29

2.88

u/ml

0.13

285

Basal cell carcinoma

176

1421

0.86

1.25

1.1

0.59

1.16

u/ml

1.90

715

Cysts of oral region, not elsewhere classified

398

1.34

1.24

1.1

0.24

2.81

u/ml

5.24

214

Colorectal neuroendocrine tumor and carcinoma

1.93

1.23

1.2

1.1

0.67

2.44

u/ml

—

Seropositive rheumatoid arthritis, strict definition

923

0.79

1.23

1.1

0.74

1.83

u/ml

1.40

449

Malignant neoplasm of prostate, including Hilmo

638

0.80

1.23

1.0

1.1

0.65

1.48

u/ml

1.63

330

Viral infections of central nervous system, not elsewhere classified/unspecified

1.99

1.23

1.1

7.58

1.79

u/ml

—

Speech and linguistic disorders

193

1604

1.16

1.23

1.2

3.06

2.81

u/ml

0.10

124

981

Other specified/unspecified hearing loss

373

1.35

1.22

1.1

0.85

2.17

u/ml

1.57

200

Small fibre neuropathy

116

1.65

1.22

1.3

1.1

0.79

2.29

u/ml

—

Single delivery by caesarean section

285

1842

0.88

1.22

1.2

1.1

3.92

1.99

u/ml

1.04

134

963

Exclusions for E4_PCOS_BROAD

215

1876

1.15

1.21

1.2

2.86

2.35

u/ml

0.24

117

1037

Other congenital malformations of the digestive system

732

1.24

1.21

1.2

3.13

3.37

u/ml

0.05

480

Disorders of lacrimal system and orbit in diseases classified elsewhere

156

1.55

1.21

1.0

1.1

0.67

2.39

u/ml

1.29

Hypertrophic disorders of skin

585

1.27

1.21

1.1

2.23

2.67

u/ml

0.19

306

Algoneurodystrophy

289

1.40

1.20

1.2

1.1

0.73

3.05

u/ml

2.12

155

Type of accident

312

2790

1.12

1.20

1.2

1.1

2.07

2.39

u/ml

0.22

178

1448

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

109

1.68

1.20

1.2

1.1

0.44

4.23

u/ml

2.14

Hyperplasia of prostate

176

854

1.17

1.20

1.1

1.78

1.83

u/ml

0.02

418

Mandibular hypoplasia

1.92

1.20

1.2

3.23

1.86

u/ml

—

Macular pucker

426

1.32

1.20

1.1

0.68

1.68

u/ml

1.28

212

Cramp and spasm

349

1.36

1.20

1.2

1.1

1.68

2.81

u/ml

0.55

181

Symptoms and signs involving emotional state

298

1.39

1.19

1.2

1.1

2.02

3.95

u/ml

0.66

156

Chronic suppurative otitis media, including avohilmo

702

1.25

1.19

1.2

1.1

0.80

2.79

u/ml

2.69

405

Asymmetry of jaw

157

1.55

1.19

1.1

2.85

4.00

u/ml

0.23

656

0.75

1.19

1.2

3.36

3.50

u/ml

0.02

448

Congenital malformations of the musculoskeletal system, not elsewhere classified

223

1.46

1.19

1.2

1.31

4.61

u/ml

1.60

130

Spinal instabilities

173

1.51

1.18

1.0

1.1

0.16

1.63

u/ml

—

Crohn's disease of small intestine

694

1.25

1.18

1.1

2.37

2.36

u/ml

0.00

350

Acne vulgaris

163

1399

1.17

1.18

1.2

1.1

2.20

2.94

u/ml

0.48

102

748

Carcinoma in situ of other and unspecified digestive organs

1.71

1.17

1.3

1.1

0.30

1.38

u/ml

1.64

Benign neoplasm: Caecum

367

1.34

1.17

1.1

1.69

1.88

u/ml

0.07

175

Prepatellar bursitis

248

1.42

1.17

1.2

1.1

0.85

2.48

u/ml

1.32

110

Unknown and unspecified causes of morbidity

481

1.29

1.17

1.1

1.18

2.05

u/ml

0.67

226

Hypogonadotropic hypogonadism

215

1.45

1.17

1.3

1.1

4.72

2.18

u/ml

0.40

112

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

190

1.48

1.17

1.2

1.1

0.48

2.29

u/ml

1.54

Other articular cartilage disorders

102

1.68

1.16

1.1

1.72

2.91

u/ml

—

Other specified and unspecified disorders of eye and adnexa

215

1.45

1.16

1.1

1.49

1.61

u/ml

0.06

112

Heterophoria

110

913

1.21

1.16

1.2

0.85

2.92

u/ml

3.89

520

Disorders of lipoprotein metabolism and other lipidaemias

599

4017

0.92

1.16

1.1

1.01

1.79

u/ml

2.40

304

1954

Other diseases of gallbladder

182

1.49

1.16

1.5

1.1

5.41

2.39

u/ml

0.25

Tongue abnormality

308

1.37

1.16

1.1

0.44

2.43

u/ml

2.51

160

Achalasia of cardia

1.82

1.15

1.2

1.1

15.64

1.99

u/ml

—

Foreign body in alimentary tract

386

1.33

1.15

1.1

0.51

3.54

u/ml

5.05

220

Drug-induced neutropenia

368

0.68

1.15

1.1

6.42

1.69

u/ml

0.47

191

Benign neoplasm: salivary glands, exclude unknown (D119)

421

1.31

1.14

1.2

1.1

0.93

2.32

u/ml

1.56

222

Melanocytic naevi, other sites/unspecified

643

1.25

1.14

1.1

1.97

2.32

u/ml

0.21

326

Chronic myeloproliferative disease

0.00

1.14

0.0

1.2

—

1.64

—

Spondylopathies

703

3900

1.08

1.14

1.1

1.57

1.86

u/ml

0.33

326

1860

Poisoning by medicine

232

2625

0.88

1.14

1.2

1.1

1.27

2.33

u/ml

2.10

134

1343

Spinal stenosis

273

1842

1.13

1.14

1.1

0.89

1.62

u/ml

1.80

131

843

Other symptoms and signs involving the nervous and musculoskeletal systems

427

3896

1.10

1.13

1.2

1.1

1.23

2.05

u/ml

1.37

244

1975

Atrial fibrillation and flutter with reimbursement

140

1048

0.85

1.13

1.1

3.12

1.35

u/ml

0.60

508

171

1480

1.16

1.12

1.1

1.01

2.25

u/ml

2.22

108

702

Exposure to other and unspecified animate mechanical forces

345

1.35

1.12

1.1

1.2

3.00

2.96

u/ml

0.01

189

Thyrotoxicosis with toxic single thyroid nodule

1.99

1.12

1.2

1.1

5.94

2.55

u/ml

—

Postpartum hemorraghe, parous women as controls

390

3017

1.10

1.12

1.1

2.65

2.11

u/ml

0.37

177

1445

Streptococcal septicaemia

505

0.73

1.12

1.2

1.1

4.04

2.88

u/ml

0.19

280

Open bite

108

901

1.21

1.11

1.2

1.60

3.25

u/ml

1.61

533

Hypoparathyroidism

168

1.50

1.10

1.2

1.1

5.88

2.36

u/ml

0.32

Arthrosis

710

3624

1.08

1.10

1.1

2.08

1.88

u/ml

0.18

365

1715

Abnormalities of forces of labour

136

1158

1.18

1.10

1.1

2.99

2.02

u/ml

0.29

527

Guttate psoriasis

1.75

1.10

1.1

6.09

2.21

u/ml

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

219

1687

0.88

1.10

1.1

1.02

1.29

u/ml

0.26

104

828

Dermatitis herpetiformis

1.74

1.09

1.0

1.1

0.64

2.18

u/ml

—

Influenza and pneumonia

1344

8114

1.05

1.09

1.1

2.60

2.18

u/ml

0.57

754

4100

Other specified/unspecified dorsopathies

193

1.46

1.09

1.1

4.84

1.98

u/ml

0.28

Disorders of vestibular function (Vertigo)

334

2967

1.11

1.09

1.1

1.59

1.79

u/ml

0.15

169

1416

Lesion of plantar nerve

303

1.36

1.09

1.1

0.55

1.81

u/ml

1.17

148

Benign neoplasm of other and unspecified female genital organs

252

1.40

1.09

1.2

1.1

4.04

1.41

u/ml

0.77

128

Congenital malformations of breast

219

1.44

1.09

1.2

1.1

2.18

3.42

u/ml

0.41

115

Juvenile arthritis (FINNGEN)

715

0.78

1.08

1.1

0.73

3.08

u/ml

4.69

410

SLE, ICD10

230

0.60

1.07

1.2

1.1

0.95

2.07

u/ml

—

121

SLE, strict definition

230

0.60

1.07

1.2

1.1

0.95

2.07

u/ml

—

121

Invasive ventilation

478

0.73

1.07

1.2

0.44

2.62

u/ml

4.74

295

malignant neoplasm of female genital organs

734

0.78

1.07

1.1

0.57

1.50

u/ml

1.95

353

Long labour

375

2919

1.10

1.07

1.1

2.69

2.10

u/ml

0.41

195

1389

Cardiomyopathy (excluding other)

581

0.76

1.07

1.3

1.1

0.62

1.60

u/ml

2.22

311

Osteoporosis

123

971

1.19

1.07

1.1

1.88

1.99

u/ml

0.05

501

Rheumatic fever incl heart disease

1.66

1.07

1.1

0.63

1.77

u/ml

—

Delayed milestone in childhood

557

0.76

1.07

1.3

1.2

2.97

3.41

u/ml

0.10

413

Explicit bacterial Sepsis

681

0.78

1.06

1.1

3.30

2.51

u/ml

0.16

368

Emergency coronary revascularization (for ACS)

594

3894

0.93

1.06

1.1

2.03

1.86

u/ml

0.13

266

1978

Shoulder region

1.73

1.06

1.1

1.2

0.43

2.33

u/ml

—

Schizotypal disorder

204

0.58

1.06

1.2

1.1

2.47

2.92

u/ml

—

104

Caries of dentine

208

1783

1.14

1.05

1.2

1.1

2.25

2.31

u/ml

0.02

129

871

Benign neoplasm: Other/unspecified site

1.81

1.05

1.1

1.04

2.45

u/ml

—

Other congenital malformations

142

1219

1.17

1.05

1.1

1.2

3.22

2.57

u/ml

0.24

712

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

529

0.75

1.04

1.1

1.2

2.57

3.26

u/ml

0.21

339

Graves ophthalmopathy

154

1.51

1.04

1.0

1.1

0.67

2.86

u/ml

1.62

Other nonscarring hair loss

1.76

1.04

1.1

5.60

2.79

u/ml

—

748

0.79

1.04

1.2

3.49

3.50

u/ml

0.00

507

Episcleritis

402

1.30

1.04

1.2

1.1

2.35

2.23

u/ml

0.02

203

Leiomyoma of uterus

563

3445

0.92

1.04

1.1

1.73

1.68

u/ml

0.04

256

1596

Colon adenocarcinoma

336

0.68

1.03

1.1

0.47

1.32

u/ml

—

172

Bullous disorders

246

1.39

1.03

1.1

0.62

2.42

u/ml

2.33

122

Other congenital malformations of skin

100

834

1.21

1.03

1.2

1.1

1.33

2.72

u/ml

1.29

451

Caught, crushed, jammed or pinched in or between objects

491

1.27

1.03

1.2

1.1

1.06

3.01

u/ml

2.37

263

Crohn disease (strict definition, all UC cases excluded)

518

1.26

1.03

1.1

3.16

2.69

u/ml

0.07

266

Other and unspecified mononeuropathies, also in other diseases

130

1.55

1.03

1.2

1.1

0.25

2.35

u/ml

—

Conotruncal defects

297

0.66

1.03

1.2

1.3

17.84

2.72

u/ml

1.18

215

Bulimia nervosa (incl. atypical)

519

1.26

1.02

1.2

1.1

1.94

3.13

u/ml

0.54

261

Fracture of neck

239

0.63

1.02

1.3

1.1

0.40

2.52

u/ml

—

122

Carcinoma in situ of breast, intraductal

439

0.73

1.02

1.1

2.47

1.32

u/ml

0.27

214

Other disorders of Eustachian tube

188

1.45

1.02

1.3

1.1

6.68

3.02

u/ml

0.34

Measles

1.67

1.02

1.1

0.70

2.67

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

515

3516

0.92

1.01

1.1

2.02

1.89

u/ml

0.09

239

1691

5-aminosalicylic acid

223

1981

1.13

1.01

1.1

1.50

1.97

u/ml

0.29

959

Other complications of labour and delivery, not elsewhere classified

183

1909

0.88

1.01

1.1

3.21

2.36

u/ml

0.56

920

157

1363

1.16

1.01

1.2

1.1

2.20

2.14

u/ml

0.02

669

Carcinoma in situ of other and unspecified sites

1.77

1.00

1.0

1.1

0.31

1.66

u/ml

—

Other predominantly sexually transmitted diseases, not elsewhere classified

256

2295

1.12

1.00

1.2

1.1

1.44

2.13

u/ml

0.77

131

1150

Transient ischemic attack

213

1944

0.89

1.00

1.1

1.23

1.50

u/ml

0.21

111

944

Other congenital malformations of ear

215

1.42

1.00

1.1

1.2

1.94

3.69

u/ml

0.57

128

Marasmic kwashiorkor

0.00

1.00

0.0

1.1

—

3.72

—

Other and unspecified injuries of forearm

1.83

0.99

1.4

1.1

12.10

3.32

u/ml

—

Skin changes due to chronic exposure to nonionizing radiation

128

1008

1.17

0.99

1.1

1.17

1.28

u/ml

0.06

514

Contact with other hot fluids

309

1.34

0.99

1.1

1.2

1.81

3.42

u/ml

0.78

176

Sacroiliitis, not elsewhere classified

503

1.26

0.99

1.1

0.95

2.63

u/ml

2.02

251

Viral conjunctivitis

379

1.30

0.99

1.1

1.42

2.66

u/ml

0.50

206

Atrophic disorders of skin

125

1068

1.17

0.99

1.1

2.01

2.07

u/ml

0.02

530

Other noninflammatory disorders of uterus, except cervix

133

766

1.17

0.98

1.1

1.64

1.81

u/ml

0.05

362

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.98

0.0

1.1

—

3.40

—

Alzheimer’s disease (Late onset)

280

0.69

0.98

1.4

1.1

0.31

0.72

u/ml

1.73

137

Other and unspecified mononeuropathies of lower limb

140

1.51

0.98

1.1

0.53

2.27

u/ml

1.27

Supernumerary ureter

0.00

0.98

0.0

1.1

—

4.57

—

Other specified and unspecified strabismus

108

1.60

0.98

1.1

1.2

0.66

4.10

u/ml

—

Bacterial pneumonia (organism specified)

331

2728

1.10

0.98

1.1

1.85

1.99

u/ml

0.07

198

1356

Routine general health check-up of defined subpopulation

199

0.60

0.97

1.2

1.1

1.49

3.09

u/ml

—

Tooth agenesis EXCLUDE clefts and syndromes

713

1.22

0.97

1.3

1.2

2.19

3.39

u/ml

0.58

422

Lymphoid leukaemia

260

0.65

0.97

1.4

1.2

0.91

2.76

u/ml

1.49

163

Abnormal blood-pressure reading, without diagnosis

275

1.35

0.97

1.2

1.1

0.29

3.54

u/ml

2.97

152

Complications of labour and delivery

795

4152

1.07

0.97

1.1

2.44

2.01

u/ml

0.47

396

2001

Campylobacter enteritis

165

1.47

0.97

1.1

0.65

3.34

u/ml

1.72

Benign neoplasm of bone and articular cartilage

703

1.21

0.97

1.1

2.00

2.50

u/ml

0.14

367

Other and unspecified coagulation defects

460

1.27

0.97

1.2

1.1

1.48

2.49

u/ml

0.56

240

Peripheral arterial reconstruction

389

0.72

0.97

1.3

1.1

2.59

1.74

u/ml

0.19

188

Other ill-defined and unspecified causes of mortality

199

0.60

0.96

1.1

1.19

1.95

u/ml

—

105

Event of undetermined intent

622

1.23

0.96

1.2

1.1

1.21

2.61

u/ml

1.35

316

Contact with heat and hot substances

514

1.25

0.96

1.1

1.2

2.87

2.88

u/ml

0.00

286

Inguinal hernia

471

3407

0.92

0.96

1.1

1.71

2.12

u/ml

0.41

223

1774

Unspecified maternal hypertension

158

1.48

0.95

1.0

1.1

3.89

3.01

u/ml

—

Acquired absence of limb

0.00

0.95

0.0

1.1

—

1.92

—

Melanocytic naevi of lower limb, including hip

355

1.30

0.95

1.0

1.1

4.48

2.90

u/ml

0.22

182

Sequelae with surgical and medical care as external cause

139

1202

1.16

0.95

1.1

0.54

2.05

u/ml

5.75

607

Coronary revascularization (ANGIO or CABG)

578

3799

0.93

0.95

1.1

2.07

1.88

u/ml

0.14

261

1922

Pre-eclampsia

202

2272

0.89

0.95

1.1

2.43

1.83

u/ml

0.29

1105

Trigeminal neuralgia

355

1.30

0.95

1.1

0.40

2.23

u/ml

2.58

178

Other benign neoplasms of skin

270

2436

1.11

0.94

1.1

2.96

1.82

u/ml

0.68

126

1199

Other diseases of blood and blood-forming organs, wide

174

1530

1.14

0.94

1.2

1.1

1.75

2.07

u/ml

0.16

105

783

Ingrowing nail

453

1.27

0.94

1.1

3.10

2.90

u/ml

0.03

235

Decubitus ulcer and pressure area

185

0.59

0.94

1.1

5.77

2.62

u/ml

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

338

3086

1.10

0.94

1.1

2.69

1.99

u/ml

0.49

176

1574

216

1.39

0.94

1.2

1.1

6.64

3.08

u/ml

0.35

102

SLE (Finngen)

257

0.66

0.93

1.2

1.1

0.90

2.21

u/ml

—

132

Bitten or struck by other mammals

146

1270

1.15

0.93

1.2

1.1

1.07

2.61

u/ml

3.36

636

Perineal laceration during delivery

260

2409

0.90

0.93

1.1

2.44

2.21

u/ml

0.16

143

1168

Malignant melanoma of skin, including Hilmo

657

0.79

0.93

1.0

1.1

0.93

1.73

u/ml

1.05

329

Viral conjunctivitis

192

1.42

0.93

1.1

1.91

2.38

u/ml

0.09

102

Bicornuate uterus

1.70

0.93

1.2

0.35

5.03

u/ml

—

Use of other anti-dementia drugs

349

0.74

0.93

1.3

1.1

0.30

0.81

u/ml

2.13

171

Use of memantine

349

0.74

0.93

1.3

1.1

0.30

0.81

u/ml

2.13

171

Crohn's disease of large intestine

499

1.25

0.93

1.1

2.04

2.54

u/ml

0.10

257

Other congenital malformations of tongue, mouth and pharynx

339

1.32

0.92

1.2

2.06

2.85

u/ml

0.36

242

Other and unspecified acne

159

1.47

0.92

1.1

1.81

3.64

u/ml

0.70

Fentanyl

350

0.71

0.92

1.1

0.84

1.81

u/ml

1.01

173

Benign neoplasm of other and unspecified sites

167

1.45

0.92

1.1

0.83

2.49

u/ml

1.09

Other and unspecified mood [affective] disorders

111

947

1.18

0.92

1.1

1.09

2.57

u/ml

1.87

489

Precocious puberty

103

0.47

0.92

1.2

0.99

4.93

u/ml

—

Sequelae of injuries of lower limb

735

1.20

0.92

1.1

1.98

2.01

u/ml

0.01

362

Carbimazole or st.post thyroidectomy, condition for graves disease

199

1769

1.13

0.92

1.1

1.75

1.89

u/ml

0.08

104

836

Use of donepezil

302

0.70

0.92

1.2

1.1

0.28

0.85

u/ml

2.07

144

Use of teriflunomide

102

1.59

0.92

1.1

4.10

2.80

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

112

957

1.18

0.91

1.2

1.1

2.23

2.16

u/ml

0.03

449

Percutaneous Coronary Intervention

578

3796

0.93

0.91

1.1

2.07

1.88

u/ml

0.14

261

1922

Diabetes mellitus in pregnancy

593

3545

1.07

0.91

1.1

1.89

2.18

u/ml

0.37

291

1749

Anogenital herpesviral [herpes simplex] infection

755

1.20

0.91

1.2

1.1

2.71

2.76

u/ml

0.02

383

Injuries to the abdomen, lower back, lumbar spine and pelvis

356

3228

1.09

0.91

1.1

2.11

2.22

u/ml

0.06

201

1654

Ovarian hyperstimulation (induction)

245

1.36

0.90

1.1

2.07

3.11

u/ml

0.31

121

Anorexia (incl.atypical)

795

0.81

0.90

1.2

1.1

2.35

2.91

u/ml

0.27

434

Gonarthrosis

539

2855

1.08

0.90

1.1

2.27

1.91

u/ml

0.29

274

1317

Benign neoplasm: Long bones of lower limb

262

1.35

0.90

1.1

4.19

3.09

u/ml

0.13

144

Cardiomyopathies, Primary/intrinsic

553

0.78

0.90

1.3

1.1

0.62

1.64

u/ml

2.29

306

Acute peritonitis

290

0.69

0.90

1.4

1.1

1.91

2.01

u/ml

0.02

158

Other viral diseases, not elsewhere classified

256

2307

1.11

0.89

1.2

1.1

1.13

2.72

u/ml

4.55

134

1264

Viral Sepsis

155

1359

1.14

0.89

1.2

1.1

1.88

2.07

u/ml

0.10

719

Finngen Rheumatological endpoints

1162

6933

0.95

0.89

1.1

1.99

2.13

u/ml

0.17

594

3495

Adjustment and management of implanted device

637

1.21

0.89

1.1

0.58

2.18

u/ml

2.99

336

Need for other prophylactic measures

466

1.25

0.89

1.2

0.75

2.51

u/ml

2.38

272

Presbyopia

439

1.26

0.89

1.1

1.02

1.69

u/ml

0.44

210

Follicular cysts of skin and subcutaneous tissue

160

1407

1.14

0.88

1.2

1.1

1.56

2.08

u/ml

0.35

699

Papulosquamous disorders

329

3011

1.09

0.88

1.1

2.93

1.78

u/ml

0.72

173

1482

Diseases of inner ear

397

3541

1.09

0.88

1.1

1.41

1.80

u/ml

0.40

205

1693

Helminthiases

440

1.26

0.88

1.2

3.48

2.86

u/ml

0.13

244

Agranulocytosis

728

0.81

0.88

1.3

1.1

3.12

2.32

u/ml

0.16

383

Other secondary gonarthrosis

237

1.36

0.88

1.0

1.1

1.73

2.19

u/ml

0.12

117

Delivery, wide proxy

359

2078

0.92

0.88

1.1

4.07

2.36

u/ml

1.23

190

1075

Pneumonia due to Streptococcus pneumoniae

220

1.37

0.87

1.0

1.1

10.75

3.29

u/ml

0.48

115

370

1.29

0.87

1.1

1.2

1.23

3.31

u/ml

2.13

227

Chronic suppurative otitis media

548

1.23

0.87

1.1

0.94

3.07

u/ml

1.98

305

Mandibular retrognathia AND surgery (BSSO)

264

1.34

0.87

1.1

0.36

3.53

u/ml

3.57

129

Other keratitis

117

1008

1.16

0.87

1.1

1.39

2.13

u/ml

0.62

503

Congenital deformities of hip

317

1.31

0.86

1.2

0.77

3.24

u/ml

2.45

194

Systemic lupus erythematosus

252

0.67

0.86

1.2

1.1

0.90

2.18

u/ml

—

135

Other disorders involving the immune mechanism, not elsewhere classified

238

1.35

0.86

1.2

1.1

3.73

2.55

u/ml

0.18

131

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.73

0.86

1.1

0.54

3.22

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

325

1.30

0.86

1.0

1.1

1.80

1.82

u/ml

0.01

167

Placental disorders

112

1.54

0.86

1.1

0.36

3.54

u/ml

—

Abnormal weight loss

531

1.23

0.86

1.1

2.37

2.47

u/ml

0.03

293

Congenital malformations and deformations of the musculoskeletal system

162

1423

1.14

0.86

1.1

1.2

1.82

3.11

u/ml

1.29

852

Open bite that required surgery (Lefort1 or BSSO)

104

1.56

0.86

1.1

0.24

4.80

u/ml

—

Unspecified lump in breast

128

1112

1.15

0.85

1.1

0.90

1.94

u/ml

2.00

524

Pedal cyclist injured in noncollision transport accidents

1094

0.85

1.1

1.60

2.25

u/ml

0.43

572

Congenital malformations of eye, ear, face and neck

106

909

1.17

0.85

1.1

1.2

0.77

3.09

u/ml

4.36

524

Toxic effect of carbon monoxide

1.58

0.85

1.1

4.51

2.49

u/ml

—

Crowding of teeth, including avohilmo

218

1621

1.12

0.84

1.2

3.57

3.46

u/ml

0.05

153

977

Implicit viral Sepsis

154

1356

1.14

0.84

1.2

1.1

1.88

2.04

u/ml

0.09

717

Erythema nodosum

179

1.41

0.84

1.2

1.1

1.42

3.18

u/ml

0.74

Use of ropinirole

1.57

0.84

1.2

1.1

0.57

1.38

u/ml

—

Injuries to the hip and thigh

351

2923

1.09

0.84

1.1

1.83

1.98

u/ml

0.11

188

1486

Oral lichen planus, including avohilmo , including avohilmo

353

1.28

0.84

1.1

2.58

2.06

u/ml

0.14

177

Myocardial infarction, unclassifiable

449

0.77

0.84

1.1

5.41

1.45

u/ml

0.35

230

Injury of unspecified body region

569

1.22

0.84

1.1

4.01

2.77

u/ml

0.21

300

Other specified/unspecified systemic involvement of connective tissue

389

1.27

0.84

1.1

2.12

2.31

u/ml

0.05

193

Spontaneous abortion

593

3748

1.07

0.83

1.1

2.02

2.09

u/ml

0.06

271

1824

Brachial plexus disorders

108

929

1.17

0.83

1.1

1.44

2.16

u/ml

0.85

437

Other diseases of blood and blood-forming organs

354

1.28

0.83

1.2

1.1

1.66

2.23

u/ml

0.17

175

Lung cancer and mesothelioma

287

1.28

0.82

1.1

0.45

1.15

u/ml

1.23

117

Alzheimer’s disease (Late onset), excluding more controls

157

0.67

0.82

1.4

1.1

0.34

0.64

u/ml

—

Congenital malformations and deformations of the musculoskeletal system

192

1709

1.12

0.82

1.1

1.2

1.60

2.89

u/ml

1.61

111

1004

Carcinoma in situ, bladder

1.70

0.82

1.0

1.1

0.31

1.37

u/ml

—

Disorders of gallbladder, biliary tract and pancreas

896

5947

0.95

0.82

1.1

1.49

1.87

u/ml

0.64

436

2904

Wide developmental disorders

739

0.82

1.1

1.2

3.00

2.83

u/ml

0.05

475

Diseases of the digestive system

358

3285

1.09

0.82

1.1

3.21

2.00

u/ml

0.93

182

1705

Other diseases caused by chlamydiae

155

1.43

0.82

1.1

2.06

3.06

u/ml

0.30

Use of rivastigmine

225

0.66

0.82

1.5

1.1

0.31

0.93

u/ml

—

115

Nontraumatic intracranial haemmorrhage

765

0.82

1.1

0.93

1.78

u/ml

1.00

403

Respiratory tuberculosis, not confirmed

1.65

0.81

1.2

1.1

1.79

1.37

u/ml

—

Gastroduodenal ulcer

108

927

1.16

0.81

1.1

2.64

1.88

u/ml

0.26

457

Glomerular diseases

109

1261

0.86

0.81

1.2

1.1

1.85

2.17

u/ml

0.13

672

Abnormal results of function studies

663

1.20

0.81

1.1

0.67

2.58

u/ml

4.60

354

Infective bursitis

130

1.47

0.81

1.0

1.1

9.57

2.86

u/ml

—

Ischaemic heart disease, wide definition

454

3022

0.93

0.81

1.1

2.26

1.64

u/ml

0.43

203

1460

conjunctival haemorrhage

302

1.30

0.81

1.1

1.32

2.12

u/ml

0.35

152

Non-small cell lung cancer, including Hilmo

407

0.76

0.81

1.1

0.64

1.43

u/ml

1.23

202

Other congenital malformations

189

1692

1.12

0.80

1.1

1.2

2.71

2.45

u/ml

0.11

120

937

Alcohol abuse, main dg

126

1441

0.87

0.80

1.2

1.1

2.28

2.30

u/ml

0.01

753

Ménière disease

436

1.24

0.80

1.1

1.82

2.06

u/ml

0.06

228

Anomalies of pupillary function

181

1.39

0.80

1.2

1.1

2.51

3.84

u/ml

—

Other leukaemias of specified cell type

0.00

0.80

0.0

1.2

—

2.00

—

Cerebral palsy

235

0.67

0.80

1.1

1.2

3.46

2.45

u/ml

0.17

153

Other disorders of breast and lactation associated with childbirth

242

1.34

0.80

1.1

0.97

3.30

u/ml

2.33

125

Other congenital malformations of the digestive system

633

1.20

0.80

1.2

3.34

3.38

u/ml

0.01

414

Cauda equina syndrome

1.74

0.80

1.0

1.1

2.34

1.62

u/ml

—

Meralgia paraesthetica

207

1.36

0.79

1.2

1.1

1.34

3.07

u/ml

0.84

109

IgA nephropathy (IgA glomerulonephritis)

139

1.45

0.79

1.1

6.72

2.21

u/ml

—

Gestational diabetes (for exclusion)

638

4181

1.06

0.79

1.1

2.08

2.26

u/ml

0.18

309

2034

Malignant neoplasm of renal pelvis, including Hilmo

0.00

0.79

0.0

1.1

—

1.02

—

Melanoma in situ

139

1.44

0.79

1.1

1.30

2.48

u/ml

0.40

Effects of other external causes

286

1.30

0.79

1.1

1.29

3.17

u/ml

1.15

153

Benign neoplasm: Descending colon

233

1.33

0.79

1.1

3.74

1.92

u/ml

0.22

116

Sleep disorders, other/unspecified

366

1.27

0.79

1.2

1.1

2.56

2.85

u/ml

0.06

194

Valvular operations

652

0.81

0.79

1.1

2.11

2.10

u/ml

0.00

378

Pervasive developmental disorders excl. Autism + Asperger

344

0.73

0.79

1.0

1.3

2.30

2.96

u/ml

0.18

255

Specific development disorders of speech and language

118

990

1.15

0.79

1.2

3.17

2.74

u/ml

0.14

631

Vasculitis limited to skin, not elsewhere classified

131

1.46

0.78

1.2

1.1

0.60

3.09

u/ml

1.70

Rheumatoid arthritis

200

1992

0.90

0.78

1.1

0.75

1.76

u/ml

2.87

101

918

Other juvenile arthritis

617

0.80

0.78

1.1

1.2

0.68

3.17

u/ml

4.66

358

Phobic anxiety disorders

216

1950

1.11

0.78

1.1

3.22

2.66

u/ml

0.19

118

986

Haemolytic anaemias

225

1.34

0.78

1.5

1.1

3.88

2.96

u/ml

0.10

133

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

740

1.18

0.78

1.1

0.76

2.41

u/ml

2.11

382

Emotional disorders and disorders of social functioning with onset specific to childhood

133

1150

1.14

0.78

1.1

1.2

2.38

3.09

u/ml

0.33

707

Other specified/unspecified disorders of bone/cartilage

148

1.43

0.78

1.1

3.73

2.28

u/ml

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.78

0.0

1.0

—

3.67

—

Pre-eclampsia or eclampsia

215

2374

0.90

0.77

1.1

2.33

1.80

u/ml

0.27

1151

Other and unspecified nail disorders

115

1.49

0.77

1.2

1.1

0.47

3.42

u/ml

—

Other and unspecified vasculitis limited to skin

115

1.49

0.77

1.2

1.1

0.51

2.68

u/ml

—

Presbycusis

206

1.35

0.77

1.3

1.1

0.36

0.78

u/ml

1.07

103

Pediculosis and phthiriasis

1.73

0.77

1.0

1.2

11.13

3.39

u/ml

—

Venous thromboembolism

353

3153

1.08

0.77

1.1

1.23

1.76

u/ml

0.90

182

1520

Other and unspecified nonscarring hair loss

1.72

0.77

1.1

6.69

3.03

u/ml

—

Viral warts

113

983

1.15

0.77

1.2

1.1

1.20

2.79

u/ml

2.32

532

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

115

1.48

0.77

1.1

0.31

0.84

u/ml

—

Amputation

303

0.72

0.76

1.1

0.81

1.55

u/ml

0.58

147

Ankyloglossia

422

1.25

0.76

1.2

2.22

3.17

u/ml

0.46

291

Injuries to unspecified part of trunk, limb or body region

797

1.17

0.76

1.1

3.49

2.54

u/ml

0.21

422

Status post-ami

596

0.83

0.76

1.1

2.41

1.20

u/ml

0.32

299

Rheumatoid arthritis, including avohilmo

236

2593

0.91

0.76

1.1

0.70

1.85

u/ml

4.42

123

1238

Crohn disease (strict definition, require KELA)

696

1.18

0.76

1.1

0.76

2.48

u/ml

2.04

357

Pedestrian injured in other and unspecified transport accidents

1.71

0.76

1.4

1.2

0.34

2.47

u/ml

—

Excessive vomiting in pregnancy

113

984

1.15

0.76

1.1

2.97

2.22

u/ml

0.21

464

Crohn disease (strict definition, require KELA, min 2 HDR)

687

1.18

0.76

1.1

0.76

2.50

u/ml

2.07

354

Relapsing fevers

2.15

0.76

1.0

1.1

—

2.45

—

Malignant melanoma, including Hilmo

790

0.83

0.75

1.0

1.1

1.13

1.88

u/ml

0.79

390

Carcinoma in situ of skin

209

1.34

0.75

1.1

1.02

1.56

u/ml

0.26

106

Parkinson's disease

393

0.76

0.75

1.1

1.26

1.56

u/ml

0.10

198

Corneal ulcer

187

1682

1.11

0.75

1.1

2.09

2.17

u/ml

0.05

101

839

Other symptoms and signs involving the urinary system

568

1.20

0.75

1.1

1.59

2.68

u/ml

0.69

283

Viral infections of the central nervous system

651

1.19

0.75

1.1

1.83

2.35

u/ml

0.18

336

Other and unspecified myopathies

381

0.76

0.75

1.1

1.17

2.04

u/ml

0.84

192

Other facial nerve disorders

158

1.40

0.75

1.4

1.1

0.25

3.29

u/ml

2.29

Congenital malformations of cardiac septa

1002

0.86

0.75

1.1

1.2

4.87

2.98

u/ml

0.39

646

Other disorders of bone density and structure

196

0.66

0.74

1.0

1.1

0.20

3.18

u/ml

—

103

Vascular disorders of the intestines

158

1.39

0.74

1.2

1.1

1.84

1.61

u/ml

0.07

Dilated cardiomyopathy

470

0.79

0.74

1.3

1.1

0.69

2.19

u/ml

2.49

247

Medial epicondylitis

245

1.31

0.74

1.3

1.1

0.37

2.39

u/ml

2.32

126

Striae atrophicae

100

1.52

0.74

1.1

1.52

3.40

u/ml

—

Heart failure and coronary heart disease

135

1083

0.88

0.74

1.1

2.11

1.24

u/ml

0.29

576

Procreative management

488

3815

1.07

0.73

1.2

1.1

2.06

2.21

u/ml

0.13

291

2036

Conditions involving the integument and temperature regulation of fetus and newborn

2.04

0.73

1.2

15.60

4.96

u/ml

—

Benign neoplasm: Vulva

100

1.51

0.73

1.3

1.1

6.16

2.20

u/ml

—

Seronegative juvenile rheumatoid arthritis

276

0.72

0.73

1.0

1.2

1.60

4.18

u/ml

—

155

Postpartum haemorrhage due to anatomy

173

1554

1.12

0.73

1.2

1.1

3.24

2.21

u/ml

0.39

755

Hypersomnia

1.54

0.73

1.2

1.1

1.71

2.78

u/ml

—

Degenerative macular diseases

343

1.26

0.73

1.1

2.38

1.57

u/ml

0.23

178

Other conjunctival vascular disorders and cysts

1.53

0.72

1.2

1.1

0.33

2.18

u/ml

—

Polycystic kidney disease

171

0.64

0.72

1.1

1.17

3.02

u/ml

—

Inguinal of femoral hernia, unilateral

1.53

0.72

1.4

1.1

1.06

1.60

u/ml

—

Inguinal hernia, unilateral

1.53

0.72

1.4

1.1

1.06

1.60

u/ml

—

Femoral hernia, unilateral

1.53

0.72

1.4

1.1

1.06

1.60

u/ml

—

Primary gonarthrosis, bilateral

263

2063

1.09

0.72

1.1

1.14

1.28

u/ml

0.17

136

957

Diseases caused by chlamydiae

151

1.41

0.72

1.1

2.06

3.01

u/ml

0.29

Background retinopathy and retinal vascular changes

1.56

0.72

1.0

1.2

0.45

2.61

u/ml

—

Thyrotoxicosis

219

1992

1.10

0.72

1.1

2.30

2.06

u/ml

0.12

104

958

Spermatocele

246

1.30

0.72

1.3

1.1

2.50

2.51

u/ml

0.00

116

Maxillary retrognathism

247

1.31

0.71

1.2

2.89

4.15

u/ml

0.21

151

Acute pancreatitis (for exclusion)

102

1171

0.87

0.71

1.1

1.62

2.08

u/ml

0.33

572

Congenital hydrocephalus

1.95

0.71

1.0

1.2

—

2.07

—

Hypotension

507

1.20

0.71

1.2

1.1

1.32

2.09

u/ml

0.43

254

Fracture of lumbar spine and pelvis

1062

0.86

0.71

1.1

0.83

1.98

u/ml

1.97

522

Heart failure and antihypertensive medication

137

1011

0.88

0.71

1.1

1.94

1.44

u/ml

0.16

507

Parkinson's disease, including avohilmo

411

0.78

0.70

1.1

1.27

1.56

u/ml

0.11

209

Viral encephalitis, not elsewhere classified/unspecified

101

1.49

0.70

1.1

1.2

0.11

2.00

u/ml

—

Right hemicolectomy

170

0.65

0.70

1.1

0.05

1.28

u/ml

—

Viral agents as the cause of diseases classified to other chapters

221

1.32

0.70

1.1

0.16

3.62

u/ml

3.51

127

Burn and corrosion of trunk

221

1.32

0.70

1.2

1.1

0.86

2.43

u/ml

1.31

129

Benign lipomatous neoplasm of other sites/unspecified

354

1.25

0.70

1.1

0.43

1.88

u/ml

2.46

182

Maternal care for known or suspected fetal abnormality and damage

236

2217

0.91

0.70

1.1

2.11

2.14

u/ml

0.01

115

1098

Other specified/unspecified inflammatory spondylopathies

436

1.22

0.70

1.2

1.1

0.93

2.29

u/ml

1.45

216

Dislocation, sprain and strain of joints and ligaments of elbow

712

1.17

0.70

1.3

1.2

3.57

2.56

u/ml

0.26

388

Unstable angina pectoris

117

1049

0.88

0.69

1.2

1.1

2.09

1.24

u/ml

0.31

534

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

134

1508

0.89

0.69

1.1

1.00

1.89

u/ml

1.42

726

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

331

0.75

0.69

1.3

1.1

1.77

1.89

u/ml

0.03

166

Benign neoplasm: Conjunctiva

169

1.37

0.69

1.1

2.20

1.56

u/ml

0.28

Unspecified misadventure during surgical and medical care

283

1.28

0.69

1.2

1.1

0.57

2.78

u/ml

2.48

149

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

103

899

1.15

0.69

1.1

2.38

2.29

u/ml

0.03

420

Burns and corrosions of multiple and unspecified body regions

169

0.65

0.69

1.1

8.85

2.31

u/ml

—

103

Bacterial pneumonia, not elsewhere classified

298

2423

1.08

0.69

1.1

1.97

2.06

u/ml

0.04

182

1218

Other and unspecified iridocyclitis

319

1.26

0.69

1.1

0.64

3.08

u/ml

3.34

171

Erectile dysfunction

228

0.70

0.69

1.1

1.2

3.23

2.07

u/ml

—

128

Ulcerative colitis, NAS

120

1358

0.88

0.69

1.2

1.1

1.05

2.41

u/ml

1.54

687

Foreign body in ear

161

1.38

0.69

1.3

1.1

4.56

4.05

u/ml

0.07

Malignant neoplasm of bladder

118

1.44

0.69

1.2

1.1

0.90

0.88

u/ml

—

Pediculosis, acariasis and other infestations

228

2085

1.10

0.68

1.1

2.56

2.74

u/ml

0.08

124

1092

Erosion and ectropion of cervix uteri

127

1.42

0.68

1.1

1.95

1.77

u/ml

0.04

Mixed disorders of conduct and emotions

484

0.80

0.68

1.1

1.2

1.74

3.21

u/ml

0.88

283

Neuromuscular dysfunction of bladder

483

1.20

0.68

1.2

1.1

0.75

2.02

u/ml

2.24

247

Glaucoma-related operations

144

1.39

0.68

1.0

1.1

0.26

1.12

u/ml

1.86

Systemic lupus erythematosus, unspecified

203

0.69

0.67

1.2

1.1

0.95

2.23

u/ml

—

107

Mandibular retrognathia

105

918

1.15

0.67

1.2

1.1

1.34

3.25

u/ml

1.96

519

Myositis

119

1.44

0.67

1.2

1.1

1.27

3.24

u/ml

—

Presence of other devices

120

1056

1.13

0.67

1.1

0.55

1.88

u/ml

4.42

515

Other Crohn's disease

743

1.16

0.67

1.1

2.03

2.29

u/ml

0.06

377

Overexertion and strenuous or repetitive movements

836

1.15

0.67

1.1

0.28

2.22

u/ml

6.81

423

Acute pancreatitis

102

1164

0.87

0.67

1.1

1.62

2.12

u/ml

0.37

560

Endocarditis

136

1.40

0.67

1.1

3.88

2.39

u/ml

0.15

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

223

1.31

0.67

1.1

4.27

2.63

u/ml

0.22

122

6-mercaptopurine

384

0.78

0.67

1.1

2.06

3.36

u/ml

0.36

205

Congenital malformations of great arteries

473

0.80

0.67

1.2

1.3

1.22

3.15

u/ml

0.97

343

Personality disorders, excluding more controls

341

3175

1.08

0.66

1.2

1.1

1.30

2.28

u/ml

2.44

193

1549

Ventral hernia

156

1402

1.11

0.66

1.1

2.30

1.88

u/ml

0.26

689

Other lesions of median nerve

1.52

0.66

1.2

1.1

1.23

1.73

u/ml

—

Failed attempted abortion

154

1.38

0.66

1.1

2.92

1.81

u/ml

—

Lesion of sciatic nerve

1.52

0.66

1.2

1.1

0.29

1.34

u/ml

—

Single delivery by forceps and vacuum extractor

255

1669

0.92

0.66

1.1

3.64

2.05

u/ml

0.88

124

869

Convergent concomitant strabismus

690

0.84

0.66

1.1

5.06

2.97

u/ml

0.26

380

Weight loss

651

1.17

0.66

1.2

2.07

2.57

u/ml

0.18

360

Chronic iridocyclitis

361

0.77

0.65

1.0

1.1

3.46

2.95

u/ml

0.06

198

Diffuse brain injury

248

0.72

0.65

1.0

1.1

0.36

2.66

u/ml

—

124

Other aneurysm

171

1.35

0.65

1.1

0.10

2.06

u/ml

2.43

Use of hypnotics and sedatives

1095

6540

0.96

0.65

1.1

1.74

1.89

u/ml

0.23

537

3246

Nail disorders

689

1.16

0.65

1.1

2.41

2.43

u/ml

0.00

354

Graves ophthalmopathy, strict

137

1.40

0.65

1.0

1.1

0.36

3.00

u/ml

—

Alcohol-induced chronic pancreatitis

327

0.76

0.65

1.0

1.1

1.69

2.28

u/ml

0.20

162

Benign neoplasm of meninges

449

1.21

0.65

1.1

0.58

1.46

u/ml

1.17

228

Laparoscopic right hemicolectomy

154

1.37

0.65

1.1

0.49

2.17

u/ml

—

Cerebral cysts

523

1.19

0.65

1.2

1.1

1.85

2.55

u/ml

0.30

274

Injury of intra-abdominal organs

201

0.69

0.64

1.1

11.38

2.90

u/ml

—

107

Mumps

163

1.36

0.64

1.2

1.1

0.56

2.06

u/ml

1.25

Certain zoonotic bacterial diseases

163

1.36

0.64

1.3

1.1

6.58

3.23

u/ml

—

Foreign body entering into or through eye or natural orifice

718

1.16

0.64

1.1

2.93

2.51

u/ml

0.12

382

Enteropathic arthropathies

172

1.35

0.64

1.1

2.27

2.59

u/ml

—

Cluster headache, strict

287

1.26

0.64

1.1

1.80

2.62

u/ml

0.19

138

Chronic hepatitis, not elsewhere classified

189

0.68

0.64

1.2

1.1

0.42

2.36

u/ml

—

106

Glomerular disorders in diseases classified elsewhere

699

0.84

0.64

1.2

1.1

2.47

2.14

u/ml

0.07

352

Prominent ears

164

1.36

0.64

1.0

1.1

2.36

3.53

u/ml

0.25

Erythema multiforme

129

1.40

0.63

1.2

1.1

0.36

4.47

u/ml

2.31

Gonococcal infection

225

1.30

0.63

1.1

0.63

2.67

u/ml

2.34

121

Hypokalaemia

607

1.17

0.63

1.1

1.65

2.00

u/ml

0.12

330

Effects of foreign body entering through natural orifice

258

2383

1.08

0.63

1.1

2.63

2.26

u/ml

0.19

123

1286

Constipation

867

5742

1.05

0.63

1.1

1.59

2.10

u/ml

0.88

439

2953

Ulcer of oesophagus

216

1.30

0.63

1.3

1.1

2.14

2.00

u/ml

0.05

111

Vertical strabismus

234

1.29

0.63

1.1

1.2

1.38

4.23

u/ml

1.22

134

Retinoblastoma

0.00

0.63

0.0

1.0

—

3.97

—

Other and unspecified iron deficiency

267

2468

1.08

0.63

1.2

1.1

1.46

2.06

u/ml

0.63

150

1242

Other congenital malformations of face and neck

288

1.26

0.63

1.1

0.39

3.16

u/ml

3.88

160

Retinoblastoma, including Hilmo

0.00

0.63

0.0

1.0

—

3.97

—

Gonococcal infection

261

1.27

0.63

1.1

0.58

2.60

u/ml

2.90

141

Seropositive rheumatoid arthritis

139

1542

0.90

0.62

1.1

0.96

1.83

u/ml

1.43

718

Cluster headache, strict, including avohilmo

470

1.20

0.62

1.1

2.89

2.78

u/ml

0.02

231

Cluster headache, wide

297

1.25

0.62

1.1

1.80

2.71

u/ml

0.22

145

Abnormal findings on examination of blood, without diagnosis

321

2745

1.07

0.62

1.1

2.65

2.12

u/ml

0.30

157

1407

Vitamin D deficiency

147

1.37

0.62

1.2

5.32

4.01

u/ml

0.13

KRA_PSY_EATING, excluding more controls

156

1403

1.11

0.62

1.2

1.1

2.15

3.02

u/ml

0.61

733

Aplastic and other anaemias

222

2251

0.92

0.62

1.1

2.93

1.66

u/ml

0.67

116

1149

Personal history of risk-factors, not elsewhere classified

130

1.40

0.62

1.3

1.2

0.36

3.90

u/ml

2.67

Other/unspecified seropositive rheumatoid arthritis

136

1515

0.90

0.62

1.1

0.98

1.88

u/ml

1.47

727

Benign neoplasm of ovary

118

1049

1.13

0.62

1.2

1.1

2.41

1.75

u/ml

0.20

499

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

452

1.20

0.61

1.1

4.09

1.99

u/ml

0.27

239

Other congenital malformations of integument

0.00

0.61

0.0

1.0

—

4.00

—

Contusion of toe(s) without damage to nail

262

1.27

0.61

1.2

1.1

1.95

3.04

u/ml

0.27

140

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

112

994

1.13

0.61

1.2

1.1

2.23

2.39

u/ml

0.06

470

Polyglandular dysfunction

0.00

0.61

0.0

1.1

—

2.84

—

Implicit fungal Sepsis

334

1.23

0.61

1.2

1.1

0.78

2.50

u/ml

1.85

161

Right ventricular outflow tract obstruction

197

0.70

0.61

1.1

1.3

26.54

3.22

u/ml

—

147

Multiple congenital exostoses

0.00

0.61

0.0

1.0

—

3.58

—

Overjet

525

1.19

0.61

1.4

1.2

4.89

3.83

u/ml

0.15

338

Alport

0.00

0.61

0.0

1.3

—

5.43

—

Malignant melanoma of skin

467

0.81

0.60

1.0

1.1

0.86

1.74

u/ml

0.86

241

Dextrocardia

0.00

0.60

0.0

1.4

—

4.55

—

Congenital deformities of hip

299

1.25

0.60

1.2

0.82

3.27

u/ml

2.26

189

Non-small cell lung cancer

231

0.73

0.60

1.1

0.83

0.87

u/ml

—

111

Blindness or visual impairment, binocular

0.00

0.60

0.0

1.0

—

1.31

—

Conduction disorders

180

1328

1.10

0.60

1.1

1.60

2.02

u/ml

0.34

698

Noonan syndrome

0.00

0.60

0.0

1.1

—

1.60

—

Seropositive rheumatoid arthritis, wide

139

1543

0.90

0.60

1.1

0.96

1.86

u/ml

1.53

740

Other specified/unspecified arthritis

247

2284

1.08

0.60

1.1

0.76

2.03

u/ml

4.61

122

1124

Ulcerative colitis

224

2430

0.92

0.60

1.1

0.84

2.15

u/ml

3.29

101

1235

Foreign object accidentally left in body during surgical and medical care

0.00

0.60

0.0

1.2

—

1.73

—

Other hearing loss

124

1084

1.12

0.60

1.1

0.90

1.77

u/ml

1.30

542

Other disorders of male genital organs

272

1.26

0.59

1.0

1.1

1.93

1.94

u/ml

0.00

145

Chronic tubulo-interstitial nephritis

183

1.32

0.59

1.3

1.1

7.28

1.67

u/ml

0.35

Other and unspecified injuries of wrist and hand

372

1.22

0.59

1.2

1.1

0.48

2.87

u/ml

4.08

205

Open wound of ankle and foot

107

949

1.13

0.59

1.1

1.83

2.44

u/ml

0.31

496

Ulcer of lower limb, not elsewhere classified

531

0.83

0.59

1.1

2.53

1.94

u/ml

0.18

274

Neuromyelitis optica

0.00

0.59

0.0

1.2

—

1.69

—

Oral lichen planus

114

1.41

0.59

1.1

7.37

1.48

u/ml

—

Multiple congenital exostoses

0.00

0.59

0.0

1.0

—

3.36

—

Coxarthrosis [arthrosis of hip](FG)

301

2272

0.93

0.58

1.1

1.82

1.79

u/ml

0.01

131

1055

Unattended death

0.00

0.58

0.0

1.2

—

1.97

—

Delayed puberty

167

1.34

0.58

1.1

1.2

10.77

3.37

u/ml

0.47

112

Personal history of malignant neoplasm

497

0.82

0.58

1.2

1.1

1.82

2.49

u/ml

0.24

259

Other abnormal immunological findings in serum

184

1.31

0.58

1.1

1.2

3.69

4.05

u/ml

0.07

103

Cardiac arrest

246

0.76

0.58

1.0

1.1

0.16

1.97

u/ml

2.86

129

Intestinal stricture

149

1644

0.91

0.58

1.1

1.11

1.81

u/ml

1.03

823

Non-ischemic cardiomyopathy

111

1003

0.89

0.58

1.1

0.52

1.55

u/ml

2.72

527

Congenital malformations of the nervous system

342

0.78

0.58

1.1

1.2

2.82

3.46

u/ml

0.14

226

Enterocolitis due to Clostridium difficile

464

0.82

0.58

1.1

1.08

2.26

u/ml

0.92

239

Undescended testicle

262

0.75

0.57

1.2

6.65

3.19

u/ml

0.37

201

Diabetic nephropathy

629

0.85

0.57

1.0

1.1

0.73

1.56

u/ml

1.09

317

Plantar fascial fibromatosis

660

1.15

0.57

1.2

1.1

0.32

2.46

u/ml

5.08

309

Superficial injury of abdomen, lower back and pelvis

161

1465

1.10

0.57

1.1

3.09

2.43

u/ml

0.20

766

Thyrotoxicosis, other and/or unspecified

181

1656

1.09

0.57

1.1

2.44

2.16

u/ml

0.11

800

Melanocytic naevi of upper limb, including shoulder

167

1.33

0.57

1.1

0.57

2.96

u/ml

2.62

Convergence insufficiency and excess

141

1.36

0.57

1.4

1.1

0.33

3.84

u/ml

3.25

Adalimumab

1052

0.88

0.57

1.1

0.46

2.28

u/ml

6.42

536

Hodgkin lymphoma, hilmo

184

0.70

0.57

1.4

1.1

0.57

3.54

u/ml

—

105

Alcohol abuse, main dg, excluding more controls

126

1400

0.90

0.57

1.2

1.1

2.28

2.39

u/ml

0.04

700

Other condition

141

1275

1.11

0.57

1.2

1.1

2.22

2.08

u/ml

0.05

644

Contact with other sharp object(s)

775

0.86

0.57

1.1

3.13

2.19

u/ml

0.25

409

Crushed, pushed or stepped on by crowd or human stampede

109

972

1.13

0.57

1.2

1.1

2.38

2.47

u/ml

0.02

535

Malignant melanoma

647

0.85

0.56

1.0

1.1

1.07

1.71

u/ml

0.53

323

Intracerebral haemorrhage

375

0.80

0.56

1.2

1.1

0.85

1.75

u/ml

0.66

195

Viral meningitis

347

1.22

0.56

1.1

1.27

3.50

u/ml

1.86

174

Diseases of peritoneum

540

1.17

0.56

1.2

1.1

1.57

2.27

u/ml

0.43

278

Fracture of forearm

521

5019

0.95

0.56

1.1

2.33

2.13

u/ml

0.16

285

2545

Malignant neoplasm of ovary, including Hilmo

330

0.79

0.56

1.0

1.1

0.85

1.95

u/ml

1.14

172

Male infertility

467

1.18

0.56

1.2

1.1

3.83

2.09

u/ml

0.45

242

Other appendicitis

653

1.15

0.55

1.1

2.22

2.13

u/ml

0.03

318

Malignant neoplasm of corpus uteri

274

0.76

0.55

1.3

1.1

0.49

1.02

u/ml

—

138

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

202

2125

0.92

0.55

1.1

1.2

3.58

2.57

u/ml

0.36

120

1217

Arthropathic psoriasis

827

0.87

0.55

1.2

1.1

0.83

1.80

u/ml

1.63

410

Other noninflammatory disorders of cervix uteri

221

1.27

0.55

1.2

1.1

0.77

1.35

u/ml

0.38

111

Coxarthrosis, primary

288

2275

1.07

0.55

1.1

1.83

1.18

u/ml

0.43

122

1117

Medical abortion

796

4140

1.04

0.55

1.1

1.33

2.11

u/ml

2.09

393

2042

Benzodiazepine use

1065

7591

0.96

0.54

1.1

1.57

2.06

u/ml

0.99

527

3799

Other specified and unspecified personality disorders

105

937

1.12

0.54

1.2

1.1

0.91

2.32

u/ml

2.41

462

Hypertrichosis

258

1.25

0.54

1.1

6.77

3.44

u/ml

0.38

130

Macular hole

142

1.34

0.54

1.0

1.1

0.51

0.97

u/ml

0.50

Other salmonella infections

294

1.23

0.54

1.1

2.29

2.53

u/ml

0.06

153

Pneumonia due to other infectious organisms, not elsewhere classified

151

1.33

0.54

1.2

1.1

2.09

2.70

u/ml

0.14

Bell's palsy

843

1.13

0.54

1.1

1.28

2.26

u/ml

0.77

416

Visual impairment including blindness (binocular or monocular)

372

0.80

0.54

1.0

1.1

0.97

2.57

u/ml

1.16

219

Fall on and from ladder

349

1.21

0.53

1.2

1.1

3.48

2.11

u/ml

0.19

176

Lichen sclerosus et atrophicus

599

1.15

0.53

1.1

1.96

2.05

u/ml

0.04

298

Acute alcohol intoxication ICD-9

125

1.36

0.53

1.1

0.46

1.85

u/ml

—

Abnormal serum enzyme levels

155

1377

1.10

0.53

1.1

1.78

1.85

u/ml

0.03

723

Car occupant injured in other and unspecified transport accidents

229

2125

1.08

0.53

1.1

2.70

2.36

u/ml

0.15

110

1080

Combinations of oral blood glucose lowering drugs

125

1384

0.90

0.53

1.1

0.74

1.45

u/ml

1.94

684

Septal defects

951

0.88

0.53

1.1

1.2

5.05

2.99

u/ml

0.42

619

Other and unspecified injuries of abdomen, lower back and pelvis

108

1.40

0.53

1.2

0.14

3.98

u/ml

—

Persons with potential health hazards related to communicable diseases

605

5731

1.05

0.53

1.2

1.1

2.95

2.39

u/ml

0.40

324

3058

Cluster headache, wide,, including avohilmo

488

1.17

0.53

1.1

2.89

2.71

u/ml

0.04

241

Thoracic aortic aneurysm

534

1.16

0.53

1.1

1.76

1.88

u/ml

0.05

274

Open wound of lower leg

137

1243

1.10

0.53

1.1

3.04

2.65

u/ml

0.12

682

Aortic aneurysm

726

1.14

0.53

1.1

1.30

1.82

u/ml

0.39

361

Other bullous disorders

143

1.33

0.52

1.0

1.1

0.64

3.32

u/ml

—

Nontoxic diffuse goitre

143

1.33

0.52

1.1

0.11

2.13

u/ml

—

Supervision of high-risk pregnancy

312

2001

0.94

0.52

1.1

3.31

2.10

u/ml

0.75

142

977

Femoral hernia

143

1.33

0.52

1.3

1.1

0.89

1.67

u/ml

0.38

Tooth eruption problems

294

2688

1.07

0.52

1.1

3.09

2.98

u/ml

0.06

175

1530

Tuberculosis

143

1.33

0.52

1.3

1.1

1.43

2.05

u/ml

—

Cyst of kidney

250

1.24

0.52

1.2

1.1

1.34

1.63

u/ml

0.11

126

Varicella [chickenpox]

480

1.17

0.52

1.1

1.2

3.22

3.41

u/ml

0.04

278

Disorders of psychological development

242

2090

1.08

0.52

1.2

2.84

2.78

u/ml

0.02

150

1251

Hypoplasia of dental enamel

332

0.79

0.52

1.5

1.3

1.44

4.64

u/ml

2.01

256

Outcome of delivery

263

1741

0.93

0.51

1.1

2.89

2.13

u/ml

0.53

150

850

Exclusion endpoint for supernumerary teeth

202

0.73

0.51

1.2

2.99

3.96

u/ml

—

137

Intracranial trauma

745

5029

1.04

0.51

1.2

1.1

1.80

2.63

u/ml

1.82

408

2581

Use of glatiramer acetate

191

0.73

0.51

1.1

0.51

2.48

u/ml

—

Vitreous haemorrhage

500

0.84

0.51

1.0

1.1

0.65

1.92

u/ml

2.12

258

Dystonia

379

1.19

0.51

1.1

2.70

2.44

u/ml

0.04

198

Impacted maxillary molar

1052

0.89

0.51

1.2

1.1

3.87

3.19

u/ml

0.18

569

Obstructed labour due to maternal pelvic abnormality

123

1113

1.11

0.51

1.1

1.41

1.84

u/ml

0.30

495

Multiple myeloma, including Hilmo

109

1.38

0.51

1.1

1.0

0.10

1.39

u/ml

—

Pectus excavatum

1.45

0.50

1.1

1.2

3.43

2.54

u/ml

—

Hypertensive diseases (excluding secondary)

674

4083

0.96

0.50

1.1

2.28

1.95

u/ml

0.31

356

2047

Pedal cyclist injured in collision with motor vehicle

270

1.23

0.50

1.1

5.05

3.29

u/ml

0.32

139

Diabetic maculopathy, excluding more controls

766

0.87

0.50

1.1

1.52

2.26

u/ml

0.52

391

Paralytic strabismus

357

0.81

0.50

1.1

0.16

2.21

u/ml

4.43

198

Social disorders starting during childhood or adolecense, excluding more controls

154

1.32

0.50

1.0

1.2

0.26

2.70

u/ml

2.31

102

Zoster [herpes zoster]

967

0.89

0.50

1.1

2.25

2.12

u/ml

0.04

493

Traumatic subarachnoid haemorrhage

127

1.34

0.49

1.1

0.36

2.30

u/ml

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

163

1.31

0.49

1.2

0.08

3.24

u/ml

2.89

107

Disorders of lens

413

2718

0.95

0.49

1.1

1.22

1.82

u/ml

1.08

218

1290

Hernia of abdominal wall, postoperative

133

1211

1.10

0.49

1.1

2.41

1.74

u/ml

0.42

587

Secondary hypertension

597

0.86

0.49

1.1

1.02

2.13

u/ml

0.65

333

Epilepsy

253

2694

0.94

0.48

1.2

1.1

1.69

2.40

u/ml

0.92

132

1448

Memory loss

289

1.21

0.48

1.3

1.1

0.22

1.70

u/ml

3.15

147

Benign neoplasm: Cerebral meninges

418

1.17

0.48

1.1

0.55

1.29

u/ml

1.02

218

Other peripheral vertigo

446

1.17

0.48

1.1

0.64

1.86

u/ml

1.53

231

Other bacterial intestinal infections

122

1107

1.10

0.48

1.1

1.58

2.07

u/ml

0.36

555

Complications of anaesthesia during labour and delivery

1.51

0.48

1.1

—

7.69

u/ml

—

Chronic respiratory disease originating in the perinatal period

0.57

0.48

1.2

1.3

0.11

3.89

u/ml

—

Iron deficiency anaemia

325

3021

1.06

0.48

1.2

1.1

1.70

1.95

u/ml

0.18

174

1526

Social disorders starting during childhood or adolescence

155

1.31

0.48

1.0

1.2

0.26

4.27

u/ml

3.66

107

Impotence

200

0.75

0.47

1.0

1.1

0.21

2.73

u/ml

—

Other strabismus

284

2661

1.06

0.47

1.1

1.62

2.69

u/ml

0.98

163

1443

Operations 2 for CAVS

733

1.12

0.47

1.1

4.01

1.31

u/ml

0.70

391

Calcific aortic valvular stenosis, diagnosis (helper)

733

1.12

0.47

1.1

4.01

1.31

u/ml

0.70

391

Postpartum haemorrhage

390

3115

1.06

0.47

1.1

2.65

2.13

u/ml

0.35

177

1495

Osteomyelitis

327

1.20

0.47

1.2

1.1

1.36

2.06

u/ml

0.29

179

Other abnormal findings in urine

1.48

0.47

1.1

0.07

1.15

u/ml

—

Calcific aortic valvular stenosis, operated

743

1.12

0.47

1.1

3.91

1.33

u/ml

0.68

399

Calcific aortic valvular stenosis

743

1.12

0.47

1.1

3.91

1.33

u/ml

0.68

399

Assault by unspecified means

218

1.25

0.47

1.1

1.07

3.49

u/ml

1.51

113

Retinal haemorrhage

1.42

0.47

1.1

0.37

1.95

u/ml

—

Etanercept

644

0.87

0.47

1.1

0.39

2.72

u/ml

6.02

332

Injury of eye and orbit

156

1436

1.09

0.47

1.1

2.03

1.95

u/ml

0.04

740

Other disorders of binocular vision

120

1.34

0.46

1.2

1.1

0.91

3.67

u/ml

—

Other disorders of ear

902

5705

1.04

0.46

1.2

1.1

1.85

2.07

u/ml

0.27

458

2875

Generalized epilepsy, mode (most common among epilepsy diagnosis)

365

1.18

0.46

1.2

1.77

3.00

u/ml

0.53

208

Embedded teeth, including avohilmo

157

1447

1.09

0.46

1.1

2.44

2.57

u/ml

0.06

786

Infections, IBD-co-morbidities

151

990

1.09

0.46

1.1

1.59

2.52

u/ml

0.82

511

Sudden idiopathic hearing loss

486

1.15

0.46

1.2

1.1

1.26

2.31

u/ml

0.60

252

Loose body in joint

129

1.32

0.46

1.2

10.40

2.70

u/ml

—

Artificial opening status

331

0.81

0.46

1.0

1.2

0.71

2.39

u/ml

2.33

193

Other disorders of skin and subcutaneous tissue

581

4950

1.04

0.46

1.1

2.19

1.91

u/ml

0.24

303

2436

Respiratory tuberculosis, confirmed and not-confirmed

129

1.32

0.45

1.2

1.1

1.56

1.41

u/ml

—

Respiratory tuberculosis

129

1.32

0.45

1.2

1.1

1.56

1.41

u/ml

—

Benign neoplasm: Lip

1.43

0.45

1.1

0.65

1.63

u/ml

—

Malignant neoplasm of colon, including Hilmo

653

0.87

0.45

1.2

1.1

0.44

1.44

u/ml

2.74

331

Iridocyclitis in diseases classified elsewhere

103

1.37

0.45

1.1

0.36

4.04

u/ml

—

274

1.21

0.45

1.1

0.83

3.16

u/ml

2.36

119

Papilloedema, unspecified

183

1.26

0.45

1.1

1.2

4.55

3.68

u/ml

0.16

102

Other and unspecified disorders of white blood cells

210

1.24

0.45

1.1

0.23

3.17

u/ml

3.53

114

Maternal care for known or suspected disproportion

525

1.15

0.45

1.1

1.02

2.24

u/ml

0.98

235

Other/unspecified reactive arthropathies

506

1.15

0.45

1.1

0.53

2.42

u/ml

3.05

264

Calcific aortic valvular stenosis, including rheumatic fever

736

1.12

0.45

1.1

4.01

1.30

u/ml

0.70

393

Dislocation, sprain and strain of joints and ligaments of head

469

1.16

0.45

1.1

0.75

2.50

u/ml

2.87

245

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

132

1189

1.10

0.44

1.2

2.26

3.03

u/ml

0.43

745

severe traumatic brain injury, does not include concussion

1032

0.90

0.44

1.1

0.91

2.15

u/ml

2.05

528

Maternal care related to the fetus and amniotic cavity and possible delivery problems

655

3695

1.04

0.44

1.1

2.23

2.16

u/ml

0.05

303

1811

Pedestrian injured in transport accident

497

1.15

0.44

1.1

0.81

2.53

u/ml

2.96

254

Calcific tendinitis of shoulder

348

1.18

0.44

1.1

6.27

1.91

u/ml

0.47

158

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

195

2026

0.93

0.44

1.1

1.2

3.73

2.57

u/ml

0.41

115

1179

Leisure time condition

176

1633

1.08

0.44

1.2

1.1

1.83

2.67

u/ml

0.86

863

Vitamin deficiency, wide

302

1.20

0.44

1.2

1.1

3.18

2.98

u/ml

0.03

164

Vitamin deficiency

302

1.20

0.44

1.2

1.1

3.18

2.98

u/ml

0.03

164

Serous carcinoma of ovary, including Hilmo

152

0.72

0.44

1.0

1.1

1.13

0.86

u/ml

—

Pneumothorax

302

1.19

0.44

1.2

1.1

2.73

1.89

u/ml

0.17

160

Burn and corrosion of wrist and hand

394

0.83

0.44

1.2

3.28

3.17

u/ml

0.02

227

Polyhydramnios

611

1.13

0.44

1.1

4.58

2.98

u/ml

0.34

293

Viral hepatitis, IBD co-morbidity

523

0.86

0.44

1.2

1.1

1.51

2.48

u/ml

0.55

262

Carrier of infectious disease

202

1.24

0.44

1.2

1.1

1.19

3.23

u/ml

0.92

106

Gout, idiopatic and unspecified

852

0.89

0.43

1.2

1.1

1.73

1.24

u/ml

0.21

435

Pyogenic arthritis

358

1.18

0.43

1.3

1.1

0.95

3.14

u/ml

2.46

188

Mixed connective tissue disease

442

1.16

0.43

1.1

2.23

2.25

u/ml

0.01

218

Reactive arthropathies

668

1.13

0.43

1.1

0.51

2.80

u/ml

4.24

321

Disorders of synovium and tendon in diseases classified elsewhere

104

1.35

0.43

1.1

4.76

3.80

u/ml

—

Other peripheral vascular diseases

536

1.14

0.43

1.1

0.79

2.73

u/ml

3.30

270

Mental and behavioural disorders due to tobacco

618

0.87

0.43

1.1

0.91

2.17

u/ml

1.36

313

Convalescence

340

1.18

0.43

1.2

1.1

1.47

2.05

u/ml

0.20

163

Lack of expected normal physiological development

530

0.87

0.43

1.3

1.2

2.72

3.35

u/ml

0.17

374

Bacterial intestinal infections, IBD co-morbidities

121

1107

1.09

0.42

1.1

1.67

2.10

u/ml

0.30

555

Noise effects on inner ear

203

1.24

0.42

1.2

1.1

0.92

2.00

u/ml

0.70

102

Intrahepatic Cholestasis of Pregnancy (ICP)

103

937

1.10

0.42

1.1

2.38

2.52

u/ml

0.04

439

Polymyalgia rheumatica

338

0.83

0.42

1.1

0.19

1.20

u/ml

2.38

172

Venous complications and haemorrhoids in pregnancy

239

0.79

0.42

1.1

1.74

2.38

u/ml

—

117

Other specified congenital malformation syndromes affecting multiple systems

304

0.81

0.42

1.1

1.2

3.51

3.24

u/ml

0.05

205

Malignant neoplasm of urinary organs

327

0.82

0.41

1.0

1.1

2.16

1.63

u/ml

0.12

165

Fluid overload

0.00

0.41

0.0

1.3

—

2.37

—

Drug-induced thyroiditis

0.00

0.41

0.0

1.2

—

0.66

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.41

0.0

1.1

—

1.34

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.41

0.0

1.0

—

2.23

—

Exposure to sunlight

0.00

0.41

0.0

1.3

—

2.00

—

Eccrine sweat disorders

0.00

0.41

0.0

1.3

—

2.89

—

Other and unspecified myoneural disorders

0.00

0.41

0.0

1.2

—

2.41

—

Progressive systemic sclerosis

0.00

0.41

0.0

1.1

—

2.00

—

Other hyperalimentation

0.00

0.41

0.0

1.2

—

0.50

—

Amputation of toe

206

0.78

0.41

1.1

0.33

1.83

u/ml

2.00

103

Malignant neoplasm of ureter, including Hilmo

0.00

0.41

0.0

1.1

—

0.66

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

0.41

0.0

1.1

—

1.65

—

Other infiltrative disorders of skin and subcutaneous tissue

0.00

0.41

0.0

1.1

—

4.20

—

Physiological and behavioural disorders associated with sexual development and orientation

0.00

0.41

0.0

1.0

—

3.13

—

Chronic ulcer of skin, not elsewhere classified

261

0.80

0.41

1.1

0.46

2.04

u/ml

2.60

133

Hypertension, essential

783

4583

0.97

0.41

1.1

2.23

1.74

u/ml

0.52

406

2183

Disorders in reading

287

1.19

0.41

1.2

6.18

3.16

u/ml

0.50

186

Smoking dependency

615

0.88

0.41

1.1

0.91

2.18

u/ml

1.37

311

Restrictive cardiomyopathy

0.00

0.41

0.0

1.2

—

2.81

—

Disorders of purine and pyrimidine metabolism

0.00

0.41

0.0

1.1

—

1.65

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

0.00

0.40

0.0

1.1

—

5.01

—

Underdevelopment of the second kidney

0.00

0.40

0.0

1.2

—

4.80

—

Bacterial, viral and other infectious agents

862

1.10

0.40

1.2

1.1

3.05

2.30

u/ml

0.29

452

Abscess of mediastinum

0.00

0.40

0.0

1.2

—

0.77

—

Periodontal disease, other/unspecified

177

1.25

0.40

1.0

1.1

1.80

2.04

u/ml

0.08

Undescended testis, unilateral

215

0.78

0.40

1.2

1.3

6.43

2.48

u/ml

—

164

Ascites

293

0.82

0.40

1.0

1.1

1.88

1.23

u/ml

0.19

155

Autoimmune diseases related-to ILD

946

7854

1.03

0.40

1.1

2.15

2.06

u/ml

0.08

458

3957

Anaemias

370

2301

1.05

0.40

1.2

1.1

2.24

2.49

u/ml

0.14

197

1234

Pneumococcal septicemia

227

0.79

0.40

1.4

1.1

6.37

2.59

u/ml

0.39

131

Other parasitologically confirmed or unspecified malaria

0.00

0.40

0.0

1.1

—

1.52

—

Retinal detachment with retinal break

549

1.13

0.40

1.1

2.28

2.01

u/ml

0.09

284

Parkinson's disease, strict definition

336

0.83

0.40

1.1

1.35

1.33

u/ml

0.01

165

Abdominal aortic aneurysm (AAA)

131

1.29

0.40

1.1

0.34

2.87

u/ml

—

Other embolism and thrombosis

701

1.11

0.40

1.1

1.01

2.14

u/ml

1.69

348

Other arthritis (FG)

289

2740

1.06

0.40

1.1

0.80

2.03

u/ml

5.08

146

1355

Reactive arthropathies, FINNGEN

578

1.13

0.40

1.1

0.51

2.40

u/ml

3.47

289

Abnormal findings on examination of urine, without diagnosis

269

1.19

0.39

1.1

3.89

3.63

u/ml

0.03

146

Superficial injury of forearm

116

1065

1.09

0.39

1.2

1.1

5.85

2.56

u/ml

1.01

574

Viral and other specified intestinal infections

350

3257

1.05

0.39

1.2

1.1

1.94

2.98

u/ml

1.43

181

1839

Cerebral oedema

0.00

0.39

0.0

1.1

—

1.71

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

0.00

0.39

0.0

1.2

—

3.38

—

Findings of drugs and other substances, not normally found in blood

0.00

0.39

0.0

1.1

—

1.11

—

Psoriasis (vulgaris), strict definition

226

0.79

0.39

1.1

0.67

2.47

u/ml

—

119

Pneumonitis due to solids and liquids

270

0.81

0.39

1.1

0.23

2.19

u/ml

3.55

145

Early lumbar disc prolapse operation

148

1374

1.08

0.39

1.1

3.01

2.25

u/ml

0.27

661

Other drug-induced secondary parkinsonism

0.00

0.39

0.0

1.1

—

1.06

—

Other diseases of arteries and capillaries

456

1.14

0.39

1.1

3.15

2.49

u/ml

0.18

232

Mixed disorders of conduct and emotions, excluding more controls

452

0.86

0.39

1.1

1.2

1.74

2.35

u/ml

0.30

261

Malignant neoplasm of colon

485

0.86

0.39

1.1

0.53

1.46

u/ml

1.67

253

Benign neoplasm: Skin of lower limb, including hip

148

0.74

0.39

1.1

0.66

2.86

u/ml

—

Chronic pancreatitis

612

0.88

0.38

1.0

1.1

1.74

2.14

u/ml

0.20

313

Bursitis of shoulder

133

1.28

0.38

1.2

1.1

0.14

3.31

u/ml

—

Other disorders of pigmentation

270

1.19

0.38

1.2

1.1

6.24

2.69

u/ml

0.38

151

Habit and impulse disorders

181

0.77

0.38

1.1

0.52

3.37

u/ml

—

Sensorineural hearing loss

527

3440

1.04

0.38

1.1

1.59

2.08

u/ml

0.51

260

1674

Mandibular prognathia

197

1.23

0.38

1.1

1.2

2.25

3.38

u/ml

0.23

124

Other symptoms and signs involving general sensations and perceptions

247

0.81

0.38

1.3

1.2

0.95

3.00

u/ml

1.57

138

1.34

0.38

1.1

1.53

3.08

u/ml

—

Nonspecific lymphadenitis

486

1.13

0.37

1.1

1.04

2.55

u/ml

1.32

245

Other benign neoplasms of connective and other soft tissue

663

0.89

0.37

1.1

1.61

2.25

u/ml

0.26

331

Chalazion

905

1.10

0.37

1.1

3.37

2.20

u/ml

0.27

454

Infectious mononucleosis

149

1387

1.08

0.37

1.1

2.27

2.81

u/ml

0.20

743

Emotional disorders starting during childhood or adolescence

120

1098

1.09

0.37

1.2

2.76

3.33

u/ml

0.22

671

Hyperprolactinaemia

383

1.15

0.37

1.2

1.1

0.42

2.95

u/ml

4.43

190

Foreign body on external eye

136

1261

1.08

0.37

1.1

2.44

2.08

u/ml

0.11

657

Pedestrian injured in collision with car, pick-up truck or van

147

0.75

0.37

1.0

1.1

1.09

2.40

u/ml

—

Maternal care for known or suspected abnormality of pelvic organs

401

2613

1.05

0.37

1.1

2.34

2.02

u/ml

0.26

200

1285

Allergic purpura

262

1.19

0.37

1.2

1.1

0.59

3.68

u/ml

3.40

139

Thyrotoxicosis with diffuse goitre

132

1223

1.08

0.37

1.1

2.41

2.08

u/ml

0.12

584

Blood alcohol or alcohol intoxication level

224

0.80

0.37

1.0

1.1

2.92

3.08

u/ml

0.04

119

Vitamin B12 deficiency anaemia

365

0.85

0.37

1.2

1.1

0.58

2.10

u/ml

2.02

184

Thrombocytopenia, unspecified

429

0.86

0.37

1.2

1.1

1.00

3.04

u/ml

2.33

244

Diseases of liver

250

2368

1.06

0.37

1.1

2.43

1.91

u/ml

0.33

124

1171

Postprocedural musculoskeletal disorders, not elsewhere classified

300

0.83

0.36

1.1

0.53

1.60

u/ml

1.73

151

Crohn disease

147

1369

1.08

0.36

1.1

1.52

2.42

u/ml

0.45

703

Hypopituitarism

776

0.90

0.36

1.2

4.86

2.75

u/ml

0.41

462

Premature rupture of membranes

335

2510

0.95

0.36

1.1

2.32

2.06

u/ml

0.17

151

1252

Iridocyclitis

187

1757

1.07

0.36

1.1

1.67

2.15

u/ml

0.32

864

Other disorders starting during childhood or adolescence

130

1195

1.08

0.36

1.2

2.28

3.18

u/ml

0.51

752

Toxic effects of substances chiefly nonmedicinal as to source

121

1119

1.08

0.36

1.1

4.82

2.14

u/ml

0.74

593

Congenital malformations of heart and great arteries

155

1607

0.93

0.36

1.1

1.2

3.56

2.67

u/ml

0.28

965

Sequelae of infectious and parasitic diseases

469

1.13

0.36

1.3

1.1

0.53

1.96

u/ml

2.39

222

Statin medication

815

4720

0.97

0.36

1.1

1.51

1.92

u/ml

0.78

396

2340

Respiratory and cardiovascular disorders specific to the perinatal period

667

1.11

0.36

1.2

1.3

3.45

u/ml

0.00

473

Other and unspecified epidermal thickening

171

1.23

0.36

1.2

1.1

1.29

2.35

u/ml

0.51

Malignant neoplasm of kidney, except renal pelvis

310

0.84

0.36

1.0

1.1

2.16

1.57

u/ml

0.14

158

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

597

0.89

0.35

1.2

1.1

1.34

2.28

u/ml

0.48

298

Hallux valgus (acquired)

252

1717

1.06

0.35

1.1

0.96

1.81

u/ml

0.92

123

770

Prolonged pregnancy

247

2277

0.95

0.35

1.1

2.35

2.17

u/ml

0.12

135

1142

Tularaemia

108

1.30

0.35

1.3

1.1

10.82

2.62

u/ml

—

Bacterial pneumoniae

314

2640

1.05

0.35

1.1

1.91

1.98

u/ml

0.03

189

1312

Other specified and unspecified retinal disorders

153

1.25

0.35

1.1

0.20

2.46

u/ml

—

Superficial injury of ankle and foot

169

1585

1.07

0.35

1.2

1.1

2.14

2.71

u/ml

0.30

850

Systemic sclerosis (FG)

126

1.27

0.35

1.1

0.49

1.78

u/ml

—

Other metabolic disorders

128

1188

1.08

0.35

1.1

1.88

2.16

u/ml

0.12

581

Benign neoplasm: Rectum

717

1.10

0.35

1.1

0.85

1.66

u/ml

1.01

368

Other disorders of amniotic fluid and membranes

201

2079

0.94

0.35

1.1

2.30

2.13

u/ml

0.07

1036

Convulsions, not elsewhere classified

245

2549

0.95

0.35

1.2

1.1

2.71

2.65

u/ml

0.03

143

1383

Use of levodopa decarboxylase inhibitor

320

0.84

0.35

1.1

1.24

1.39

u/ml

0.05

159

Lymphangioma, anys site

1.38

0.35

1.0

1.2

0.12

3.09

u/ml

—

Follow-up examination after treatment for malignant neoplasms

341

0.85

0.34

1.2

1.1

0.55

1.29

u/ml

1.24

153

Anankastic personality disorder

394

0.86

0.34

1.2

1.1

0.78

2.85

u/ml

2.29

194

Isolated proteinuria

181

1.22

0.34

1.1

5.75

3.71

u/ml

0.18

Colectomy operation

753

0.90

0.34

1.1

0.29

2.03

u/ml

5.61

385

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

154

1.25

0.34

1.2

2.65

3.81

u/ml

0.25

100

Other congenital malformations, not elsewhere classified

145

1.26

0.34

1.2

1.31

4.03

u/ml

1.37

100

Torticollis

163

1.23

0.34

1.2

1.77

4.06

u/ml

0.62

Thyrotoxicosis with toxic multinodular goitre

255

1.18

0.34

1.1

0.37

1.46

u/ml

1.77

125

Scarlet fever

136

1.26

0.34

1.1

1.2

13.50

4.72

u/ml

—

Contusion of other and unspecified parts of foot

614

1.11

0.34

1.2

1.1

1.73

3.02

u/ml

0.53

338

Missing teeth due to accident, extraction or parodontitis

364

3575

0.96

0.34

1.1

1.70

1.79

u/ml

0.06

201

1716

Other (seronegative) rheumatoid arthritis, wide

1075

0.92

0.34

1.1

0.75

2.08

u/ml

2.41

533

Malignant neoplasm of rectum, including Hilmo

436

0.87

0.34

1.1

4.05

1.52

u/ml

0.37

222

Labour and delivery complicated by fetal stress [distress]

409

2786

0.96

0.34

1.1

1.84

2.17

u/ml

0.33

209

1340

Nystagmus and other irregular eye movements

127

1.27

0.33

1.0

1.2

0.39

3.40

u/ml

2.48

Other and unspecified injuries of thorax

100

1.31

0.33

1.0

1.1

0.91

3.41

u/ml

—

Viral infections of the central nervous system

586

1.11

0.33

1.1

2.06

2.48

u/ml

0.13

304

Corns and callosities

361

0.86

0.33

1.2

1.1

7.67

2.48

u/ml

0.45

191

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

101

931

1.09

0.33

1.1

0.62

2.08

u/ml

3.45

453

!Aliquae complicationes praecoces traumatis

275

0.83

0.33

1.0

1.1

0.88

2.67

u/ml

1.82

141

Early complications of trauma

275

0.83

0.33

1.0

1.1

0.88

2.67

u/ml

1.82

141

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

253

0.83

0.33

1.0

1.1

2.49

2.94

u/ml

—

122

Anisometropia and aniseikonia

256

1.18

0.33

1.1

0.15

3.31

u/ml

—

143

Other CVD

691

1.10

0.33

1.2

1.1

1.14

2.16

u/ml

0.77

361

Autoimmune hyperthyroidism

539

1.12

0.33

1.1

3.41

2.28

u/ml

0.22

257

Pleural effusion

488

0.88

0.33

1.1

0.29

2.18

u/ml

3.40

253

Hydrocephalus

307

0.85

0.33

1.0

1.2

0.32

2.23

u/ml

3.40

180

Viral haemorrhagic fevers, not elsewhere classified/unspecified

501

1.12

0.33

1.1

1.28

2.48

u/ml

1.03

257

Emotionally unstable personality disorder

165

1754

0.94

0.33

1.2

1.1

1.43

2.42

u/ml

1.38

871

Personal history of other diseases and conditions

193

1816

1.06

0.33

1.1

2.42

2.88

u/ml

0.19

109

1006

Inflammatory bowel disease, strict (require KELA)

244

2564

0.95

0.32

1.1

1.56

2.22

u/ml

0.46

103

1315

Hypoplasia of dental enamel , including avohilmo

817

0.91

0.32

1.3

1.2

1.85

3.29

u/ml

1.18

553

Autoimmune diseases

1399

7265

0.98

0.32

1.1

2.03

2.27

u/ml

0.34

698

3789

Herpesviral keratitis and keratoconjunctivitis

238

1.18

0.32

1.2

1.1

9.54

2.30

u/ml

1.04

121

Other noninfective disorders of lymphatic vessels and lymph nodes

220

0.82

0.32

1.3

1.1

0.63

2.35

u/ml

—

118

Acute appendicitis, with complications

131

1403

0.93

0.32

1.1

1.09

1.95

u/ml

1.43

670

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.28

0.32

1.2

1.1

0.81

3.18

u/ml

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

116

1078

1.08

0.32

1.1

2.07

2.11

u/ml

0.01

520

Malignant neoplasm of cervix uteri, including Hilmo

176

0.79

0.32

1.0

1.1

0.16

2.82

u/ml

—

Hypermetropia

841

0.91

0.32

1.3

1.2

0.97

3.06

u/ml

3.48

516

Injury of muscle and tendon at forearm level

119

1.27

0.32

1.1

0.35

2.25

u/ml

—

Pustular psoriasis

284

0.84

0.31

1.1

0.87

2.20

u/ml

1.23

151

L02BA Anti-estrogens

1070

0.92

0.31

1.1

1.97

1.33

u/ml

0.39

485

Wide developmental disorders, excluding more controls

663

0.90

0.31

1.1

1.2

3.00

2.97

u/ml

0.01

418

Congenital malformations of eyelid, lacrimal apparatus and orbit

184

1.21

0.31

1.2

0.14

3.55

u/ml

2.75

122

Inflammatory diseases of the central nervous system

632

0.90

0.31

1.1

2.83

2.34

u/ml

0.10

318

Amenorrhoea

103

955

1.08

0.31

1.1

2.51

2.46

u/ml

0.01

490

Diabetic retinopathy, strict definition

757

1.09

0.31

1.1

1.64

1.42

u/ml

0.15

380

Disorders resulting from impaired renal tubular function

186

0.80

0.31

1.1

0.81

2.43

u/ml

—

112

Other other unspecified disorders of the circulatory system

186

0.80

0.31

1.1

0.14

2.41

u/ml

—

102

Other or ill-defined heart diseases

333

1.14

0.31

1.2

1.1

1.79

2.43

u/ml

0.22

177

Pectus excavatum

1.35

0.31

1.1

3.43

2.59

u/ml

—

Lactose intolerance

277

1.16

0.31

1.1

1.2

2.71

3.44

u/ml

0.11

159

Other and unspecified psoriasis

371

1.13

0.30

1.3

1.1

3.97

2.30

u/ml

0.20

195

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

225

2141

1.05

0.30

1.1

1.07

2.03

u/ml

1.86

1009

Glucagon-like peptide-1 (GLP-1) analogues

225

2141

1.05

0.30

1.1

1.07

2.03

u/ml

1.86

1009

Primary open-angle glaucoma, strict

755

0.91

0.30

1.1

0.40

1.21

u/ml

2.54

380

Postprocedural disorders of nervous system

860

0.92

0.30

1.1

1.21

2.56

u/ml

1.90

440

Scabies

197

1869

1.06

0.30

1.1

2.20

2.78

u/ml

0.34

111

977

Fracture of shoulder and upper arm

277

2890

0.96

0.30

1.1

2.56

2.34

u/ml

0.10

140

1539

Multiple myeloma and malignant plasma cell neoplasms

120

1.25

0.30

1.1

0.10

1.44

u/ml

—

Other misadventures during surgical and medical care

111

1.27

0.30

1.2

1.1

0.15

2.35

u/ml

—

Macular cyst

1.31

0.30

1.0

1.1

1.33

0.94

u/ml

—

Other heart diseases

650

4366

0.97

0.30

1.1

2.54

2.04

u/ml

0.42

350

2274

Hemiplegia

287

1.15

0.30

1.1

1.84

3.25

u/ml

0.34

153

Pregnancy examination and test

299

1779

1.05

0.30

1.1

2.88

2.29

u/ml

0.37

154

874

Myocardial infarction, with ST-elevation

494

0.89

0.30

1.1

0.47

1.81

u/ml

2.28

253

Burn and corrosion of hip and lower limb, except ankle and foot

174

0.80

0.29

1.0

1.1

1.56

3.68

u/ml

—

Viral agents as the cause of diseases classified to other chapters

194

1.19

0.29

1.1

0.16

3.48

u/ml

3.09

111

Thiazolidinediones

410

1.12

0.29

1.1

1.15

1.81

u/ml

0.49

213

Implicit fungal Sepsis

157

1.21

0.29

1.2

1.1

0.87

1.57

u/ml

0.43

Other disorders of optic [2nd] nerve and visual pathways

525

1.11

0.29

1.2

2.70

2.81

u/ml

0.04

310

Other epidermal thickening

269

1.16

0.29

1.2

1.1

1.17

2.36

u/ml

0.89

144

Primary open-angle glaucoma

890

0.92

0.29

1.1

0.34

1.35

u/ml

3.93

449

Hirsutism in women

232

1.17

0.29

1.1

7.40

3.64

u/ml

0.38

117

Granulomatous disorders of skin and subcutaneous tissue

195

0.82

0.29

1.2

1.1

0.41

3.53

u/ml

—

110

Other and unspecified abdominal hernia

176

1.20

0.29

1.1

3.56

1.87

u/ml

—

Malignant neoplasm of bladder, including Hilmo

277

1.15

0.28

1.1

0.69

1.50

u/ml

0.89

137

Raynaud syndrome

747

1.09

0.28

1.1

1.02

2.50

u/ml

2.30

367

Cutaneous lupus erythematosus

112

1.25

0.28

1.2

1.1

0.28

1.90

u/ml

—

Deep endometriosis

863

1.08

0.28

1.2

1.1

1.35

2.35

u/ml

0.43

425

Chromosomal abnormalities, not elsewhere classified

416

0.88

0.28

1.2

8.53

2.99

u/ml

0.81

286

Ectopic pregnancy

178

1689

1.06

0.28

1.2

1.1

1.34

1.81

u/ml

0.42

795

Lung diseases due to external agents

536

1.10

0.28

1.2

1.1

2.11

2.32

u/ml

0.05

273

Paroxysmal tachycardia

237

1895

1.05

0.28

1.1

1.28

2.18

u/ml

1.33

132

961

Other disorders of bladder

498

1.11

0.28

1.2

1.1

1.20

2.39

u/ml

1.03

249

Haemorrhage, not elsewhere classified

149

1.21

0.28

1.2

1.1

0.07

3.92

u/ml

—

Other diseases of pancreas

346

1.13

0.27

1.1

3.24

2.00

u/ml

0.19

181

Chronic Coagulation defects

226

0.84

0.27

1.2

1.1

1.76

3.14

u/ml

—

127

Retinal vascular occlusion

327

1.13

0.27

1.1

0.55

1.80

u/ml

2.08

167

Congenital musculoskeletal deformities of head, face, spine and chest

168

1.20

0.27

1.1

1.2

1.69

3.19

u/ml

0.56

112

Carcinoma in situ of cervix uteri

112

1195

0.94

0.27

1.1

2.23

2.33

u/ml

0.03

587

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

122

1.24

0.27

1.3

1.1

4.61

4.49

u/ml

—

Hereditary corneal dystrophies

122

1.23

0.27

1.3

1.1

1.10

1.59

u/ml

—

Wet age-related macular degeneration

281

1.14

0.27

1.1

0.45

0.86

u/ml

0.72

141

L01XX Other antineoplastic agents

150

0.80

0.27

1.1

0.19

1.71

u/ml

—

Malnutrition

159

1.20

0.27

1.4

1.3

6.28

3.02

u/ml

0.31

110

Twin gestation

108

1153

0.93

0.27

1.1

3.30

1.89

u/ml

0.57

562

Abnormal findings on antenatal screening of mother

144

1361

1.06

0.27

1.1

3.36

2.27

u/ml

0.45

681

Other endocrine disorders

885

1.07

0.26

1.2

1.91

3.17

u/ml

0.69

585

Ulcerative enterocolitis

234

1.16

0.26

1.2

1.1

0.56

3.25

u/ml

2.62

122

IBD patients in KELA-register

244

2545

0.96

0.26

1.1

1.56

2.17

u/ml

0.42

103

1305

Somnolence

1.27

0.26

1.3

1.2

0.62

2.48

u/ml

—

Other and unspecified mononeuropathies of upper limb

182

0.82

0.26

1.1

0.24

2.40

u/ml

—

Recurrent dislocation and subluxation of joint

749

0.92

0.26

1.1

1.21

2.58

u/ml

0.98

364

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

780

0.92

0.26

1.2

1.1

2.08

2.29

u/ml

0.05

383

Arthropod-borne viral fevers and viral haemorrhagic fevers

606

1.09

0.26

1.1

1.27

2.74

u/ml

1.56

298

Spondylopathies (FG)

145

1372

1.06

0.26

1.1

1.67

2.32

u/ml

0.40

665

Encephalitis

203

0.84

0.26

1.1

0.61

3.26

u/ml

2.36

109

Golimumab

341

0.88

0.26

1.1

0.51

3.26

u/ml

3.24

178

Placenta praevia

613

0.91

0.26

1.0

1.1

3.26

2.71

u/ml

0.13

295

Other sexually transmitted chlamydial diseases

112

1052

1.07

0.26

1.1

2.69

2.19

u/ml

0.19

543

Graves disease, strict definition

104

974

1.07

0.26

1.1

2.56

2.02

u/ml

0.15

472

Primary coxarthrosis, bilateral

976

0.93

0.25

1.2

1.1

3.12

1.28

u/ml

0.49

490

Female infertility, associated with anovulation

127

1198

1.06

0.25

1.1

2.86

2.39

u/ml

0.19

587

Supervision of normal pregnancy

359

2122

0.96

0.25

1.1

2.71

2.19

u/ml

0.32

175

1032

Arthropathies in other diseases classified elsewhere

192

0.83

0.25

1.0

1.1

1.98

2.92

u/ml

—

Problems related to social environment

188

1.17

0.25

1.2

1.1

3.49

2.97

u/ml

—

Other obstructed labour

737

0.92

0.25

1.2

1.1

1.96

2.12

u/ml

0.04

341

Disorders of mineral metabolism

492

1.10

0.25

1.1

0.42

1.92

u/ml

4.06

270

Problems related to lifestyle

1057

0.94

0.25

1.2

1.1

3.43

2.19

u/ml

0.27

520

Inguinal hernia, bilateral

406

1.11

0.25

1.0

1.1

0.86

2.55

u/ml

1.91

210

Calculus of lower urinary tract

159

0.82

0.24

1.1

0.12

2.30

u/ml

—

HSIL lesion of the vagina

1.26

0.24

1.1

0.34

1.96

u/ml

—

Hypertensive heart and/or renal disease

712

0.93

0.24

1.1

1.21

1.08

u/ml

0.14

364

Multiple delivery

870

0.93

0.24

1.1

2.59

1.94

u/ml

0.22

428

Other vitreous opacities

170

1.18

0.24

1.1

0.57

1.55

u/ml

—

Abscess of anal and rectal regions

705

1.08

0.24

1.1

0.79

2.20

u/ml

2.46

361

Mesial bite

126

0.79

0.24

1.2

0.57

3.63

u/ml

—

Contusion of ankle

407

1.11

0.24

1.1

2.08

3.25

u/ml

0.38

217

Other diseases of pericardium

191

0.84

0.24

1.1

0.21

1.91

u/ml

—

107

Abnormal spermatozoa

340

1.12

0.24

1.0

1.1

6.04

2.03

u/ml

—

177

Maternal care for known or suspected malpresentation of fetus

328

2296

1.04

0.24

1.1

2.74

2.03

u/ml

0.61

154

1130

Fracture of rib(s), sternum and thoracic spine

180

1718

1.05

0.24

1.1

1.69

1.87

u/ml

0.12

848

Autism

506

0.91

0.24

1.2

2.83

2.81

u/ml

0.00

302

Labour and delivery complicated by umbilical cord complications

542

1.09

0.24

1.1

2.26

2.57

u/ml

0.12

250

Dermatophytosis

793

1.07

0.24

1.1

3.10

2.47

u/ml

0.16

421

Retinal vascular disorders

331

1.12

0.24

1.1

0.55

1.78

u/ml

2.07

168

Disorders of speech understanding and production

712

1.08

0.24

1.3

1.2

3.79

2.79

u/ml

0.25

464

Cardiovascular diseases (excluding rheumatic etc)

1107

6249

1.02

0.24

1.1

2.10

2.21

u/ml

0.13

596

3260

Congenital malformations of pulmonary and tricuspid valves

179

0.83

0.24

1.1

1.3

23.90

3.50

u/ml

—

132

Specific development disorders of scholastic skills

898

1.07

0.24

1.2

3.48

2.62

u/ml

0.31

560

Gingival hyperplasia

328

0.88

0.24

1.2

0.48

3.45

u/ml

3.47

206

Malignant neoplasm of oral cavity, including Hilmo

158

0.82

0.23

1.2

1.1

3.65

2.09

u/ml

—

Vestibular neuronitis

485

0.91

0.23

1.1

3.16

2.38

u/ml

0.10

246

Parkinson's disease, excluding more controls

319

0.89

0.23

1.1

1.26

1.44

u/ml

0.06

153

Disorders of continuity of bone

823

1.07

0.23

1.1

3.48

2.18

u/ml

0.34

417

Other pleural conditions

284

1.13

0.23

1.1

0.43

1.64

u/ml

2.16

145

Cirrhosis of liver, NAS

199

1.16

0.23

1.0

1.1

6.70

2.33

u/ml

0.43

106

Open wound of forearm

794

1.07

0.23

1.1

3.93

2.23

u/ml

0.33

397

Lesion of lateral popliteal nerve

275

0.87

0.23

1.2

1.1

3.21

2.99

u/ml

0.03

144

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

341

3506

0.97

0.23

1.1

1.54

2.50

u/ml

1.82

173

1719

Congenital malformations of aortic and mitral valves

411

0.90

0.23

1.2

1.07

2.94

u/ml

1.57

256

Systemic sclerosis, icd10

134

1.20

0.23

1.1

0.49

1.88

u/ml

—

Spontaneous rupture of synovium and tendon

380

1.11

0.23

1.1

1.12

2.04

u/ml

0.65

187

Rare circulating lymphoid malignancy, including Hilmo

200

0.85

0.23

1.2

0.93

2.65

u/ml

—

136

Gout, unspecified

650

0.92

0.22

1.2

1.1

1.82

1.51

u/ml

0.09

315

Anxious personality disorder

221

0.86

0.22

1.1

0.15

4.08

u/ml

—

113

Osteomalacia

1.25

0.22

1.2

1.1

0.07

1.50

u/ml

—

Vascular diseases of the intestine

1.25

0.22

1.4

1.1

2.64

2.22

u/ml

—

Congenital malformations of genital organs

138

1441

0.95

0.22

1.2

1.1

1.79

2.75

u/ml

0.58

805

Congenital iodine-deficiency syndrome/hypothyroidism

172

1.17

0.22

1.2

1.1

1.43

3.05

u/ml

0.50

102

Neovascular glaucoma

172

1.16

0.22

1.1

0.19

1.86

u/ml

—

Other sexually transmitted chlamydial diseases

183

1754

1.04

0.22

1.1

2.90

2.94

u/ml

0.01

923

Molar incisor enamel hypoplasia

852

0.93

0.22

1.3

1.2

1.72

3.20

u/ml

1.36

577

Benign neoplasm: Aortic body and other paraganglia

0.00

0.22

0.0

1.1

—

1.05

—

Congenital malformations of uterus and cervix

273

0.88

0.22

1.1

0.33

3.46

u/ml

—

135

Nonischemic cardiomyopathy

430

0.91

0.22

1.2

1.1

0.35

1.90

u/ml

4.34

219

Other/unspecified disorders of vestibular function

191

1.15

0.22

1.2

1.1

0.10

2.19

u/ml

—

100

Linear scleroderma

0.00

0.22

0.0

1.4

—

0.76

—

Peripheral artery operations in Hilmo

357

0.90

0.21

1.2

1.1

1.11

1.89

u/ml

0.59

175

Motorcycle rider injured in noncollision transport accidents

315

0.89

0.21

1.0

1.1

3.07

4.02

u/ml

0.25

172

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

0.21

0.0

1.0

—

0.44

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

107

1.22

0.21

1.1

0.49

3.43

u/ml

—

Other and unspecified disorders of globe

0.00

0.21

0.0

1.3

—

2.68

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

357

0.90

0.21

1.0

1.1

1.92

1.46

u/ml

0.12

184

Endovascular or surgical operations to intracerebral aneurysms

315

0.89

0.21

1.2

1.1

1.38

1.57

u/ml

—

162

Other parasitologically confirmed or unspecified malaria

0.00

0.21

0.0

1.0

—

0.99

—

Amyloidosis, other/unspecified

1.19

0.21

1.0

1.2

—

1.54

—

Drowning and submersion while in natural water

0.00

0.21

0.0

1.1

—

1.30

—

Ankylosing spondylitis

681

1.07

0.21

1.1

1.94

2.55

u/ml

0.19

328

Complications of surgical and medical care, not elsewhere classified

1045

7032

1.02

0.21

1.1

1.39

2.07

u/ml

2.40

549

3466

Hypertensive Heart Disease

621

0.93

0.21

1.1

1.22

1.06

u/ml

0.15

316

Calcinosis cutis

0.00

0.21

0.0

1.1

—

0.68

—

Dengue fever [classical dengue]

0.00

0.21

0.0

1.3

—

2.33

—

Hip and thigh

0.00

0.21

0.0

1.3

—

0.97

—

Other and unspecified pemphigus

0.00

0.21

0.0

1.1

—

2.75

—

Benign neoplasm: Skin of upper limb, including shoulder

1.23

0.21

1.1

0.37

2.85

u/ml

—

Cachexia

0.00

0.21

0.0

1.1

—

1.50

—

Unspecified nephritic syndrome

1.23

0.21

1.1

0.51

2.52

u/ml

—

Psychotic depression

488

1.09

0.21

1.2

1.1

2.11

2.32

u/ml

0.05

259

Disorders of copper metabolism

0.00

0.21

0.0

1.0

—

1.03

—

Hypo-osmolality and hyponatraemia

697

1.07

0.21

1.2

1.1

0.67

1.78

u/ml

2.31

375

Acute disseminated encephalitis/encephalomyelitis

0.00

0.21

0.0

1.2

—

2.10

—

HSIL lesion of the cervix uteri

256

2474

1.04

0.21

1.1

2.82

1.78

u/ml

0.70

128

1209

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.21

0.0

1.1

—

2.52

—

Fitting and adjustment of external prosthetic device

0.00

0.21

0.0

1.2

—

3.02

—

Malignant neoplasm of ovary

230

0.87

0.21

1.1

1.07

1.59

u/ml

—

118

All pneumoniae

1205

7925

1.02

0.21

1.1

2.68

2.09

u/ml

0.79

676

4011

Malignant neoplasm of floor of mouth

0.00

0.21

0.0

1.1

—

1.84

—

Collapsed vertebra, not elsewhere classified

0.00

0.21

0.0

1.4

—

0.98

—

Glomerulonephritis

698

0.93

0.21

1.2

1.1

0.88

2.42

u/ml

2.21

385

Intestinal adhesions without obstruction

354

1.10

0.20

1.1

0.35

2.04

u/ml

2.69

196

Essential (haemorrhagic) thrombocythaemia

145

1.17

0.20

1.1

0.10

1.80

u/ml

—

Intussusception

117

1.20

0.20

1.1

0.65

1.55

u/ml

—

Ulcerative ileocolitis

345

0.90

0.20

1.1

0.36

2.68

u/ml

3.65

176

Psoriatic arthropathies, ICD10

749

0.93

0.20

1.1

0.81

2.08

u/ml

1.95

366

Scabies

441

1.09

0.20

1.2

1.1

3.62

3.23

u/ml

0.06

238

LSIL lesion of the cervix uteri, vagina or vulva

165

1721

0.96

0.20

1.2

1.1

2.28

2.06

u/ml

0.12

810

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.20

0.0

1.0

—

2.90

—

Myeloproliferative diseases

324

0.89

0.20

1.1

0.19

1.65

u/ml

3.12

165

Toxic effect of ethanol

376

0.90

0.20

1.1

1.16

2.89

u/ml

1.16

197

Thromboangiitis obliterans

0.00

0.20

0.0

1.2

—

0.48

—

Other osteochondrodysplasias

108

1.21

0.20

1.1

1.3

0.17

4.16

u/ml

—

Preparatory care for dialysis

187

0.85

0.20

1.1

0.28

2.14

u/ml

—

102

Complications of other internal prosthetic devices, implants and grafts

187

0.85

0.20

1.1

0.23

2.62

u/ml

2.63

Gout

876

0.94

0.20

1.2

1.1

1.75

1.46

u/ml

0.13

430

Cutaneous abscess, furuncle and carbuncle

248

2565

0.97

0.20

1.1

2.83

2.11

u/ml

0.40

144

1299

HSIL lesion of the cervix uteri, vagina or vulva

267

2585

1.03

0.20

1.1

2.72

1.77

u/ml

0.64

133

1256

All dysplastic lesions of the cervix uteri

367

3541

1.03

0.20

1.1

2.80

1.98

u/ml

0.69

178

1699

Other and unspecified injuries of head

521

0.92

0.20

1.2

1.1

1.73

2.39

u/ml

0.37

270

Divergent concomitant strabismus

703

1.07

0.20

1.1

1.38

2.45

u/ml

0.91

369

Sequelae of other and unspecified infectious and parasitic diseases

432

1.09

0.20

1.3

1.1

0.55

2.09

u/ml

2.33

205

Somnolence, stupor and coma

229

0.87

0.20

1.2

1.1

0.48

3.20

u/ml

2.89

128

Visual field defects

438

0.91

0.20

1.1

1.26

2.33

u/ml

0.58

219

Other coagulation defects

645

1.07

0.20

1.2

1.68

2.60

u/ml

0.52

335

Azathioprine

137

1434

0.95

0.20

1.2

1.1

1.66

2.49

u/ml

0.37

732

Gonarthrosis,primary

613

3695

1.02

0.20

1.1

1.95

1.64

u/ml

0.31

309

1703

Endometriosis ASRM stages 3,4

227

2192

1.04

0.20

1.1

1.20

1.77

u/ml

0.52

111

1041

Unspecified dementia

120

0.82

0.19

1.2

1.1

0.31

0.99

u/ml

—

Anorexia

127

1.19

0.19

1.5

1.1

0.91

3.13

u/ml

—

Pneumonia, organism unspecified

1011

6970

1.02

0.19

1.1

2.65

2.01

u/ml

0.79

564

3536

Idiopathic gout

269

1.12

0.19

1.2

1.1

1.13

2.28

u/ml

0.84

140

Glaucoma secondary to other eye disorders

174

1.15

0.19

1.1

0.19

2.33

u/ml

—

101

Chronic nephritic syndrome

197

0.86

0.19

1.1

0.14

1.52

u/ml

—

Injuries to the shoulder and upper arm

831

6575

1.02

0.19

1.1

2.09

2.07

u/ml

0.01

431

3334

Fracture of lower leg, including ankle

489

4952

0.98

0.19

1.1

1.15

2.05

u/ml

3.62

267

2481

Mixed and other personality disorders

850

1.06

0.19

1.2

1.1

1.23

2.19

u/ml

0.87

420

Symptoms and signs involving the urinary system

626

4866

0.98

0.19

1.1

1.81

2.00

u/ml

0.21

338

2439

Traumatic subdural haemorrhage

378

1.09

0.19

1.1

1.11

1.98

u/ml

0.51

187

Strabismus

306

2964

1.03

0.19

1.1

1.54

2.58

u/ml

1.01

172

1598

Volume depletion

406

0.91

0.19

1.3

1.2

1.14

2.59

u/ml

1.08

230

Early syphilis

1.23

0.19

1.2

1.1

2.87

1.89

u/ml

—

Disorder of the sleep-wake schedule

207

0.87

0.19

1.1

1.2

4.89

2.88

u/ml

—

129

Radial styloid tenosynovitis [de Quervain]

491

1.08

0.19

1.1

2.54

2.47

u/ml

0.02

241

Benign neoplasm: Rectum, anus and anal canal

821

1.06

0.19

1.1

0.93

1.71

u/ml

1.04

421

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

186

0.86

0.19

1.0

1.1

0.32

1.62

u/ml

—

Diseases of pulp and periapical tissues, including avohilmo

1334

6812

1.01

0.19

1.1

2.19

2.40

u/ml

0.28

737

3425

Polycystic ovarian syndrome, broad definition

183

1762

1.04

0.19

1.1

2.51

2.25

u/ml

0.13

869

Methotrexate

890

0.94

0.19

1.1

0.90

2.52

u/ml

2.84

415

Elevated blood glucose level

569

1.07

0.19

1.3

1.1

3.58

2.65

u/ml

0.15

303

Foreign body or object entering through skin

540

1.08

0.19

1.1

1.88

2.73

u/ml

0.58

279

Hyperkinetic disorders (excl. ADHD)

420

1.09

0.19

1.2

1.3

1.46

3.02

u/ml

1.04

296

Other abnormal findings of blood chemistry

270

1.11

0.19

1.1

0.82

2.87

u/ml

1.73

141

Other and unspecified disorders of skin and subcutaneous tissue

366

1.09

0.19

1.1

1.64

2.51

u/ml

0.33

189

Contact with sharp glass

405

0.91

0.18

1.1

0.62

3.17

u/ml

3.24

216

Diabetic retinopathy, excluding more controls

141

826

0.96

0.18

1.1

1.49

1.33

u/ml

0.13

402

Hepatic failure, not elsewhere classified

156

1.16

0.18

1.1

0.26

2.11

u/ml

—

Other chromosome abnormalities, not elsewhere classified

121

0.82

0.18

1.3

16.85

2.24

u/ml

—

Senile cataract

337

2008

1.03

0.18

1.1

1.09

1.40

u/ml

0.55

184

951

Use of interferon beta-1a

227

0.88

0.18

1.2

1.1

2.32

2.26

u/ml

—

107

Inguinal or femoral hernia, bilateral

415

1.09

0.18

1.0

1.1

0.86

2.49

u/ml

1.85

216

Accidental poisoning by and exposure to alcohol

174

0.86

0.18

1.1

2.46

4.11

u/ml

—

Other diseases of spinal cord

174

0.86

0.18

1.0

1.1

0.63

2.13

u/ml

—

Other heart diseases, wide

1145

7098

0.99

0.18

1.1

1.98

2.09

u/ml

0.13

594

3624

Multiple gestation

115

1204

0.95

0.18

1.1

3.03

1.85

u/ml

0.50

582

Purpura and other haemorrhagic conditions

1010

0.95

0.17

1.2

1.1

0.96

2.38

u/ml

2.19

554

Arthropathy in ulcerative colitis

1.21

0.17

1.1

3.71

2.16

u/ml

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

887

0.95

0.17

1.1

1.2

0.85

2.57

u/ml

2.76

508

Agoraphobia

416

1.08

0.17

1.1

0.96

2.94

u/ml

1.99

204

Pneumonias (Asthma/COPD co-morbidities)

1194

7905

1.01

0.17

1.1

2.66

2.04

u/ml

0.86

672

3998

Clear cell adenocarcinoma of kidney

142

0.84

0.17

1.1

1.00

1.73

u/ml

—

Other and unspecified intracranial injuries

176

1.14

0.17

1.2

1.1

5.10

3.59

u/ml

—

Other disorders of kidney and ureter

661

0.94

0.17

1.2

1.1

3.96

2.05

u/ml

0.32

347

Conduct disorder

351

0.91

0.17

1.0

1.2

0.85

2.59

u/ml

2.04

215

Tuberculosis, IBD comorbidity

195

1.13

0.17

1.2

1.1

1.30

1.85

u/ml

—

Undefined dementia

121

0.84

0.17

1.2

1.1

0.31

0.98

u/ml

—

Gout, strict definition

527

0.93

0.17

1.2

1.1

2.54

1.73

u/ml

0.20

261

Benign neoplasm: Skin, unspecified

224

1.12

0.17

1.0

1.1

0.25

1.77

u/ml

2.88

120

Left ventricular outflow tract obstruction, narrow definition

516

0.93

0.17

1.1

1.2

0.92

2.80

u/ml

2.09

316

Nephrotic syndrome

257

0.89

0.17

1.5

1.2

0.92

1.89

u/ml

0.65

171

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

571

4871

1.02

0.17

1.1

2.08

1.96

u/ml

0.10

254

2334

Crohn's disease NAS

631

1.06

0.16

1.1

0.21

2.51

u/ml

7.26

334

Exclusion endpoint for clefts

339

0.91

0.16

1.1

1.2

2.93

3.43

u/ml

0.12

230

Congenital musculoskeletal deformities of head, face, spine and chest

196

1.13

0.16

1.1

1.2

1.69

3.71

u/ml

0.79

135

Cardiomyopathy

895

0.95

0.16

1.2

1.1

0.43

1.68

u/ml

4.67

478

Pregnancy with abortive outcome

822

4221

1.02

0.16

1.1

2.02

2.17

u/ml

0.15

383

2085

Optic neuritis

412

0.92

0.16

1.1

3.17

2.72

u/ml

0.13

212

Left bundle-branch block

263

1.10

0.16

1.2

1.1

1.57

1.50

u/ml

0.02

139

Gout, FINNGEN

984

0.95

0.16

1.2

1.1

1.75

1.35

u/ml

0.20

501

Diabetic neuropathy

396

1.08

0.16

1.2

1.1

0.59

1.68

u/ml

1.72

193

Other or unspecified ileus, impaction or obstruction

797

1.05

0.16

1.1

0.75

1.82

u/ml

2.12

403

Systemic sclerosis

139

1.15

0.16

1.1

0.49

1.64

u/ml

—

Angina pectoris

285

1848

1.03

0.16

1.1

1.38

1.35

u/ml

0.02

117

902

Other and unspecified disease of Bartholin gland

158

1.14

0.16

1.2

1.1

4.01

2.88

u/ml

0.16

Congenital deformities of feet

302

1.10

0.16

1.1

1.2

4.10

3.42

u/ml

0.10

172

Symptoms and signs involving cognition, perception, emotional state and behaviour

1042

7005

1.01

0.16

1.1

1.40

2.11

u/ml

2.19

565

3481

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1122

7748

0.99

0.16

1.1

2.66

2.01

u/ml

0.85

628

3934

Injuries involving multiple body regions

302

1.09

0.16

1.1

3.42

2.64

u/ml

0.18

163

Other and unspecified haemorrhagic conditions

1.20

0.16

1.0

1.1

0.07

2.96

u/ml

—

Haemorrhagic and haematological disorders of fetus and newborn

598

0.94

0.16

1.3

3.51

3.29

u/ml

0.05

429

Manic episode

256

0.90

0.16

1.1

0.33

3.00

u/ml

3.38

134

Other disorders of skin and subcutaneous tissue, not elsewhere classified

853

0.95

0.16

1.1

1.43

2.18

u/ml

0.52

430

Injury of other and unspecified intrathoracic organs

339

0.91

0.16

1.2

1.1

3.58

2.21

u/ml

0.25

174

Other meningitis

111

1.17

0.15

1.0

1.1

1.13

4.18

u/ml

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

104

995

1.05

0.15

1.2

1.1

2.29

2.01

u/ml

0.12

466

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

351

1.08

0.15

1.1

1.87

1.84

u/ml

0.01

166

Injuries to the elbow and forearm

772

6887

0.98

0.15

1.1

2.85

2.25

u/ml

0.64

427

3542

Meningitis

359

0.92

0.15

1.2

1.1

1.08

2.82

u/ml

1.30

186

Bacterial, viral and other infectious agents

790

1.05

0.15

1.1

2.71

2.33

u/ml

0.13

412

Chorioretinal inflammation

161

0.87

0.15

1.1

0.58

2.64

u/ml

—

Optic atrophy

121

1.16

0.15

1.0

1.2

0.28

3.55

u/ml

—

Primary ovarian failure

207

1.11

0.15

1.1

0.39

2.64

u/ml

2.37

Benign neoplasm: Rectosigmoid junction

121

1.16

0.15

1.1

0.07

1.95

u/ml

—

Spondyloarthritis

156

1507

1.04

0.15

1.1

2.71

2.05

u/ml

0.21

736

Unspecified abortion

410

1.07

0.15

1.1

2.54

1.33

u/ml

0.22

207

Transitory endocrine and metabolic disorders specific to fetus and newborn

440

1.07

0.15

1.3

5.52

3.58

u/ml

0.29

319

Endometriosis diagnosis and infertility diagnosis occurring together

124

1288

0.96

0.14

1.1

1.92

2.09

u/ml

0.06

601

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

625

1.06

0.14

1.2

1.52

3.38

u/ml

1.56

379

Transient synovitis

1.19

0.14

1.0

1.3

0.40

3.61

u/ml

—

Torsion of ovary, ovarian pedicle and fallopian tube

217

1.11

0.14

1.1

1.66

2.71

u/ml

0.45

110

Benign neoplasm of thyroid gland

169

1.13

0.14

1.2

1.1

0.92

1.91

u/ml

0.52

Other eating disorders

849

0.95

0.14

1.2

1.1

1.88

3.16

u/ml

0.67

478

Conductive hearing loss, unspecified

625

1.06

0.14

1.1

2.02

2.54

u/ml

0.19

331

Complications following abortion and ectopic and molar pregnancy

198

1.11

0.14

1.1

0.61

1.12

u/ml

—

107

Malignant neoplasm of endocrine gland

491

0.94

0.14

1.0

1.1

1.75

2.75

u/ml

0.65

261

Other anaemias

213

2081

0.97

0.14

1.1

3.03

1.59

u/ml

0.75

111

1061

Ulcerative rectosigmoiditis

706

0.95

0.14

1.1

2.08

2.13

u/ml

0.02

344

Other necrotizing vasculopathies (FG)

233

0.90

0.14

1.0

1.1

3.48

2.10

u/ml

—

122

Hyperfunction of pituitary gland

538

1.06

0.14

1.2

1.1

0.37

2.57

u/ml

5.70

288

Other and unspecified glaucoma

179

1.12

0.14

1.1

0.30

2.10

u/ml

—

Other maltreatment syndromes

295

0.91

0.14

1.1

0.63

2.64

u/ml

2.62

148

Unspecified haematuria

240

1938

1.03

0.14

1.2

1.1

1.77

1.97

u/ml

0.12

118

986

Other necrotizing vasculopathies

295

0.91

0.14

1.1

2.81

1.90

u/ml

0.15

155

Degeneration of macula and posterior pole

162

1248

1.03

0.14

1.1

1.22

1.39

u/ml

0.14

624

Cardiodefibrillation

125

1293

0.96

0.14

1.1

0.89

1.41

u/ml

0.66

663

Malignant neoplasm of thyroid gland

439

0.93

0.14

1.0

1.1

1.79

2.53

u/ml

0.41

231

Hypocalcemia

122

1.15

0.14

1.2

1.1

0.66

1.71

u/ml

—

Other cataract

231

1794

0.97

0.13

1.1

0.96

1.62

u/ml

0.85

115

884

Foreign body in respiratory tract

441

1.07

0.13

1.1

4.59

3.07

u/ml

0.25

252

Bacterial meningitis

222

0.90

0.13

1.2

1.1

0.97

2.28

u/ml

0.73

118

Pacemaker

988

0.96

0.13

1.1

1.18

1.96

u/ml

0.49

530

Peripheral retinal degeneration

170

1.12

0.13

1.1

2.88

2.37

u/ml

—

Nutritional anaemias

357

3372

1.02

0.13

1.2

1.1

1.59

1.84

u/ml

0.19

193

1701

Diplopia

823

1.05

0.13

1.2

1.1

0.27

2.39

u/ml

7.28

405

Follow-up care involving plastic surgery

232

0.90

0.13

1.2

1.1

1.77

1.82

u/ml

—

113

Other and unspecified anaemias

211

2064

0.97

0.13

1.1

3.05

1.59

u/ml

0.76

110

1053

Other mental disorders due to brain damage and dysfunction and to physical disease

397

0.93

0.13

1.1

0.45

2.07

u/ml

2.69

206

Other disorders of the genitourinary system

561

0.94

0.13

1.2

1.1

1.53

1.71

u/ml

0.07

275

Burns and corrosions

148

1434

1.03

0.13

1.1

2.04

2.20

u/ml

0.08

774

Spasmodic torticollis

209

1.10

0.13

1.0

1.1

0.60

2.52

u/ml

1.72

107

Scar conditions and fibrosis of skin

335

1.08

0.13

1.1

0.19

3.36

u/ml

4.47

169

Used for control exclusion in common control thyroid runs

1385

6928

1.01

0.13

1.1

2.31

2.28

u/ml

0.03

698

3628

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

262

0.91

0.12

1.0

1.3

0.52

3.68

u/ml

3.83

173

Causalgia

123

1.14

0.12

1.1

0.06

1.66

u/ml

—

Parapsoriasis

123

1.14

0.12

1.1

1.50

3.55

u/ml

—

Other specific arthropathies, wide

123

1.14

0.12

1.1

1.65

2.40

u/ml

—

Premature separation of placenta [abruptio placentae]

258

1.09

0.12

1.1

4.07

3.18

u/ml

0.09

124

Monoarthritis, not elsewhere classified

287

1.08

0.12

1.1

1.24

2.80

u/ml

0.96

147

Complications of internal orthopaedic prosthetic devices, implants and grafts

874

1.04

0.12

1.1

0.85

1.91

u/ml

1.74

435

Sequelae of injuries of head

365

0.93

0.12

1.1

1.25

2.34

u/ml

1.02

189

Pustulosis palmaris et plantaris

262

0.91

0.12

1.1

0.87

2.34

u/ml

1.32

141

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

425

1.07

0.12

1.2

1.3

4.27

3.37

u/ml

0.13

307

Tuberculosis, wide

200

1.10

0.12

1.2

1.1

1.30

1.98

u/ml

—

Melanocytic naevi of scalp and neck

179

0.89

0.12

1.1

0.58

3.23

u/ml

—

Fall on same level

1456

8019

0.99

0.12

1.1

1.88

2.30

u/ml

0.80

807

4064

Bipolar affective disorders

226

2208

1.02

0.12

1.1

0.88

2.30

u/ml

5.14

120

1085

Pathological resorption of teeth

249

1.09

0.12

1.0

1.1

0.46

3.04

u/ml

2.95

131

Contact with other hot metals

114

1.14

0.12

1.1

7.23

2.40

u/ml

—

Specific personality disorders

293

2988

0.98

0.11

1.2

1.1

1.42

2.23

u/ml

1.47

165

1499

Pedal cyclist injured in other and unspecified transport accidents

104

1004

1.04

0.11

1.1

1.86

2.27

u/ml

0.19

511

Other dialysis

199

0.90

0.11

1.7

1.1

0.17

2.14

u/ml

2.55

121

Cerebral palsy and other paralytic syndromes

894

0.96

0.11

1.1

1.85

2.36

u/ml

0.25

473

Congenital malformations of the circulatory system

186

1759

1.03

0.11

1.1

1.2

3.42

2.56

u/ml

0.32

113

1040

Fetus and newborn affected by maternal complications of pregnancy

211

1.10

0.11

1.1

1.3

2.58

3.24

u/ml

0.10

159

Postpartum hemorraghe, all women as controls

390

3775

1.02

0.11

1.1

2.65

2.06

u/ml

0.43

177

1830

Abnormalities of gait and mobility

621

1.05

0.11

1.2

4.28

2.83

u/ml

0.31

339

Pneumonia derived septicemia

209

0.91

0.11

1.4

1.1

6.37

2.19

u/ml

0.44

115

Feeding problems of newborn

163

1.12

0.11

1.2

1.3

0.26

3.37

u/ml

2.32

131

Other disorders of fluid, electrolyte and acid-base balance

154

1507

0.97

0.11

1.1

1.28

1.98

u/ml

0.56

767

Cyst of Bartholin Gland

357

1.07

0.11

1.2

1.1

1.88

2.75

u/ml

0.31

171

Bicuspidal aortic valve syndrome

279

1.08

0.11

1.1

1.38

3.91

u/ml

1.55

167

Other inflammatory liver diseases

396

1.06

0.11

1.1

0.54

2.01

u/ml

2.10

204

Sixth [abducent] nerve palsy

153

1.11

0.11

1.0

1.1

0.19

2.03

u/ml

—

Exposure to smoke, fire and flames

157

0.89

0.11

1.1

6.10

2.55

u/ml

—

ILD medications: azathioprine

137

1410

0.97

0.11

1.2

1.1

1.66

2.65

u/ml

0.45

722

Other blood glucose lowering drugs, excl. Insulins

602

1.05

0.11

1.1

0.44

1.72

u/ml

3.08

309

Artificial joint operation, meniscal resection

720

4618

1.01

0.11

1.1

1.35

1.76

u/ml

0.77

354

2212

Coxarthrosis

289

1945

0.98

0.11

1.1

1.89

1.88

u/ml

0.00

126

885

Gonarthrosis [arthrosis of knee](FG)

606

3477

1.01

0.11

1.1

2.05

1.80

u/ml

0.22

312

1605

Enterobiasis

311

0.93

0.10

1.3

1.2

5.92

2.76

u/ml

0.48

179

Unspecified urinary incontinence

475

1.05

0.10

1.1

2.61

2.19

u/ml

0.15

259

Family history of certain disabilities and chronic diseases leading to disablement

593

1.05

0.10

1.1

3.05

2.48

u/ml

0.15

299

Abscess of Bartholin gland

270

1.08

0.10

1.1

1.94

3.47

u/ml

0.54

124

Benign leiomyoma with endometriosis

908

1.04

0.10

1.1

0.53

1.56

u/ml

2.59

429

Artificial joint re-operation

202

1.09

0.10

1.1

1.42

0.99

u/ml

0.20

Superficial injuries involving multiple body regions

208

0.91

0.10

1.1

3.07

3.39

u/ml

0.05

112

Other renal tubulo-interstitial diseases

177

0.90

0.10

1.1

0.75

1.82

u/ml

—

Diabetic maculopathy

577

1.05

0.10

1.1

1.49

1.59

u/ml

0.05

295

Second line medication for Crohn's disease

580

5869

0.99

0.10

1.1

2.42

2.04

u/ml

0.28

290

3002

Benign neoplasm of breast

871

0.96

0.10

1.2

1.1

0.59

2.06

u/ml

3.07

422

Total colectomy

290

0.93

0.10

1.1

0.29

2.50

u/ml

3.52

150

Total colectomy operation

290

0.93

0.10

1.1

0.29

2.50

u/ml

3.52

150

Personal history of certain other diseases

259

0.92

0.10

1.1

7.63

3.00

u/ml

0.29

139

Malignant neoplasm of other connective and soft tissue, including Hilmo

183

1.09

0.10

1.1

3.74

2.42

u/ml

—

Recurrent dislocation of patella

722

1.04

0.10

1.1

1.02

2.53

u/ml

1.64

355

Other psoriatic arthropathies

728

0.96

0.10

1.1

0.81

2.15

u/ml

2.05

355

Conductive and sensorineural hearing loss

594

3959

1.01

0.10

1.1

1.55

2.04

u/ml

0.55

292

1938

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

271

1.07

0.09

1.0

1.1

0.39

2.18

u/ml

2.39

141

Other surgical follow-up care

279

0.93

0.09

1.0

1.1

0.79

4.01

u/ml

3.08

148

Varicella [chickenpox]

673

1.04

0.09

1.1

1.2

4.05

3.05

u/ml

0.22

417

Von Willebrand disease

114

0.87

0.09

1.3

1.1

3.14

2.07

u/ml

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

237

0.93

0.09

1.1

4.52

1.25

u/ml

0.46

112

Pregnancy hypertension

532

4708

1.01

0.09

1.1

2.16

1.98

u/ml

0.15

237

2257

Osteonecrosis

291

1.07

0.09

1.1

0.36

1.52

u/ml

2.02

148

Dissociative [conversion] disorders

448

1.05

0.09

1.2

1.1

3.14

3.03

u/ml

0.02

227

Normotensive glaucoma

213

1.08

0.09

1.0

1.1

0.23

1.45

u/ml

1.64

106

Assault

168

1643

1.02

0.09

1.2

1.1

1.34

2.25

u/ml

1.23

108

845

Focal brain injury

340

1.06

0.09

1.2

1.1

0.90

2.52

u/ml

1.49

167

Liveborn infants according to place of birth

216

1.08

0.09

1.1

1.2

6.60

3.85

u/ml

0.34

141

Distal bite

779

1.03

0.08

1.2

6.92

3.79

u/ml

0.56

487

Behavioural disorders

349

0.94

0.08

1.0

1.2

0.80

3.34

u/ml

3.13

213

Benign neoplasm: Adrenal gland

341

1.06

0.08

1.1

0.64

1.98

u/ml

1.58

174

Benign neoplasm of urinary organs

175

0.91

0.08

1.1

1.58

3.05

u/ml

0.56

Arterial embolism and thrombosis

165

1.09

0.08

1.1

0.26

2.28

u/ml

2.23

Motor disorders

478

0.95

0.08

1.2

1.3

3.71

3.01

u/ml

0.15

355

Endometriosis of intestine

175

1.09

0.08

1.1

3.77

2.33

u/ml

0.16

Fracture of skull and facial bones

191

1947

0.98

0.08

1.1

0.94

2.06

u/ml

2.63

101

1009

Fracture of foot, except ankle

266

2618

1.02

0.08

1.1

1.98

2.40

u/ml

0.31

148

1326

Fungal Sepsis

175

1.09

0.08

1.2

1.1

0.87

1.39

u/ml

0.32

Duodenal ulcer

302

1.06

0.08

1.2

1.1

6.02

2.01

u/ml

0.57

151

All dysplastic lesions of the cervix uteri, vagina or vulva

393

3822

1.01

0.08

1.1

2.69

1.98

u/ml

0.61

190

1826

Infections of genitourinary tract in pregnancy

101

1038

0.97

0.08

1.2

1.1

4.42

2.10

u/ml

0.61

527

In situ neoplasms

246

2420

1.02

0.08

1.1

1.48

1.78

u/ml

0.26

127

1171

Brain meningioma

224

1.07

0.08

1.2

1.1

0.36

1.03

u/ml

1.13

113

Ankylosing spondylitis, strict definition

399

0.95

0.08

1.0

1.1

2.64

2.27

u/ml

0.06

198

Pyothorax

156

1.09

0.08

1.0

1.1

1.51

2.45

u/ml

—

Amiodarone users

297

0.94

0.08

1.1

0.24

2.19

u/ml

2.60

150

Medical treatment for female infertility

313

3153

0.99

0.08

1.1

1.81

1.94

u/ml

0.10

152

1511

Benign neoplasm of brain and other parts of central nervous system

419

0.95

0.08

1.1

2.42

2.64

u/ml

0.05

228

Disorders of puberty, all

382

1.05

0.07

1.1

1.2

6.28

3.79

u/ml

0.29

249

Molar incisor enamel hypoplasia, with caries

294

0.94

0.07

1.5

1.3

0.59

3.87

u/ml

3.39

219

Disorders of puberty

337

0.95

0.07

1.2

7.80

4.04

u/ml

0.38

218

All dysplastic lesions of the vulva

327

0.95

0.07

1.1

1.22

2.57

u/ml

—

162

Scissor bite

583

1.04

0.07

1.2

2.80

4.02

u/ml

0.39

376

Infections of breast associated with childbirth

461

1.04

0.07

1.2

1.1

0.60

2.51

u/ml

3.03

231

Osteoporosis with pathological fracture (FG)

184

0.92

0.07

1.2

1.1

0.19

1.63

u/ml

—

Congenital deformities of feet

471

1.04

0.07

1.1

3.11

3.24

u/ml

0.03

260

Other diseases of the digestive system

170

1731

0.98

0.07

1.2

1.1

2.51

1.73

u/ml

0.42

900

Benign neoplasm of other and unspecified endocrine glands

817

1.03

0.07

1.1

0.87

2.26

u/ml

2.21

405

Hyperkalaemia

153

0.91

0.07

1.0

1.1

2.26

2.28

u/ml

—

Gonarthrosis, primary, with knee surgery

264

2072

1.01

0.07

1.1

0.97

1.33

u/ml

0.59

127

967

Malignant neoplasm of thyroid gland, including Hilmo

501

1.04

0.07

1.0

1.1

1.43

2.68

u/ml

0.99

261

Unspecified jaundice

206

1.07

0.07

1.1

1.2

0.71

2.15

u/ml

—

113

Ovarian dysfunction

115

1125

1.02

0.07

1.2

1.1

1.38

2.62

u/ml

1.40

560

Acute and subacute iridocyclitis

152

1492

1.02

0.07

1.2

1.1

1.88

2.14

u/ml

0.12

728

Adhesive middle ear disease

128

1.10

0.06

1.1

0.25

3.30

u/ml

—

Optic atrophy

128

1.10

0.06

1.0

1.2

0.28

3.44

u/ml

—

Injury of nerves at wrist and hand level

285

1.05

0.06

1.0

1.1

1.13

2.50

u/ml

0.91

140

Orchitis and epididymitis

508

0.96

0.06

1.1

1.34

1.95

u/ml

0.35

271

Non-invasive ventilation

226

1989

1.01

0.06

1.1

1.40

2.04

u/ml

0.62

133

1007

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

European house dust mite IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS